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Practical everyday help to the busy European Practitioner
The challenge in our everyday working life is to provide medical care to companion animals based on 
the latest and best state of the art scientiﬁ c information. Every case is individual and unique. That’s 
why we never become bored in our profession. We acquire continuing education from our every day 
experience. Our knowledge grows with every case we see. Our university studies often seem very far 
away. A senior colleague once told me that getting the diploma/university degree can be likened to 
gaining a driving license. It gives us permission to improve our ability through our everyday work. 
Our increased knowledge not only results from our valuable personal experience. We must also keep 
our minds open to the newest advances in research. We must constantly synthesize and compare our 
personal experiences with state of the art knowledge gained from reading and other CE opportunities. 
We must reﬂ ect, discuss and stay critical. But who has the time to do this and at the same time work 
in a busy practice?   We have to struggle through the huge mass of available information, selecting 
if possible, the best scientiﬁ cally based practical information. Wouldn’t it be nice if we had an 
independent veterinary expert who objectively selects and peer-reviews information for us?  Well, we 
have this in the EJCAP! I am happy to rely on EJCAP for practical scientiﬁ c guidance in my very busy 
practising vet’s life. For me good examples of EJCAP’s guidance were the recent papers on medical 
heart therapy and the evaluation of in-house blood analysis: basic, scientiﬁ cally accurate, short, and 
practical! The knowledge that in the region of 30.000 companion animal practitioners all over Europe 
may well be gaining the same beneﬁ t as myself on this   subjects after reading the articles gives me a 
good feeling of a strong Europe wide veterinary community. Coming as I do from Luxembourg, one 
of the smallest countries in Europe without its own speciﬁ c national veterinary scientiﬁ c journal, 
I welcome very much the ability to stay well informed on topics that are important to European 
Veterinarians with the help of FECAVA and  EJCAP.
This vet-community will become even stronger when we can interact in the near future on our new 
FECAVA-internet-platform!
Katia Di Nicolo FECAVA Director, Luxembourg
Expertise. Practicality. Results.
Nutritional Management of
Skin and Gastrointestinal Hypersensitivities
ATOPIC DERMATITIS:
 Significant improvement in CADESI and pruritis scores.  
 Superior results vs compared veterinary hypoallergenic diets.1
HOME-COOKING:
 Significant better performance of Dermatosis Fish & Potato than  
 home-cooked fish & potato diet in dogs with atopic dermatitis.2
PERIANAL FISTULAE:
 Successful treatment with surgery + long-term dietary management. 
 Considerably less complications compared to previous reports.3
1. The efficacy of commercially available veterinary diets recommended for dogs with atopic dermatitis. Glos K, Linek M, Loewenstein C, Mayer U, Mueller R. 
Journal of Veterinary Dermatology 2008; 19: 280-287
2. Efficacy of an essential fatty acid-enriched diet in managing canine atopic dermatitis: a randomized, single-blinded, cross over study. Bensignor E, Morgan DM 
and Nuttall T. Journal of Veterinary Dermatology 2008; 19: 156-162
3. Long-term evaluation of canine perianal fistulae disease treated with exclusive fish and potato diet and surgical excision. Lombardi RL & Marino DJ. JAAHA 
2008; 44: 302-307
Dermatosis Fish & Potato
winning through Evidence Based Medicine
290123_Adv_Dermatosis_FP.indd   1 10-02-2009   16:01:41
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FECAVA NEWS
Simon Orr, FECAVA Vice 
President reports:    
Education
Veterinary Teaching 
Establishments
From the FVE Newsletter - December 2010
Evaluation: currently 48 out of 100 
schools ‘approved’
Professor László Fodor, president of the 
European Association of Establishments 
for Veterinary Education (EAEVE), guest 
speaker at the November General 
Assembly of the Union of European 
Veterinary Practitioners, gave an update 
on the evaluation of veterinary schools.  
The EAEVE now had 100 member schools 
in 34 countries. At the time of his 
presentation 48 of the 100 veterinary 
teaching establishments were approved. 
He explained the background of the 
evaluation system and the detailed 
functioning of an evaluation visit. In 2010, 
19 establishments had been visited, and 
11 were planned for 2011. Updating the 
standard operation procedures, the 
visiting expert list and an improved 
harmonisation of visits were among the 
goals during his mandate, Professor 
Fodor added.
Legislation
From the FVE Newsletter – December 2010
Illegal puppy trade now a 
criminal offence in Italy
The illegal trade of pets is now an 
officially recognised crime under the 
Italian Legal System. Three to 12 months’ 
imprisonment and a €3,000 to €15,000 fine 
can be expected by anyone who 
repeatedly or as an organised activity 
introduces, sells or buys dogs or cats 
without identification (microchip or 
tattoo), and without the required health 
certificate and/or passport. Individual 
buyers and single offenders will also be 
pursued under the Illegal Introduction of 
Pet Animals. The penalty varies from 
€100 to €1000 for every dog or cat 
introduced in Italy without identification, 
and from €500 to €1000 for every dog or 
cat carried or sold without the required 
Health Certificate and/or the European 
Pet Passport.  In both cases, the penalty 
will be raised if the pets are under 12 
weeks of age or come from areas with 
restrictive veterinary measures.
Callisto project
The “CALLISTO” project proposal 
(Companion animals multisectorial 
interprofessional interdisciplinary 
strategic think tank on zoonoses) was 
finally submitted to the European 
Commission Directorate General for 
Research & Innovation at the end of 
January. The aim of the project is to 
identify knowledge and technology gaps 
in the management of the most important 
zoonoses transmitted by companion 
animals as well as to propose targeted 
actions that contribute to reduce the risk 
for infectious disease outbreaks in 
humans and food producing animals 
associated with keeping companion 
animals.
We are grateful to FVE for supplying this 
report
PSAVA appoints 
new Director to 
FECAVA
Dr. Blimke is the next President of PSAVA 
(Poland) and our new FECAVA Director.
Animal welfare
From the FVE Newsletter – December 2010
EU-wide identification 
& registration of pets 
“feasible and necessary”
A joint statement on identification and 
registration of companion animals in the 
European Union was released on 12 
November 2010 by representatives of 
National, EU and International 
organisations working on databases for 
companion animals 
(http://www.carodog.eu/)
 
The signatories stressed that 
“identification, registration and traceability 
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are essential tools to promote the responsible 
ownership of companion animals” and that a 
compatible system of data management is 
“feasible and necessary”. They call for the 
establishment of a Europe-wide 
registration of companion animals. 
Mandatory identification, registration 
and traceability would not only support 
minimising the risk of zoonoses and 
constitute an important aspect of One 
Health, but would also enable efficient 
reuniting of pets and owners.  The 
signatories of the statement agreed that 
this process, rather than leading to 
increased bureaucracy and costs, would 
actually simplify many procedures and 
save taxpayers’ money at the local and 
national level, facilitating the reunion of 
lost pets with their families. European-
wide compatible systems of data 
management should be further 
developed, and established. Veterinarians 
should play a key role giving a 
professional approach to identification 
and registration, education of the public 
and promotion of this message. From 
January 2010, CAROdog (Companion 
Animal Responsible Ownership – Dog) 
will issue a monthly newsletter and hold 
regular webinars.
Companion animals 
“to be included in 
AW Action Plan”
From the FVE Newsletter – December 2010
“An effective and reliable system of dog 
registration is crucial for successful animal 
health and welfare management, not only to 
reunite stray dogs with their owners, but also 
to help prevent illegal puppy trading and to 
promote responsible ownership”. So said 
Christophe Buhot, FVE vice president, 
capturing the opinion of those present at 
the conference “Responsible Dog Ownership 
in Europe” held in Brussels on the 4th and 
5th October 2010. The conference, 
organised by CAROdog (Companion 
Animal Responsible Ownership – Dog), 
an initiative of “Four Paws” and Istituto 
G. Caporale, attracted 100 participants 
from over 25 countries. They represented 
European and National institutions, 
International Organisations, NGOs, 
private sector and Veterinary 
organisations.  Regarding canine 
overpopulation, there was also a broad 
consensus that this should be addressed 
by the prevention of unwanted puppies, 
control of stray dogs and responsible dog 
ownership.  The conference also called 
for institutional action, urging the 
Council of the EU to recognise the 
importance of companion animal welfare 
as a relevant issue for EU legislation, 
while the EU Commission should include 
references to companion animals in the 
second Animal Welfare Action Plan.  
Areas for action, according to the 
conference conclusions, include the 
regulation and licensing of breeding and 
trade, EU-wide compatible identification 
and registration. “Without registration, 
identification is of little value and traceability 
is an important tool to fight diseases and to 
protect welfare.”, Christophe Buhot 
stressed, calling for a mandatory pet 
identification, registration in a national 
database and the transmission of ID 
numbers to a central European database. 
FVE is an active project partner of 
CAROdog.
European Board 
for Veterinary 
Professional 
Development
From Andrew Byrne FECAVA Senior Vice 
President
The last General Assembly/Council 
meetings of the Federation of 
Veterinarians of Europe (FVE), the Union 
of European Veterinary Practitioners 
(UEVP) and FECAVA approved the 
formation of an interim European Board 
for Veterinary Professional Development 
(EBVPD). The function of this board is to 
oversee the introduction of the 
Acknowledged Veterinarian programmes 
and to explore harmonization of CPD 
points in Europe. This board will 
comprise a representative from the main 
veterinary organisations i.e. FVE, UEVP, 
FECAVA, the European Board of 
Veterinary Specialisation (EBVS), the 
European Association of Establishments 
for Veterinary Education (EAEVE) and 
the statutory bodies. The interim board 
hopes to convene in the spring of this 
year and will establish its statutes and 
objectives. 
The FECAVA Working Group on 
Postgraduate Education has begun 
working on developing a structure for the 
Acknowledged Companion Animal 
Veterinarian programme and has begun 
a consultation process with its member 
associations. 
FECAVA will report regularly on the 
progress on this education initiative.
FECAVA Working 
Group on Hygiene 
and the Use of 
Antimicrobials in 
Veterinary Practice
From Alexandra Vilén
Chair of Working Group on Hygiene and the 
Use of Antimicrobials in Veterinary Practice
2010 was certainly an exciting year for 
this working group. Not only did the 
group release a poster with hygiene 
guidelines but also several of the group 
members have been giving lectures 
throughout Europe on the topic of 
veterinary hygiene as well as on the use 
of antimicrobials. The Group was 
instrumental in organising the FECAVA 
Symposium 2010 ‘Hygiene and 
Antimicrobial Resistance’ which was 
held during the FECAVA Eurocongress 
held in Geneva last June. Papers from the 
symposium are published in full in this 
issue.
The interest from different organisations 
and companies wishing to become 
associate members of this group is 
growing and clearly shows the 
importance of this kind of work. The 
group consists not only of FECAVA 
directors but also external experts from 
different fields and this creates a 
dynamic and skilled group. So far, the 
main task has been to provide hygiene 
guidelines for veterinary practitioners in 
Europe.
The FECAVA hygiene poster (see p 86)
that was released during 2010 can be 
downloaded for free from the FECAVA 
website http://www.fecava.org/files/981.
pdf
There are several FECAVA member 
associations currently working on 
translations of the poster to provide their 
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Many distinguished speakers, including 
WVA President Tjeerd Jorna, OIE Director 
General Bernard Vallat, WHO General 
Director Margaret Chan, and FAO 
Director General Jacques Diouf took the 
floor and highlighted the importance of 
veterinary medicine for the health and 
welfare of animals and people. Also 
UNESCO and IUCN (the international 
Union for Conservation of Nature) 
emphasized the role they see for the 
veterinary profession.
Although very important, the support of 
these influential people alone will not be 
enough to ensure the future of the 
veterinary medicine. Crucial will be how 
much we will be able to convey the 
message to the public at large and to gain 
and keep their support. Vet-2011 offers a 
unique opportunity to communicate 
about the importance of ensuring the 
health and welfare of animals and 
people.
Interesting therefore is the launch of 6 
video clips about the different aspects of 
the veterinary profession.
http://ec.europa.eu/dgs/health_
consumer/information_sources/world_
vet_year_2011_en.htm
Another funny video clip announces a 
photo competition organised by the 
European Commission.
http://www.youtube.com/
watch?v=pbGVq-wTPQc
At this moment Vet-2011 comprises 1040 
corresponding members in over 119 
countries. In 42 countries all Vet-2011 
initiatives are coordinated by a national 
Vet 2011 committee. Don’t miss it. A very 
informative website provides all kinds of 
members with the information in their 
own language. The Greek association is 
the first one to have finished this task but 
more will be available during the first 
months of 2011. If you wish your 
association to translate the poster please 
contact the Director of your national 
association.
The future aim for the working group is 
to continue the work with hygiene 
routines and the responsible use of 
antimicrobials. We want to improve the 
European veterinarian’s awareness of 
these matters as well as provide tools to 
implement a healthy approach for 
practitioners.
Vet-2011: the 
future of veterinary 
medicine
“Happy birthday and my very best 
wishes for the next 250 years”. With these 
words Mr John Dalli, EU Commissioner 
for “health and consumers” formally 
opened the celebration of World 
Veterinary Year Vet-2011.
The opening ceremony took place at the 
historical site of Versailles, the former 
residence of the French kings. It was here 
that 250 years ago Mr Claude Bourgelat 
managed to convince King Louis XV to 
set up the first veterinary school: a 
landmark in the development of 
veterinary education and the veterinary 
profession. Claude Bourgelat also 
promoted comparative pathobiology, the 
foundation of our current One Health 
concept.
information related to Vet 2011
http://www.vet2011.org. Not surprisingly 
the number of visitors has to the Vet-2011 
web site has gone up enormously over the 
last few months.
We are grateful to FVE for supplying this 
report.
European Pet Night 
2011
From Monique Megens
Honorary Secretary FECAVA
As a partner association, FECAVA joined 
the European Pet Night for the second 
year. EU decision makers, animal welfare 
non-governmental organisations, the 
animal health industry, veterinarians and 
pet owners gathered for this event in 
Brussels’ Bibliothèque Solvay to highlight 
the importance of pets. This year tribute 
was paid to the many ways in which 
animals assist humans and the work of 
dogs trained to rescue survivors after 
natural disasters was showcased.
Member of Parliament Dr. Schnellhardt, 
who himself is a veterinarian, welcomed 
the November 2010 Council of the 
European Union conclusions on the 
welfare of cats and dogs: “For the first 
time, the Member States have recognised the 
need to introduce more guarantees for the 
welfare of our four-footed and feathered 
friends. I wholeheartedly welcome this 
development and hope that the many 
organisations participating in tonight’s event 
see it as recognition of their diligent work 
delivered year in, year out”.
Member of Parliament I.G. Perez said 
“The fact that the Council now has called for 
promotional and educational campaigns for 
responsible pet ownership is a very important 
step forward in raising public awareness of 
these matters.”
The event was well organised by 
IFAH-Europe, the representative body of 
manufacturers of veterinary medicines, 
vaccines and other animal health 
products. At the reception afterwards 
special interest was shown in FECAVA’s 
documents on the economic importance 
of companion animals and the Health 
benefits (socioeconomic value) of 
companion animals. It was an excellent 
opportunity for FECAVA to have direct 
exchanges with partner organisations 
and EU decision makers.
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Members of the WSAVA One Health Committee at the inaugural meeting: (L-R): 
J. Kirpensteijn, M. Lappin, M. J. Day [Chair], C. Rubin, C. Palatnik-de-Sousa, C. Khanna.
WSAVA Enters into 
Agreement With Kenes as 
Core Professional Congress 
Organizer
During the Sao Paulo 2009 WSAVA 
Assembly Board meeting, the Assembly 
members voted to revise the method of 
bidding for and hosting the annual 
WSAVA Congresses. The result was that 
WSAVA has entered into a partnership 
agreement with Kenes, one of the largest 
and  Internationally diverse PCOs, 
following an extensive PCO review 
process. The agreement  will see Kenes 
centrally administer WSAVA Congresses, 
beginning in 2014, in partnership with 
the local host bidding association, 
thereby building on and strengthening 
the reputation of WSAVA Congresses as 
culturally unique with cutting-edge 
scientific sessions. The bidding process 
will also follow a set region-to-region 
approach, beginning with Capetown, 
South Africa (Europe and Africa) in 2014, 
Asia and Oceania in 2015, and the 
Americas (South and North) in 2016. 
WSAVA One Health 
Initiative
The WSAVA One Health Committee 
(OHC) held its inaugural meeting over 
two days preceding the NAVC meeting in 
Orlando, Florida in January 2011.  The 
OHC was launched officially at the 2010 
Geneva WSAVA/FECAVA Congress and 
the core members of the committee are: 
M.J. Day [Chair; University of Bristol, UK]
J. Kirpensteijn [WSAVA Board; Utrecht 
University, the Netherlands]
A. Thiermann [OIE; Paris, France]
C. Rubin [CDC; Atlanta, USA]
M. Lappin [Colorado State University, 
USA)
S. Cleaveland [Glasgow University, UK]
C. Khanna [NIH; Maryland, USA]
C. Palatnik-de-Sousa [Federal University 
of Rio de Janeiro, Brazil]
U. Karkare [Practitioner Representative; 
Mumbai, India]
At the January meeting, the OHC 
considered that there were three key 
areas of One Health with which it should 
engage: (1) the human-companion animal 
bond, (2) comparative and translational 
medicine and (3) zoonotic infectious 
disease. 
The initial focus of the committee would 
be in the area of zoonotic infectious 
diseases.  There are already many 
excellent initiatives related to key 
zoonotic diseases (in particular rabies) 
and the committee would endorse and 
support such initiatives.
The WSAVA OHC has already had one 
review paper published (Veterinary Record 
2010 167: 847) and has another in press 
(Parasites and Vectors).  The committee will 
be presenting two papers at the 1st 
International One Health Conference in 
Melbourne, Australia in February 2011, 
ensuring that companion animals are 
strongly represented in this first truly 
global discussion of One Health.
The work of the WSAVA OHC is made 
possible by a consortium of industry 
sponsors who have contributed to the 
WSAVA Foundation specifically to fund 
this project.  The OHC is grateful to our 
sponsors who include at the time of 
writing (in alphabetical order): Bayer 
Animal Health, Hills Pet Nutrition, 
Intervet-Schering Plough Animal Health, 
Merial, Nestlé Purina, Novartis Animal 
Health, Pfizer Animal Health, Waltham 
and the WSAVA itself.
Save the dates! 
WSAVA 2011 Jeju World Congress, 
October 14-17, 2011 in Jeju, Korea. For 
more information, including scientific 
programme and registration, please visit 
the Congress website at 
http://www.wsava2011.com/ 
Future Congresses:
•  Birmingham, England April 12-15, 
2012 (with FECAVA)
•  Christchurch, New Zealand March 
6-9, 2013 
•  Capetown, South Africa - Date to be 
confirmed
How to contact the FECAVA 
Office and Secretary
Our secretarty is Ulrike Tewes. 
You can contact Ulrike:
By phone : +32 (0)2 533 70 20
By e-mail : ulrike@fve.org
The office is open from 8.30 am  
to 4.30 pm Monday to Friday.
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UEVP NEWS
Report on the 
general assembly 
of the Union of 
European Veterinary 
Practitioners
Our last meeting took place in Brussels 
on 11th November 2010 and was well 
attended by the twenty five member 
countries that comprise the UEVP.
Our aim is to represent the interests of 
veterinary practitioners throughout 
Europe in whatever capacity that they 
work. This means good cooperation with 
the other sections of the Federation of 
Veterinarians in Europe – EVERI which 
represents education, research and 
industry; UEVH who represent 
hygienists and public health; EASVO 
which is the section representing state 
officers. 
As usual we had a full agenda which 
included a joint session with EVERI on 
educational issues.
We received a presentation by Professor 
Laszlo Fodor the Dean of Budapest 
Veterinary School, who is the current 
President of EAEVE, on the working and 
current situation of the inspection of 
veterinary schools throughout Europe.  
This is based on Directive 2005/36/EC 
(which is under review) and is a 
voluntary inspection but EAEVE and 
FVE are trying to be recognised by ENQA 
in order to give the inspection a legal 
standing.
We also heard the interim results on the 
questionnaire, designed by FECAVA, on 
the availability of post-graduate 
qualifications in Europe, which was 
disseminated after our last GA. This 
shows that only one third of the 19 
responding countries had a formal post 
graduate qualification available to 
practitioners.
Our aim is to encourage the design of a 
European post graduate qualification 
referred to as the ‘acknowledged vet’ and 
to quantify CPD so that it becomes a 
known quality and is transferrable 
between countries.
A session on practice economics will now 
be a regular feature at our GA. Some 
practice turnover figures were given from 
France, UK, Netherlands and Germany.
It would appear that all countries are 
seeing a reduction in income in real terms 
with Germany being little affected whilst 
horse work in the Netherlands and large 
animal work in France being the worst 
affected. There were signs that there was 
a slight recovery in 2010 on figures from 
2009 but less than the rate of inflation.
A questionnaire has been disseminated 
asking our member countries what are 
the main problems facing veterinary 
practice. It is important for our 
organisation to recognise common 
problems, such as the working time 
directive and availability of medicines, in 
order to place them in perspective and to 
assist in findings solutions.
We had a presentation by René 
Beaumont, a Senator from Bourgogne in 
rural France, on the state of veterinary 
work in France.  Although he reported 
that 30% of registered veterinary 
surgeons were still working in rural 
regions this is declining and is of 
concern. They are trying to encourage 
younger members of the profession to 
work in rural areas by giving them 
financial incentives such as higher fees 
and an improved interpretation of the 
veterinary act.
There were several other issues reported 
on Medicines, Animal Welfare and 
radiological protection.
All presentations are available on the 
UEVP website.
Andrew Robinson
UEVP General Secretary
www.fecava.org 
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Patients with respiratory distress are, regardless of the underlying cause, emergency patients and the initial 
approach to these patients determines prognosis and survival. Animals with respiratory distress are stressed which 
makes most diagnostic procedures impossible or counter-productive. By localising the respiratory problem using the 
initial clinical exam of the animal, the clinician can narrow down the causes of respiratory distress. Looking at the 
type of breathing, type of dyspnoea and using auscultation findings and information from the history, the problem 
can be localised, limiting possible differential diagnoses. This allows institution of not only supportive measures 
such as oxygen supplementation, stress-free handling or analgesia but also a more specific therapy of the problem 
causing respiratory distress. The stabilised animal can then undergo further diagnostic procedures and receive 
specific treatment. 
Key words: respiratory distress, emergency stabilisation, thoracocentesis, oxygen
INTRODUCTION
This paper originally appeared in: 
Kleintierpraxis* 55, 2, (2010), 85-96 #
13
CRITICAL CARE
Introduction
The rapid identification of life-threatening emergency conditions 
in small animals followed by immediate stabilisation can be 
lifesaving. Stabilisation is concentrated on the maintenance 
of respiration and circulation. The acronym ABC  – Airway-
Breathing-Circulation – is used in both veterinary and human 
medicine for the resuscitation of patients with cardiopulmonary 
arrest [Mitka 2003]. Compliance to this order of stabilisation 
is recommended for all emergency patients. The prompt 
identification of life threatening conditions requires a routine 
approach  and a so-called “horizontal case management”: 
medical history, short physical examination, initial diagnostic 
tests and treatment modalities are evaluated and instituted 
not consecutively, but concurrently to allow for immediate 
stabilization of the patient [Aldrich 2005]. The measures, 
however, focus primarily on the stabilisation of the patient and 
not on the complete diagnosis and specific treatment (unless 
the diagnosis is obvious). The following review article therefore 
primarily focuses on measures to stabilize the emergency patient 
with respiratory distress. 
Respiratory distress or dyspnoea is a condition of lack of air, 
which a sick person feels at rest or during mild exercise 
[American Thoracic Society, 1999]. Although the perception of 
a feeling of breathlessness cannot be proven in animals, one 
must assume that animals feel similar to humans. In veterinary 
medicine, dyspnoea is defined as the patient showing clinical 
signs of respiratory distress that are associated with a feeling 
of breathlessness in people. The clinical signs in animals as 
well as humans include tachypnoea, orthopnoea, open mouth 
breathing, increased abdominal breathing effort, abnormal 
breathing patterns or chest movements, laboured breathing 
and / or cyanosis [American Thoracic Society, 1999]. Respiratory 
distress may result from hypoxia, hypoventilation or breathing 
associated with an increased effort, or pain. A simple and 
effective means to assess the respiration of the veterinary 
patient, is the imitation of the respiration of the animal by the 
(1) Department of Clinical Veterinary Medicine, Vetsuisse Faculty of Bern and Veterinary Emergency and Critical Care Continuing Education 
Länggasstrasse 128 CH-3012 Bern  E-mail: nadja.sigrist@kkh.unibe.ch
* Presented by SVK/ASMPA (Switzerland)
# Copyright permission gratefully received from M. & H. Schaper GmbH, Kleintierpraxis - www.vetline.de/zeitschriften/ktp  
RepRint papeR (CH)
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veterinarian himself. In most cases, after a very short time, it is 
clear whether the animal’s breathing is normal or abnormal and 
whether it is associated with dyspnoea or not. 
Signalment
Respiratory distress is not associated with species, breed or age. 
These parameters can though be helpful to include or exclude 
certain differential diagnoses. Paediatric animals and small 
mammals show physiologically an increased respiratory rate.
History
The duration of symptoms and their progression can provide 
information regarding diagnosis and treatment. Information such 
as progress and details of any previous therapy (self-treatment 
by the owner or therapy initiated by another veterinarian), 
pre-existing disease or related symptoms (heart disease), and 
the possibility of a trauma must be obtained from the owner. 
Questions regarding the previous history are important even with 
severe difficulty in breathing, because this information may be 
useful for emergency treatment [Silverstein and Drobatz, 2005]. 
A short history can be obtained while the patient’s breathing is 
observed and the animal is being supported with oxygen.
Following primary stabilisation of the patient, a complete history 
regarding vaccination and deworming status, stays abroad, 
frequency and nature of cough, etc. are important for further 
diagnostic examinations and treatment. A cough can be dry 
or moist and the latter  is often confused with gagging by the 
owner. Nocturnal cough is more likely associated with a disease 
of the lower respiratory tract (accumulation of fluid while lying), 
while upper airway disease can be expected with a history of a 
cough associated with excitement or pull on the collar. The broad 
direction of further diagnostic exams can often be defined on 
the basis of the prevailing cardinal symptoms.
Primary survey
The initial physical examination of the emergency patient 
should give an overview of the function of vital organs including 
the lung, the cardiovascular and the central nervous systems. 
The evaluation of the respiratory tract includes the evaluation 
of respiratory rate, respiratory type, presence and type of 
dyspnoea, lung and heart auscultation with concurrent pulse 
quality assessment, and identification of obvious external injuries 
to the trachea and thorax [Snyder, 2003; Tseng and Waddell, 
2000]. Patients with respiratory distress must be supplemented 
with oxygen even during the short primary survey and should 
be examined in as stress-free manner as possible [Tseng and 
Waddell, 2000; Rozanski and Chan, 2005]. The animals should 
be allowed to adopt the preferred position themselves. 
The type of dyspnoea may be inspiratory, expiratory or 
mixed. The type of respiration may be fast and shallow, with 
increased effort, or asynchronous, and provides the most useful 
information for the anatomical localization of the problem. 
With asynchronous breathing, the chest and abdominal wall 
movement during inspiration is not synchronized. The initial 
clinical survey should also assess the posture of the animal. 
An extended neck or abducted elbows are signs of severe 
respiratory distress. Cyanotic mucous membranes are associated 
with a massive increase in deoxygenated haemoglobin (> 3-5 g / 
dl). A clinically apparent cyanosis is therefore a sign of significant 
hypoxaemia although a normal mucous membrane colour 
does not exclude hypoxemia, as the presence of cyanosis is 
haemoglobin dependent [Petrie 2005]. Auscultation results will 
help to further localize the problem. All lung fields as well as the 
heart should be thoroughly auscultated. Increased, decreased, 
missing or moist lung sounds may be identified. 
If the patient is stable enough, palpation of the cervical trachea, 
laryngeal inspection, chest percussion, abdominal palpation and 
the evaluation of mucosal colour and moisture may also provide 
important clues to the cause of dyspnoea. Obvious injuries are 
usually identified without palpation depending on the length 
and condition of the fur, smaller penetrating chest injuries, or 
emphysema are only evident on palpation of the chest wall. 
Precipitation of cough by palpation of the trachea and / or 
the larynx can locate the problem in this region. Results from 
abdominal palpation, such as an “empty abdomen” due to a shift 
of abdominal organs into the thoracic cavity with diaphragmatic 
hernia, ascites or a space-occupying lesion, which lead to impaired 
ventilation, should also be included in the problem-oriented 
diagnostic workup of patients with respiratory distress. 
Emergency stabilisation
Oxygen supplementation, stress free handling of the patient 
and adequate analgesia for painful patients should be instituted 
prior to the clinical examination in any animal with respiratory 
distress. Specific, acute emergency measures such as a 
tracheostomy, thoracocentesis or medical stabilization options 
are discussed under the appropriate localization or differential 
diagnoses, respectively. 
Oxygen is the treatment of choice for all patients with 
respiratory distress as all possible causes respond to oxygen 
supplementation to some degree [Camps-Palau, 1999]. Initially, 
oxygen may be applied with 5-15 l / min rate by mask or flow-
by (Fig. 1). If an oxygen cage is available, small pets can be 
transferred directly from the transport basket into the oxygen 
Figure 1: Oxygen supplementation by flow-by
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cage [Mandell, 2004].  The primary examination including 
palpation and auscultation of the thorax may be conducted with 
the animal in the oxygen cage. Subsequently, it is more practical 
to place a nasal oxygen tube or apply oxygen by an oxygen tent 
made out of a half-covered e-collar [Tseng and Drobatz, 2004]. 
The oxygen flow is 100 ml / kg / min for the nasal oxygen tube 
(1-2 l / min for cats and small dogs, 2-3 l / min for medium dogs 
and 4-6 l / min for large dogs) [Fitzpatrick and Crowe, 1986] and 
200 ml / kg / min for the oxygen tent (2-8 l / min) [Crowe, 1995]. 
Stress leads to an additional increase in oxygen consumption 
and should be avoided at all costs. Animals should be able to 
determine their position themselves and should not be forced in 
a lateral or supine position, or be restrained [Lee and Drobatz, 
2004]. 
With evidence for an upper airway obstruction, such as 
inspiratory dyspnoea, stridor or respiratory movements without 
an obvious exchange of air, the airways must be secured [Lee 
and Drobatz, 2004]. 
Pain can intensify or cause the symptoms of respiratory distress 
(e.g., rib fractures, sternal luxation). Trauma patients especially 
should be promptly and adequately covered with analgesics 
[Sigrist, 2004]. Opioids such as methadone, butorphanol, or 
fentanyl are preferred, as these are short effective, titratable 
and reversible (Table 1). All opioids cause some degree of 
respiratory depression, which, however, at low doses has no 
effect clinically [Campbell et al., 2003]. Butorphanol leads to 
less inhibition of respiration, but has also a less potent analgesic 
effect and is therefore more likely indicated for sedation [Plumb, 
2004]. If sedation is required in addition to an analgesic effect, 
the above-mentioned opioids can be combined with low-dose 
acepromazine (0,005 mg/kg). However, any sedation may lead 
to further respiratory depression and failure of compensatory 
mechanisms [Perkowski, 2004]. In this case, intubation and 
ventilation are mandatory and the appropriate equipment should 
have been prepared prior to sedation: cuffed endotracheal tubes 
in various sizes, stylet, functional laryngoscope, gauze, syringe 
to inflate the cuff, securing strap and possibly lidocaine spray. 
Animals with agonal breathing must immediately be intubated 
and mechanically ventilated [Cole, 2002]. 
To perform mechanical ventilation, an airway must be 
established. The pharynx is cleared of any blood, saliva, or 
gastric contents and obvious foreign bodies are removed. 
Long surgical clamps are especially helpful in doing so. 
Animals with agonal breathing may bite uncontrollably and 
the throat should never be attempted to be cleared using the 
fingers. If orotracheal intubation is not possible immediately, 
an emergency tracheotomy must be performed. If the 
airways are clear, the animal is intubated. The choice of 
a perfectly sized endotracheal tube is less important than 
immediate intubation, as the placement of a too small tube 
is less problematic than needlessly losing time searching for 
the perfect tube. However, the endotracheal tube should 
be cuffed and the cuff must be inflated after intubation 
in order to allow mechanical ventilation. Intubation should 
preferably be carried out under visual control to ensure 
an endotracheal intubation. After intubation, the animal 
is ventilated 2-3 times (using an Ambu bag or by mouth-
to-tube ventilation) and is then - if not already in place 
– connected to an Ambu bag or an anaesthetic machine 
supplemented with 100% oxygen. The recommended 
respiratory rate is 10-20 breaths per minute. Ventilation 
should achieve normal chest wall excursions, without 
having to apply too much pressure. If orotracheal intubation 
has not been performed under direct vision, correct tube 
positioning has to be confirmed by auscultation of lung 
sounds bilaterally.
Drug Brand name Dosage effect
Acepromazine Prequilan®, Fatro S.p.A., I 0.005 mg/kg i. v. / i. m. Sedation
Beclomethasone Beconasol®, GlaxoSmithKline, GB 1 puff locally Decreases swelling
Butorphanol Morphasol®, Dr. E. Graeub AG, CH 
Alvegesic®, Virbac, CH others
0.2 mg/kg i. v. / i. m. / s. c. Analgesia (40 minutes), 
sedation (2-4 hours)
Dexamethasone various 0.25 mg/kg i. v. Anti-inflammatory, decreases 
swelling
Fentanyl various 2−5 μg/kg i. v. / i. m. Analgesia (20 minutes)
Fluticasone Axotide®, GlaxoSmithKline, GB 
others
44−220 ug inhalation BID Steroid, decreases swelling
Furosemide various 1−2 mg/kg kg i. v. / i. m. / s. c. Diuresis  decreases 
hydrostatic pressure
Methadone various 0.1-0.2 mg/kg kg i. v. / i. m. Analgesia (1-2 hours)
Salbutamol Ventolin®, GlaxoSmithKline, GB 108 ug (1 puff) by inhalation 
as often as required
Selective local bronchodilator
Terbutaline Bricanyl®, AstraZeneca, CH 0.01 mg/kg i.m/s.c every 
4 hours
Selective bronchodilator
Theophylline Euphillin®, Nicomed Pharma AG, CH 4 mg/kg slowly i. v. / i. m. Bronchodilator (non-selective)
Table 1: Emergency drugs for patient with respiratory distress
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If orotracheal intubation is delayed for any reason, the animal 
can be ventilated mouth-to-nose (with closed mouth). The 
oesophagus is compressed by grasping the anterior neck 
caudal to the larynx with one hand, ensuring that air applied by 
ventilation does not enter the stomach. However, this method is 
not a substitute for intubation, as some of the air is always lost 
and the oxygen concentration of the air is less than 20%. After 
securing the airways and instituting ventilation, cardiac arrest is 
identified by assessing the heart beat and pulse. In the absence 
of a femoral pulse and a lack of heart sounds, external cardiac 
compressions are started. External cardiac compressions are –in 
contrast to humans- performed in right lateral recumbency.  
If the animal shows severe respiratory distress or cyanosis despite 
oxygen supplementation, analgesia, and initial stabilization 
measures according to the localization of dyspnoea, the animal 
should be intubated and ventilated before respiratory and 
cardiac arrest occurs [King and Hendricks, 1994; Campbell and 
King, 2000]. Orotracheal intubation requires an unconscious or 
anaesthetized patient. The anaesthetic protocol chosen should 
include drugs that enable rapid intubation, such as propofol 
or etomidate. The dosage is chosen to effect. Whenever 
possible, intravenous access should therefore be achieved after 
the initial stabilization. An iv access will enable administration 
of drugs such as analgesics or sedatives and allows induction 
of anaesthesia followed by intubation and ventilation in case 
of worsening breathing [Lee and Drobatz, 2004]. Again, the 
goal should be that the animal is not stressed when placing 
an intravenous catheter and to provide supplemental oxygen 
during the procedure.
Intubation and ventilation with 100% oxygen have the great 
advantage that ventilation is maximally controlled and the 
animal can be monitored, so that further investigations can be 
carried out without stressing the animal. 
Localisation of the respiratory problem 
and specific therapy
Based on the type of respiration, auscultation results, inspection 
and palpation of the thorax, the respiratory problem can in most 
cases be anatomically localized [Tseng and Waddell, 2000]. 
The list of differential diagnoses can then be reduced to a few 
diseases (Figure 2). Based on the localization more specific 
stabilization measures can also be initiated (Table 2). 
Upper respiratory tract 
The upper respiratory tract includes the mouth, nose, pharynx 
and larynx, trachea, and the main bronchi [Lee and Drobatz, 
2004]. Animals with upper airway disease show an inspiratory 
dyspnoea with a prolonged inspiratory phase. Stressed, animals 
may also show panting or rapid shallow breathing [Tseng and 
Type of dyspnoea 
inspiratory 
expiratory 
Asynchronous 
breathing 
noise? 
Extrathoracic 
upper airways 
Nose 
Larynx, 
extrathoracic 
trachea 
Intrathoracic 
upper airways 
Intrathoracic 
trachea, main 
bronchus 
Lower 
airways 
Auscultation? 
Increased / 
moist 
Bronchi, 
Bronchioli 
Alveoli 
Wheezing 
Pleural space 
Auscultation? 
Effusion 
Ventrally ↓ Dorsally ↓ 
Diaphragmatic 
hernia 
Pneumo- 
thorax 
One sided ↓,  
Intestinal sounds 
yes no 
Oedema 
Contusion 
Pneumonia 
Asthma 
Foreign body, 
mass, laryngeal 
paralysis 
Tracheal 
collapse, 
foreign 
body 
Cough? 
Figure 2: Localization of the respiratory problem
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Waddell, 2000; Holt 2004]. With a loud inspiratory breath 
sound (stridor or stertor), the cause is more likely  found in the 
extrathoracic upper respiratory tract, while expiratory sounds 
are more frequently associated with intrathoracic upper airway 
problems [Herrtage and White, 2000; Silverstein and Drobatz, 
2005]. Stertor represents a low-pitched snoring sound that 
arises primarily from obstructed diseases affecting the nose 
or nasopharynx. Respiratory stridor describes a higher pitched 
respiratory noise heard during inspiration that is associated with 
an extrathoracic obstruction affecting the larynx or trachea. 
By opening the mouth, the respiratory noise can be located in 
the nose or throat. Diseases of the nasopharynx also often lead 
to nasal discharge and / or swallowing abnormalities. Diseases 
of the trachea will lead to increased lung sounds or wheezing 
heard on auscultation [Koch et al., 2003; Payen et al, 2006], 
and coughing may also be a common symptom [Mason and 
Johnson, 2004]. 
Differential diagnoses of upper respiratory tract lesions are 
foreign bodies, masses, swelling, laryngeal paralysis, tracheal 
collapse, or the brachycephalic syndrome. A tentative diagnosis 
can often be made based on the breed: brachycephalic breeds 
are predisposed to respiratory distress associated with the 
brachycephalic obstructive syndrome [Koch et al., 2003], middle-
aged to older large dogs (Huskies, Dalmatians, Rottweilers 
and Bull Terriers) for laryngeal paralysis [Gaber et al., 1985; 
Holt and Brockman, 2004; Silverstein and Drobatz, 2005] and 
small dogs, especially Yorkshire Terriers, for tracheal collapse 
[Mason and Johnson, 2004; Payen et al., 2006]. Nasal discharge 
or swallowing and choking have frequently been reported in 
conjunction with a foreign body [Juergens and Wrieg, 1991; 
Hackenbroich et al., 2008].
In addition to the emergency stabilisation, the specific 
treatment is adjusted to the individual situation. A sedation is 
especially useful in patients with inspiratory dyspnoea due to 
tracheal collapse, laryngeal paralysis and to prevent further 
swelling of the upper respiratory tract [Holt and Brockman, 
2004]. Acepromazine alone (0,025 -0.05 mg / kg IM or IV) or in 
combination with butorphanol (butorphanol 0.2-0.4 mg / kg plus 
acepromazine 0.005-0.01 mg / kg) or diazepam (0.2-0.5 mg / 
kg) in combination with an opioid can be used as sedatives. The 
sedation not only leads to a decrease in oxygen consumption, 
but also reduces the laryngeal and tracheal collapse by reducing 
the inspiratory intrapleural pressure [Holt and Brockman, 2004]. 
All materials necessary for intubation and tracheotomy should 
be prepared before sedating an animal because sedation may 
result in severe cyanosis, respiratory distress, or even respiratory 
Localization type of respiration auscultation results Differential diagnoses emergency treatment
Extrathoracic upper 
airways
Inspiratory dyspnoea Stridor/stertor FB, swelling, laryngeal 
paralysis, tracheal 
collapse, brachycephalic 
syndrome
O
2
 
Sedation 
+/- local steroids 
+/- Intubation/ 
tracheotomy
Intrathoracic upper 
airways (trachea, 
main bronchus)
Inspiratory dyspnoea Cough, stridor heard 
only with stethoscope
FB, mass, tracheal 
collapse, -rupture with 
swelling
O
2
 
+/- sedation 
Intubation
Lower airways 
(bronchi, bronchioli)
Expiratory dyspnoea Wheezing Asthma, 
bronchopneumonia
O
2
 
Rest 
Bronchodilators 
Steroids 
Pulmonary 
parenchyma
Mixed dyspnoea or 
shallow breathing
Increased lung sounds Contusions, pneumonia, 
neoplasia, (oedema)
O
2
 
Analgesia 
+/- bronchodilators
Pulmonary 
parenchyma
Mixed dyspnoea, 
Prolonged expiration or 
shallow breathing
Moist lung sounds, 
+/- arrhythmias, heart 
murmur
Pulmonary oedema 
(cardiogenic / non-
cardiogenic)
O
2
 
Rest 
+/- butorphanol 
Furosemide 
+/- bronchodilators 
Plerual space Asynchronous breathing 
or shallow breathing 
Decreased dorsally / 
ventrally
Pneumothorax, Pleural 
effusion
O
2
 
Analgesie
Decreased 
asymmetrically, intestinal 
sounds
Diaphragmatic hernia, 
mediastinal mass
O
2
 
Thoracocentesis
Analgesia
Chest wall Fast shallow breathing 
Abnormal chest wall 
movements
normal Rib fractures, flail chest, 
muscle torsion
O
2
 
Analgesia 
Chest wall stabilisation 
FB: Foreign body
Table 2: Localization, differential diagnoses and emergency treatment
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arrest. Swelling of the upper respiratory tract can be treated 
locally and / or systemically using corticosteroids [Holt and 
Brockman, 2004]. Depending on the extent of the swelling local 
beclomethasone (Beconasol®, GlaxoSmithKline, UK) and / or 
systemic dexamethasone (0.25 mg / kg IV) have been shown to 
be effective. Hyperthermic animals should be actively cooled by 
wetting the fur with water or using a fan [Holt and Brockman, 
2004]. 
If the animal shows severe respiratory distress and intubation 
is not possible, an emergency tracheotomy must be performed 
[Hedlund, 1994]. 
Emergency tracheotomy
An emergency tracheotomy differs from a surgical 
tracheostomy, because in the former case the animal is 
not anaesthetized and ventilated and therefore a fast 
access to the trachea is mandatory. If possible, the animal 
is placed in a supine position with the neck stretched and 
positioned as symmetrical as possible. After a quick clip 
and wash a long 3-5 cm longitudinal incision is placed 
over the midline of the ventral neck caudal to the palpable 
laryngeal cartilages. The subcutaneous tissue and muscles 
above the trachea are separated by blunt dissection and the 
trachea is exposed. This is, depending on breed, nutritional 
status and mentation of the animal, the hardest part. After 
exposing the trachea, a transverse incision of approximately 
40 - 50% of the tracheal circumference is placed between 
the third and fourth or fourth and fifth tracheal ring, and 
the animal is immediately intubated using an endotracheal 
or tracheotomy tube, and mechanical ventilation is started 
with supplemented oxygen. Subsequently, stay sutures are 
placed both at the cranial and caudal tracheal incision in 
order to facilitate change of the tracheotomy tube. The 
tracheal tube is fixed with a tie around the neck of the 
animal and should never be attached with sutures. The 
wound is covered with a sterile gauze. Generally, a bandage 
is not placed as obstruction (by thickened secretions), or 
loss of the tube, require a rapid access to the trachea.
Lower respiratory tract 
The lower respiratory tract consists of the bronchi, bronchioles 
and alveoli. Animals with lower airway disease often show 
expiratory dyspnoea [Mandell, 2004], which appears particularly 
pronounced in cats with asthma [Corcoran et al., 1995]. On 
auscultation, wheezing and both inspiratory and expiratory 
increased breath sounds can be detected. Cats with asthma 
often have a history of coughing [Corcoran et al., 1995; Dye et 
al., 1996]. Moist lung sounds are a sign of bronchial or alveolar 
fluid accumulation, which may be associated with pulmonary 
haemorrhage (look for further evidence for a trauma) or 
pulmonary oedema (rule out arrhythmias and a heart murmur). 
Differential diagnoses of lower respiratory tract lesions are 
asthma, chronic bronchitis, pulmonary oedema, pulmonary 
haemorrhage, and COPD (very rare). 
Feline asthma is the primary differential diagnosis in a cat 
with severe expiratory dyspnoea (and possibly wheezing at 
auscultation) in the absence of symptoms indicating a trauma 
(scuffed nails, fractures, wounds), or evidence of heart disease 
(arrhythmias, heart murmur, hypothermia). In the dog with 
expiratory dyspnoea heart disease and trauma should be ruled 
out.
The emergency treatment of animals with lower respiratory 
tract disease includes the administration of oxygen, stress-free 
handling, rest in a quiet environment, and the administration of 
bronchodilators and steroids if indicated. Terbutaline (Bricanyl®) 
is a selective bronchodilator, and preferable to methylxanthine 
derivatives, such as theophylline. Terbutaline (0.01 mg / kg IM or 
SC every 4-8 hours) can be used as an emergency drug in cats 
with expiratory dyspnoea [Bay and Johnson, 2004]. Theophylline 
(Euphillin®, Nicomedes Pharma AG, Switzerland) at a dose of 4 
mg / kg slowly IV is an alternative. An increase in heart rate may 
occur as a side effect of bronchodilators, the indication in animals 
with tachycardia is therefore restricted. Cats, which respond to 
bronchodilators and oxygen, show a decrease in respiratory rate 
within 30-45 minutes [Bay and Johnson, 2004]. If no effect is 
seen, terbutaline can be repeated and a corticosteroid at anti-
inflammatory dosage (0.25-1 mg / kg dexamethasone) can be 
administered IV [Dhupa and Byers, 2004]. 
Both bronchodilators and corticosteroids may also be 
administered locally by inhalation [Padrid, 1992]. A useful 
system is on the market (AeroKat®, Trudell Medical International, 
USA). The dosage of salbutamol (Ventolin®, GlaxoSmithKline, 
UK), a β-2 adrenergic agonist, is 108 μg (1 puff), while that of 
fluticasone (Axotide®, GlaxoSmithKline, UK), a corticosteroid for 
inhalation, is 44-220 μg [Dhupa and Byers, 2005]. 
Lung parenchyma
This includes the lung interstitium, the vascular supply, and 
parts of the alveoli. Animals with parenchymal lung disease 
show either a mixed dyspnoea with frequently an expiratory 
component or a very fast and shallow breathing [Silverstein and 
Drobatz, 2005]. Increased or wet lung sounds can be heard on 
auscultation [Thayer and Robinson, 1984; Kogan et al., 2008]. 
Differential diagnoses include lung contusions, infectious 
pneumonia, aspiration pneumonia and cardiogenic or non-
cardiogenic pulmonary oedema [Nelson and Sellon, 2005]. 
Pulmonary contusions are the primary differential diagnosis in 
the trauma patient [Powell et al., 1999]. Animals with a heart 
murmur or arrhythmias are primarily classified and treated as 
cardiac disease-related dyspnoea patients. Cats with cardiogenic 
pulmonary oedema often show signs of shock and hypothermia 
[Shoemaker, 1999]. 
In younger dogs, which present with cough and tachypnea / 
respiratory distress and expiratory dyspnoea or shallow breathing, 
“newer” diseases such as Angiostrongylus pneumonia [Bolt et al., 
1994], distemper, or leptospirosis associated pulmonary 
haemorrhage [Schweighauser and Francey, 2008] should be 
ruled out. 
The treatment of parenchymal lung disease include the 
continuous supplementation of oxygen, antibiotic treatment for 
bacterial pneumonia, and supportive measures such as analgesia, 
gastric protection, anti-emetics (aspiration pneumonia) and 
bronchodilators [Lee and Drobatz, 2004]. Less often, ventilation 
therapy is required [Campbell and King, 2000]. 
When moist lung sounds without clinical evidence of hypovolemia 
or dehydration are identified, a single dose of furosemide (1-2 
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mg / kg IV) can be administered [Mandell, 2004]. If there is a 
reasonable suspicion of cardiogenic pulmonary oedema, and no 
response to the initial dose of furosemide, furosemide (1 mg / 
kg) may be repeated at intervals of 30 minutes up to a maximum 
dose of 4-8 mg / kg. Furosemide reduces the intrapulmonary 
hydrostatic pressure by diuresis and has a vasodilating effect in 
the lung [Lundergan et al., 1988]. This leads to a decreased fluid 
shift into the lungs and increased reabsorption of water from 
the pulmonary interstitial space. Furosemide has no significant 
effect on non-cardiogenic pulmonary oedema which is caused 
by increased permeability [Molloy et al., 1985]. 
Methylxanthine bronchodilators such as theophylline also 
increase tracheal mucocilliary transport capacity, inhibit mast cell 
degranulation and increase diaphragmatic contraction [Boothe, 
2000]. Due to the positive chronotropic and inotropic effects 
they should be used carefully in patients with cardiac disease. 
There is no specific treatment for lung contusions. These animals 
need oxygen supplementation, rest and analgesia [Jackson 
and Drobatz, 2004]. Antibiotics and steroids are generally not 
indicated [Powell et al., 1999]. 
Pleural space
The parietal and visceral pleura form the pleural space, which 
for clinical localisation of respiratory distress- includes the 
mediastinum and the diaphragm. Animals with a pleural space 
disease often show asynchronous breathing with outward 
movement of the chest and inward movement of the abdomen 
during inspiration. This type of respiration is generated by 
changes in intrapleural pressure. Other authors describe a fast 
and shallow breathing or panting [Harpster, 2004; Silverstein 
and Drobatz, 2005]. 
The auscultation results may help differentiate between a 
pneumothorax, pleural effusion, or diaphragmatic hernia, 
respectively. With pneumothorax, the lung sounds are diminished 
dorsally, rather than ventrally as seen with pleural effusion. However, 
trauma patients with pulmonary contusions and pneumothorax 
may show apparently normal lung sounds (increased plus muffled 
= normal). A diaphragmatic hernia often causes a one-sided or at 
least asymmetrical attenuation of the lung sounds [Silverstein and 
Drobatz, 2005], and bowel sounds may be heard under certain 
circumstances [Bjorling and Sicard, 2004]. A pneumomediastinum 
may be associated with a subcutaneous emphysema of the neck 
or thoracic inlet [Macklin and Macklin, 1944]. 
The emergency treatment of animals with pleural space disease 
includes oxygen supplementation and the improvement 
of ventilation by thoracocentesis (for pneumothorax, 
pleural effusion), the elevation of the front half of the 
body (diaphragmatic hernia) or intubation and ventilation 
(diaphragm paralysis). Thoracocentesis should be carried out 
in all patients with decreased breath sounds on auscultation 
and an appropriate history of trauma. Thoracocentesis should 
preceed further diagnostic exams such as thoracic radiographs. 
Thoracocentesis is both diagnostically and therapeutically useful. 
Using a proper procedure, the risk of complications is very low. 
Thoracocentesis is performed in the upper third of the 7th to 
9th intercostal space if a pneumothorax is suspected, and in the 
5th to 7th intercostal space or under ultrasound guidance with 
pleural effusion [Sigrist, 2008a]. The aspiration site is clipped 
and prepared aseptically. If necessary, a local anaesthesia is 
performed with lidocaine. A butterfly catheter, IV catheter or 
a normal hypodermic needle can be used for the procedure. 
An extension set between the needle and 3-way stopcock 
with attached syringe is used for aspiration of air or fluid (Fig. 
3). Generally, bilateral thoracocentesis should be performed. 
Recurrent pneumothorax is treated with a chest tube after the 
3rd or 4th thoracocentesis in order to continuously evacuate the 
chest [Sigrist, 2008b]. 
Chest wall 
Chest wall injuries (ribs, intercostal muscles) are very painful and 
therefore generally lead to very shallow breathing. The animals 
are often panting. Other clinical signs of chest wall injury are 
pain on palpation, subcutaneous oedema of the chest wall, 
and abnormal chest wall movements as seen with a flail chest. 
A flail chest results from segmental rib fractures and leads to 
a paradoxical movement of the affected region of the thorax 
during respiration [Capello et al., 1995]. A flail chest is usually 
associated with severe chest trauma [Ciraulo et al., 1994; Smith, 
2004]. 
The treatment of chest wall injuries consists of adequate 
analgesia (see emergency stabilisation), treatment of associated 
lung injury, and primary wound care if necessary [Risselada et 
al., 2008]. A penetrating chest wound should never be closed 
by a pressure bandage because the closure of the chest may 
lead to a life-threatening tension pneumothorax. Larger wounds 
can be protected by gauze, which is attached on 3 sides. For 
transport, a chest drain can be placed directly into the wound, 
but this needs to be under continuous suction or attached to a 
Heimlich valve. A Heimlich valve works only as long as it is not 
exposed to fluid, as any fluid will make it dysfunctional (as with 
a hemothorax). 
Other causes of respiratory distress
Causes of respiratory distress may also be non-respiratory. Pain is 
a paramount differential diagnosis of tachypnoea, and a rapidly 
effective and potent analgesic (eg methadone 0.1-0.2 mg / kg 
IV) should be administered to all potentially painful patients 
prior to further investigations. Hyperthermia, shock, acidosis, 
and massive central nervous system disorders can also lead to 
tachypnoea or an abnormal type of respiration. The auscultation 
findings in these cases are often normal. 
Figure 3: Thoracocentesis using a butterfly catheter
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Diagnostic procedures
Diagnostic procedures associated with stress are in most cases 
unnecessary and should be performed in stable patients only. 
If an intravenous access can be placed, blood can be obtained for 
a stat lab. Hematocrit, total solids, venous blood gases, glucose 
and examination of a blood smear may give helpful indications 
of possible causes of respiratory distress [Drobatz, 2000]. 
Thoracic radiographs provide valuable diagnostic information 
[Nitzl, 2009]. However, radiographs taken in patients with 
respiratory distress may lead to aggravation of respiratory signs. 
Meaningful radiographs require proper positioning [Nitzl, 2009], 
which may lead to destabilization of the animal and potentially 
lead to respiratory arrest. Therefore, only stable patients should 
undergo diagnostic imaging. Chest X-rays may be helpful to give 
a prognosis, document any progress of the disease, or obtain a 
diagnosis if initial stabilization measures were not successful.
The only accurate way to measure the blood oxygenation is by 
means of an arterial blood gas analysis [Drobatz, 2000]. The 
measurement of SpO2 allows an indirect assessment. Normal 
saturation values are > 95%. If the measured value is <90%, 
a significant oxygenation problem must be expected and the 
patient should be supplemented with oxygen, or be intubated 
and ventilated, respectively [Fairman, 1993]. 
Fluid obtained by thoracocentesis should be analysed including 
measurement of total solids, haematocrit, cell count and 
include a cytologic evaluation in order to distinguish between 
a transudate, a modified transudate and an exudate (septic, 
inflammatory, neoplastic). This classification will further 
reduce the list of potential differential diagnoses [Sanders 
and Sleeper, 2004]. Analysis of oedema fluid may also give an 
indication regarding the oedema type. Fluid resulting from non-
cardiogenic pulmonary oedema is more protein-rich than fluid 
from cardiogenic pulmonary edema [Rozanski et al., 1998]. 
Monitoring 
The respiratory rate and the type of respiration should be 
regularly monitored, since they may change depending on the 
cause of respiratory distress and may also worsen after initial 
improvement. The body temperature should also be regularly 
monitored in patients with dyspnoea, as the increased muscle 
work can lead to hyperthermia [Holt and Brockmann, 2004]. 
Heart rate, pulse quality, mucous membrane colour and SpO2 
measurements allow the monitoring of oxygenation and should 
therefore also be checked regularly [Fairman, 1993]. In the 
intubated patient, measurement of end-tidal CO2 provides 
important information regarding ventilation. In the awake 
patient, this information can be obtained by the analysis of 
arterial or venous blood gases. Cyanosis is a very late clinical sign 
of hypoxia and requires immediate treatment. Cyanosis occurs 
when more than 5 g / dl haemoglobin is unsaturated [Lee and 
Drobatz, 2004]. Therefore, anaemic patients will never show 
cyanosis, despite massive hypoxia! 
After stabilisation of respiration and normalisation of blood 
oxygenation, the transport of oxygen to the tissues must be 
ensured by an appropriate circulation.
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Inflammatory ear polyps are the most common non-neoplastic masses in the middle ear of the cat. These polyps 
tend to occur in younger cats. The two cases described in this paper show that ventral bulla osteotomy
is a promising surgical option to successfully manage the condition and prevent recurrence. Cytologically, these 
polyps show all the characteristics of a chronically inflamed middle ear mucosa, i.e. massive lymphocytic and 
purulent inflammation as well as metaplasia of the mucoperiosteum displaying ciliated columnar epithelium and 
goblet cells. Impression smears of the polyps also show lymphocytes in follicular arrangement. Cytology is a suitable 
method to quickly obtain a preliminary intraoperative diagnosis.
However, this initial diagnosis needs to be confirmed by histological examination of biopsy samples. Chronic 
otitis media with effusion (COME) is a possible cause of the disease. It can also serve as a model to explain the 
pathogenesis of inflammatory auro-nasopharyngeal polyps in the cat.
Abbreviations: COME = chronic otitis media with effusion; MALT = mucosal-associated lymphoid tissue; VBO = 
ventral bulla osteotomy
Keywords: Otitis media, ear polyp, cytology, metaplasia, cat
SUMMARY
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Introduction
Ear polyps are nodular and often pedunculated non-neoplastic 
masses, which originate from the mucosal lining of the middle 
ear and/or from the transition zone to the Eustachian tube 
[Pope and Constantinescu, 2000]. 
They tend to occur in younger cats [Donnelly and Tillson, 2004], but 
have also been reported in older cats aged up to 15 years [Faulkner 
and Budsberg, 1990; Veir et al., 2002]. Cats often suffer from otitis 
media due to viral infections of the upper respiratory tract [Venker-
van- Haagen, 2005]. Polyps are considered a late sequela of the 
chronification of an inflammation of the middle ear [Salvinelli et al., 
1999; Fan and De Lormier, 2004; Zender et al., 2007]. 
The middle ear is formed by the tympanic cavity and the 
embedded auditory ossicles. The major portion, the tympanic 
cavity, is a hemispherical bulla with a smooth surface, projecting 
above the base of the feline cranium. A medially protruding 
septum divides the cavity incompletely into a ventral and 
a dorsal compartment. The auditory tube, a narrow bony 
and cartilaginous channel, connects the middle ear to the 
nasopharynx [Seiferle, 1984]. 
The lining of the bony middle ear wall consists of modified 
respiratory squamous epithelium. The thin and poorly 
vascularised mucosa closely overlies the periosteum and has 
therefore been named mucoperiosteum [Paul, 2008]. The 
mucoperiosteum contains some ciliary and secretory cells as 
well as goblet cells [Seiferle, 1984; Jung HWA Pieper, 2003]. In 
the region of the promontory, on the medial wall of the middle 
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ear, and particularly in the transition zone to the Eustachian 
tube, cuboidal to columnar stratified epithelium, with or 
without kinocilia, and goblet cells can be found. The transition 
from modified squamous epithelium to respiratory epithelium 
with kinocilia is continuous [Arnold, 1977; Harvey et al., 2003; 
Liebich, 2003). The Eustachian tube is completely lined with 
stratified ciliated epithelium containing goblet cells [Liebich, 
2003]. Inflamed mucoperiosteum contains highly organized 
lymphatic tissue called MALT (mucosal-associated lymphoid 
tissue). In humans and in rats, it has been demonstrated that 
no lymphatic follicles develop in the normal, non-inflamed 
mucosal membrane of the middle ear. Lymphoid follicles 
require an external stimulus to develop, e.g. a viral or bacterial 
pathogen. Paul (2008) called this the “triggered dynamics“ of 
the development of MALT. 
Depending on the cause, and under the influence of 
pathophysiological conditions in the middle ear (partial pressure 
of carbon dioxide and oxygen), inflamed mucoperiosteum 
undergoes muciparous or keratinizing metaplasia [Parker and 
Binnington, 1985; Kuijpers et al., 1996; Esterline et al., 2005; 
De Lorenzi, 2005; Ressel and Poli, 2007; Paul, 2008; Rossi, 
2009]. In addition, lymphatic follicles can always be found 
in the submucosa. Aural discharge, pruritus and pain are the 
most common clinical signs of otitis media. Some animals also 
show neurological symptoms such as head tilt, nystagmus, 
Horner´s syndrome or facial nerve paralysis. Up to one third of 
the patients develop deafness in the affected ear [Anders et al., 
2008; Diel, 2008]. If inflammatory polyps reach as far as into the 
nasopharynx, animals display respiratory symptoms [Macphail, 
2008; Werner-Tutschku, 2008]. 
In the literature, two methods have been discussed for removing 
ear polyps. 
1) One option is the manual removal by traction-avulsion via 
the ear canal, a method, which is related to high recurrence 
rates [Anderson et al., 2000]. Recently, this technique has been 
further developed performing “perendoscopic transtympanic 
excision“ [Mortellaro et al., 2001; Diel, 2008]. 
2) Ventral bulla osteotomy (VBO) is a surgical procedure to 
remove ear polyps and may produce complications e.g. Horner´s 
syndrome, vestibular disturbances, otitis media, haemorrhage, 
hypoglossal nerve damage, facial nerve paralysis and damage to 
the structures of the auditory apparatus. However, recurrence 
rates are lower after ventral bulla osteotomy [Donelly and 
Tillson, 2004]. 
In humans, COME often occurs without perforation of the 
tympanic membrane or without otorrhoea and may therefore 
take an asymptomatic course. In cases with late clinical 
manifestation, sensorineurally induced reduction of the patient´s 
ability to hear, acute exacerbation of a chronic otitis media 
and complications regarding the bony structures may occur. 
Starting as a simple purulent, and at a later stage mucopurulent, 
inflammation, the condition may worsen producing granulation 
tissue (polyps) and cholesteatomas. 
In most cases, the disease is caused by a viral infection of 
the upper respiratory tract and the resulting acute middle 
ear infection. Babies and infants are predominantly affected, 
particularly those who are cared for in nurseries. 
The larger the number of children living together, the higher 
the incidence of upper respiratory tract diseases. Bacterial 
contamination as a sequela of an impaired auditory tube 
function and massive development of subepithelial follicles, 
serving as a histomorphological substrate, are perpetuating 
factors of chronic otitis media with effusion (COME) [Sautter 
and Hirose, 2007; Paul, 2008]. 
Inflammatory mediators also play an important role in the 
development of COME. Bacterial endotoxins perpetuate the 
condition by migrating into the inner ear where they cause a 
loss of auditory capacity [Juhn et al., 2008]. 
Material and methods 
Cytology 
A sample of the aural discharge is retrieved from the ear canal 
using a cotton swab. The collected sample is then rolled onto a 
glass microscope slide and stained using Haema Schnellfärbung® 
(quick stain) (Labor+Technik, Berlin, Germany) and evaluated 
under the light microscope. Intraoperatively, cells are obtained 
by direct impression smear and then stained using Haema 
Schnellfärbung® as well as modified May-Grünwald Eosin 
Methylene Blue® (Merck, Darmstadt, Germany) and Giemsa® 
(Merck, Darmstadt, Germany) before evaluating them under 
the microscope.
Imaging techniques 
Lateral oblique and rostrocaudal radiographs are taken of the 
sedated patient, as described by Harvey et al. (2003). 
Surgery 
Venker-van Haagen (2006) describes the traction-avulsion 
technique often used; Knudig (2002), Harvey et al. (2003), 
White (2003) and Grevel (2005) describe how to perform a 
ventral bulla osteotomy. 
Anaesthesia and analgesia 
To sedate patients for radiographic examination and to 
anaesthetize them prior to surgery, medetomidine at a dose of 
0.05 mg/kg (Domitor®, Pfizer, Vienna) und ketamine (8 mg/kg 
(Ketamidor®, Richter Pharma, Wels) were given IM. Anaesthesia 
was maintained with isoflurane (Isoflo®, Abbott, Richter 
Pharma, Wels). Whenever necessary, a bolus of fentanyl (0.5 
mg Fentanyl-Janssen®, Janssen-Cilag, Vienna) diluted in 100 
ml 0.9 % saline solution (Natrium chloratum pysiologicum®; 
Fresenius Kabi, Graz) was administered via the infusion line, up 
to a maximum of 0.25 ml per kg body mass per 5 minutes. 
Before and after surgery, patients were given carprofen (2 mg/
kg) (Rimadyl®, Pfizer, Vienna) as an analgesic. 
Case details 
Case 1 
A 15-month-old castrated, regularly vaccinated, male Maine 
Coon cat with a body weight of 9.5 kg was presented with 
pruritus and pain in the right ear. The cat lived in a household 
together with one of his male litter mates. The second cat was 
asymptomatic. Clinical examination revealed unilateral purulent 
otitis. Differentials to consider include bacterial inflammation, 
Malassezia otitis, ear mange caused by Notoedres, allergic 
otitis and/or neoplasias in the external ear canal or the middle 
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ear. First samples were taken for smear preparations and the 
external ear canal was examined using an otoscope. Cytological 
findings revealed the presence of neutrophil granulocytes with 
large quantities of phagocytised cocci, consistent with bacterial 
otitis.
Due to the copious purulent otic discharge, the tympanic 
membrane could not be evaluated. The cat received 
marbofloxacin 2 mg/kg s.i.d. PO (Marbocyl®, Vetoquinol, Vienna) 
for one week together with a topic treatment b.i.d. (0.05 % 
chlorhexidine otic solution; Clorexyderm®, ICF, Cremona, Italy). 
At follow-up examination, the volume of the otic discharge 
was significantly reduced. Haematological and blood chemistry 
findings were normal. The patient was sedated according to the 
previously described protocol and the ear canal was cleaned 
using diethylhexyl sodium sulfosuccinate and urea hydrogen 
peroxide (Otoprof®, ICF, Cremona, Italy). 
The following otoscopic examination revealed a pink bulging 
mass in the region of the tympanic membrane; remnants of the 
ruptured  eardrum could be discerned at the wall of the external 
ear canal. The patient was diagnosed with otitis media with 
eardrum perforation caused by an ear polyp. 
The soft palate was carefully elevated  using a feline spay hook 
to visualize the pharynx, but no nasopharyngeal polyps were 
detected. Radiographic examination in oblique lateral projection 
showed a soft tissue opacity in the right tympanic cavity. The 
contralateral bulla appeared as a thin-walled dense bony 
structure (Fig. 1). 
The owner agreed to have the polyp removed using the traction-
avulsion technique (Fig. 2). Samples for bacteriological culture 
and histopathological examination were obtained during 
surgery. Postoperatively, antibiotic therapy was started with 
amoxicillin-clavulanic acid (Clavaseptin®, Vetoquinol, Vienna) 
at a dose of 20 mg/kg b.i.d. PO. Bacterial culture proved the 
presence of enterococcus sp., and the antibiogram showed that 
the responsible organism was sensitive to the initial antibiotic 
treatment, so the therapy was extended to a total of one 
month. Histopathology revealed that only some regions on 
the external surface of the polyp were covered by one or two 
layers of cuboidal epithelium, while the majority of the surface 
was eroded (Fig. 3a). In addition, some adenoid indentations 
with columnar ciliated epithelium were seen (Fig. 4a). In the 
loose connective and granulation tissue of the polyp stroma 
Fig. 1: Oblique skull radiograph of the Maine Coon cat (Case 1). 
The healthy bulla (a) appears as a thin-walled dense bony structure 
at the base of the skull, while the affected right side (b) shows a soft 
tissue opacity in the tympanic cavity.
Fig. 2: Ear polyp removed by traction (size compared to a  
1 € coin).
Fig. 3: Longitudinal histological section of the polyp of Case 1: a) In the loose connective and granulation tissue of the polyp stroma, 
follicle-like accumulations of small lymphocytes can be seen. b) Lymphocyte follicular aggregates are also observed in the impression smear 
preparation (Haemacolor).
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follicle-like accumulations of small lymphocytes were found 
(Fig. 3b). The purulent inflammatory component was only mildly 
developed. 
After only three weeks, the tympanic membrane was fully 
restored and closed, and the cat was discharged as healthy. 
One year later, the cat was again presented, this time with 
bilateral nasal discharge and a unilateral purulent discharge from 
the right ear. After one week of pretreatment with amoxicillin-
clavulanic acid and acetylcysteine 50 mg (ACC® Hexal, Hexal 
Pharma, Vienna) per meal twice daily, skull radiographs were 
taken revealing a soft tissue opacity. The opacity was interpreted 
as a regrowth of the ear polyp. The pharyngeal cavity was 
clinically normal. 
This time, a ventral bulla osteotomy was the treatment of choice 
because this technique is associated with low recurrence rates. 
Due to the bone density of the ventral wall of the tympanic 
cavity in this Maine Coon cat, it was quite difficult to perform 
the osteotomy and achieve perforation of the bulla. 
Again, samples for bacteriological and cytological examination 
were collected intraoperatively, and the removed polyp was 
submitted for histopathological examination. Bacteriological 
findings did not differ from those of the first examination. 
At a magnification of x4, cytology was characterized by dark-blue 
cell accumulations consisting of numerous lymphocytes, plasma 
cells, many neutrophils, macrophages and phagocytised cocci 
(Fig. 3b). Outside these areas, columnar epithelium with (Fig. 
4d) and without kinocilia (Fig. 4b) as well as some goblet cells 
were observed (Fig. 4c). Fig. 5 shows the stratified composition 
of the epithelia. Type and structure were compatible with 
metaplastic inflammatory ear polyps. 
After one month of antibiotic therapy with amoxicillin- clavulanic 
acid (Clavaseptin®, Vetoquinol, Vienna) and once the eardrum 
had closed again, the cat was discharged as healthy. 
Two years later, no regrowth of the polyp had occurred. 
Case 2 
A 10-month-old castrated European Shorthair cat with a 
body weight of 3 kg was presented with pruritus, pain and a 
yellow discharge in the right ear. The cat came from an animal 
shelter where she had contracted infectious rhinitis at the age 
of 8 weeks. She suffered from a severe nasal discharge and 
respiratory symptoms. At the age of four months, the cat was 
diagnosed with generalized dermatophytosis, which was treated 
successfully. The animal had received the usual vaccinations 
Fig. 4 Details of Fig. 3: Pseudo-stratified columnar ciliated epithelium with goblet cells in a glandular invagination (a); (histological 
section). Cells with kinocilia (b) and numerous goblet cells (c) as well as columnar cells (d) can also been seen. In Fig. 4d, the epithelial 
cell is embedded in inflammatory tissue with large and small lymphocytes and plasma cells. Near the top margin, a lymphatic cell in 
division can be discerned (Haemacolor stain). Both cytological and histological findings are consistent with muciparous metaplasia of the 
respiratory epithelium.
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regularly. Apart from the purulent otitis, the cat was clinically 
normal. After one week of antibiotic therapy (amoxicillin- 
clavulanic acid; Clavaseptin®, Vetoquinol, Vienna), the external 
ear canal could be examined with the otoscope, revealing a 
pink mass deep down in the ear canal. After sedation of the 
patient, rostrocaudal radiographs were obtained showing a 
soft tissue opacity in the right bulla (Fig. 6); the contralateral 
tympanic cavity did not show any pathological alterations. After 
cleaning the ear with Otoprof® (ICF, Cremona, Italy), the polyp 
could be visualized with the otoscope. The pharyngeal cavity 
was examined as described in Case 1. 
Due to the experience gained with the patient of Case 1, 
the immediate performance of ventral bulla osteotomy was 
suggested to the owners. In contrast to Case 1, osteotomy of 
the tympanic cavity and dissection of all relevant structures 
were performed very easily (Fig. 7). As usual, samples for 
bacteriological culture and cytological and histological 
examination were obtained during surgery. Findings showed the 
presence of diplococci sensitive to amoxicillin-clavulanic acid as 
well as haemolysing staphylococci. 
Over a background of inflammatory cells containing neutrophils, 
lymphocytes, plasma cells and macrophages, the cell-rich 
impression smear preparation contained ciliated epithelial cells 
with a relatively high cytoplasm:nucleus ratio. 
These epithelial cells were characterized by nuclei with clumpy 
chromatin, indicating an increased nuclear activity. Histology 
revealed an inflammatory infiltrate covered by a layer of 
prismatic, ciliated epithelial cells. Both findings are consistent 
with inflammatory ear polyps (Figs. 3, 4 and 5). 
Postoperatively, reduced unilateral retractability of the tongue 
Fig. 5 Over a protein-rich background, there is a group of five cells 
displaying epithelial characteristics. Two types of cells can be seen: 
On one side, there are goblet cells (*) close to epithelial cells with 
eccentric nuclei and eosinophilic cytoplasm; on the other side, the 
ciliated epithelium (#) can be identified because of the elongated 
cell shape, the eccentric nucleus and the kinocilia. These five cell 
types are characteristic of a pseudo-stratified epithelium. Knowing 
the topographic location of the sample, this microscopic picture is 
consistent with muciparous, metaplastic, inflammatory mucosa of 
the middle ear.
Fig. 6 Skull radiograph of the European Shorthair cat (Case 2). The 
healthy bulla (a) appears as a thin-walled symmetrical dense bony 
structure at the basis of the skull, while the affected side (b) shows 
a soft tissue opacity.
Fig. 7 Surgical field showing the affected bulla. The digastric 
muscle has been separated from the mylohyoid muscle, and a 
retractor is used to hold the wound open. The venous bifurcation 
lies ventrally just under the surface, while the hypoglossal nerve 
runs under the two dissected muscles.
COMEinfection 
of the ear
acute otitis 
media
healing
increased 
secretion
mucosal lesions
muciparous mucosal 
proliferation
polyp
rupture of the 
tympanic membrane
swelling of the mucosa of the upper 
respiratory tract and the middle ear
Fig. 8 Self-perpetuating circle of chronic secretory otitis media.
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was noticed, which resolved within the next four weeks. The 
tympanic membrane took more than two months to heal 
completely. During the four weeks after surgery, the cat received 
antibiotic treatment (amoxicillin-clavulanic acid, Clavaseptin®, 
Vetoquinol, Vienna). 24 months after performance of the ventral 
bulla osteotomy, the cat was still asymptomatic. 
Discussion 
Histopathological and cytological findings are consistant with 
the changes described by Paul (2008) in human patients with 
middle ear disease. As the healthy mucosa of the middle ear in 
both men and rats is practically devoid of lymphoid follicles, an 
increased presence of lymphoid follicles in the feline middle ear 
may also be considered characteristic of chronic inflammation. 
In young cats, just as in children, multiple viral and bacterial 
infections of the upper respiratory tract may cause inflammation 
of this kind. In most young animals, infections of the upper 
respiratory tract are asymptomatic or show a mild course. As in 
humans, middle ear infections in the cat often occur unnoticed, 
as they are almost always self-limiting. The majority of cases of 
ear polyps published in studies refer to young animals. In only a 
very small number of affected animals, the condition is preceded 
by clinically manifest symptoms of an upper respiratory tract 
disease [Veir et al., 2002; Mac Phail et al., 2007]. The Maine 
Coon cat, in Case 1, showed nasal discharge at the time of 
regrowth of the polyp, which in this case was most probably a 
sequela and not the cause of middle ear inflammation. In Case 2, 
the European Domestic Shorthair cat had suffered from massive 
upper respiratory tract disease at the age of eight weeks, with 
the ear polyp only developing seven to eight months later. In an 
analogy to man, living in a densely populated surroundings also 
represents a contributing factor in the cat (in this case, the patient 
lived in an animal shelter). Densely populated catteries carry a 
high risk of transmitting upper respiratory tract infections. The 
type of metaplasia depends to a great extent on its anatomical 
location. Nasopharyngeal polyps growing from the Eustachian 
tube into the pharynx may develop a keratinizing epithelium due 
to increased contact with oxygen [Esterline et al., 2005]. 
However, one of the authors (a pathologist) affirms that he 
has never diagnosed keratinization in nasopharyngeal polyps. 
Both cases described in this paper can be clearly related to the 
respiratory epithelium as the tissue of origin; this was confirmed 
by both histological and cytological findings. In particular, the 
metaplasia can be diagnosed cytologically on the basis of the 
tissue structure (Fig. 5). 
Both cats presented here exclusively displayed symptoms 
compatible with otitis externa or otitis media, respectively, 
which in both patients affected one side only. In the literature, 
this complex of symptoms is often referred to as otorrhea, visible 
polyps, sneezing and/or nasal discharge [Anderson et al., 2000; 
Harvey et al., 2003]. In contrast, no central nervous symptoms 
were observed in either of the cases. One explanation could 
be that the cats were presented in a very early stage of the 
condition and that the immediate onset of appropriate therapy 
prevented the development of central nervous symptoms. 
As far as a possible breed predisposition is concerned, no 
binding statement can be made, as the total case volume - 
approximately 130 published cases since 1990 – is quite small. 
What is striking, however, is the fact that Maine Coon cats are 
listed in all reported cases [Kapatkin et al., 1990; Anderson 
et al., 2000; Veir et al., 2002; Diel, 2008]. This may suggest a 
predisposing anatomical conformation of the auditory tube in 
this breed. Before CT and MRI had started to be widely used 
as imaging techniques, radiography was the only means to 
visualise the tympanic cavity and several authors have described 
this technique [Harvey et al., 2003]. However, Remedios et al. 
(1991) point to its low sensitivity as 25% of the findings are 
false negative. If the clinical presumptive diagnosis cannot be 
confirmed by radiology, computed tomography is the method 
of choice to achieve a final diagnosis. 
Although the traction-avulsion method is an accepted technique 
for removing nasopharyngeal polyps [Werner-Tutschku, 2008), 
the correct initial treatment for polyps in the middle ear is 
still discussed controversially in the literature: While some 
surgeons advocate traction-avulsion of the polyp [Gotthelf, 
2000; Diel, 2008], others consider ventral bulla osteotomy 
as the method of choice [Trevor and Martin, 1993; Anderson 
et al., 2000; Muilenburg and Fry, 2002; Harvey et al., 2003; 
Anders et al., 2008; Macphail, 2008]. Both Gotthelf (2000) 
and Diel (2008) removed polyps under endoscopic control by 
traction and avulsion applied to the stalk of the polyp. Trevor 
and Martin (1993), in contrast, removed ear polyps in 22 cases 
performing  ventral bulla osteotomy; seven of these procedures 
were performed to remove inflammatory ear polyps and no 
regrowth was observed in these patients. Anderson et al. (2000) 
published a retrospective study with 37 cases; of these, 30 cats 
underwent removal of the polyp by traction-avulsion. Follow-
up examinations were carried out in 22 animals, of which nine 
(41%) developed recurrences. That case study did not mention 
details of the applied technique of polyp resection. The success 
rate of the traction technique is clearly higher when applied 
to polyps in the Eustachian tube rather than to polyps in the 
external ear canal. However, considering the total number of 
surgeries for polyp removal, ventral bulla osteotomy proved to 
be superior to the traction method. Anders et al. (2008) found 
that ventral bulla osteotomy as a surgical technique can neither 
cure deafness caused by the polypoid condition nor damage an 
intact sense of hearing in an animal. 
As can be deduced from literature, ventral bulla osteotomy has 
a high success rate as it is a reliable method to permanently 
remove inflammatory ear polyps without the risk of recurrences; 
the two cases described in this paper fully confirm this. If the 
traction method is performed under endoscopic control, a lower 
recurrence rate seems to be possible. Traction-avulsion without 
any visual assistance is less successful - as could be seen in Case 
1. Another explanation for the reduced success rate of the 
traction-avulsion technique could be the fact that considerable 
quantities of inflammatory tissue and – even more importantly 
– of pus and mucus remain in the middle ear despite proper 
lavage. Most probably, this does not alter the microclimate in the 
middle ear (sero-purulent material and reduced oxygen partial 
pressure) sufficiently, preventing involution of the metaplasia. 
The situation is different with ventral bulla osteotomy. 
The better approach via the ventral aspect of the tympanic bulla 
enables performance of a meticulous curettage of the inflamed 
mucosa. In addition, remaining liquid and other material can 
easily drain and air can enter to ventilate the middle ear. The 
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higher oxygen partial pressure and reduced quantity of mucus 
facilitate reversion of the metaplasia. 
Faulkner and Budsberg (1990) reported that a wide range of 
bacterial agents was isolated from the samples obtained from 
the tympanic cavity of the 12 patients studied. In the two cases 
described in this paper many different organisms were isolated; 
however, two cases are insufficient to permit a scientifically 
relevant conclusion. 
Cytology yielded similar results in both patients: inflammatory cells 
and non-keratinising prismatic epithelium [Corazza and Poli, 2007] 
or ciliated epithelium as well as goblet cells (Fig. 3 and 4). Cytology 
is a suitable method to allow intraoperative differentiation 
between inflammatory/metaplastic and neoplastic masses. 
In selected cases, the differentiation between dysplastic and 
neoplastic cells can be difficult due to the massive inflammatory 
process. Quick stains tend to overemphasize the malignancy 
criteria, while the May-Grünwald-Giemsa staining method has 
delivered an optimal performance in such cases. The suitability of 
cytology as a diagnostic tool to evaluate tumours in the middle ear 
has been proven by De Lorenzi et al. (2005). 
In human medicine, chronic secretory media with effusion 
was unknown prior to the advent of antibiotics [Sautter and 
Hirose, 2007]. In veterinary literature, it is also remarkable that 
the number of published cases of the condition has dramatically 
increased since the 1970s. The fact that it is more frequently 
diagnosed than before may be related to the increased use of 
antibiotics for the treatment of infectious diseases of the upper 
respiratory tract and the increasing application of topical otic 
preparations. Considering the state of knowledge in human 
medical literature and the course of the two cases described 
in this paper together with the histological and cytological 
findings, the concept of a chronic otitis media with effusion as 
described by Sautter and Hirose (2007) may also be considered 
as a valid hypothesis in feline medicine. 
Chronic otitis media with effusion 
(COME) – a possible pathophysio- 
logical course 
(Fig. 8). At the beginning, there is an infection of the upper 
respiratory tract. This may occur without or with only mild 
clinical signs [Ibarolla et al., 2005). However, a generalized 
lymphatic reaction of the mucous membranes in the affected 
region takes place. Mucosal swelling in the upper respiratory 
tract and frequent sneezing lead to an increased pressure 
in the nasopharynx and to the opening of the auditory tube. 
With the reflux flow from the pharynx, infectious organisms are 
transported into the middle ear (Sautter and Hirose, 2007). 
Due to the inflammation, oedema of the epithelium in the 
Eustachian tube develops, resulting in an occlusion of the tube.
The occluded tube produces negative pressure within the cavity 
system of the middle ear. With serous liquid penetrating the 
tympanic cavity, a process of transformation into columnar 
respiratory epithelium is induced. Dysfunction of the auditory 
tube is considered a decisive aetiological factor for middle ear 
inflammation [Paul, 2008]. Independently from an invasion of 
the tympanic cavity by infectious agents, the mucous membrane 
of the middle ear has already reacted. Oedema, hyperplasia and 
metaplasia of the mucosa as well as development of follicles 
in the submucosa, are the consequences [Arnold, 1977; Veir et 
al., 2002]. Neither mucosal-associated tissue (MALT) nor large 
numbers of goblet cells or intraepithelial glands form part of the 
healthy mucosa, but are the result of a reaction to stimuli. 
There is a continuous drop in oxygen partial pressure, while 
the partial pressure of carbon dioxide is continuously rising. 
Secretions and inflammatory mediators also play an important 
role. The result is a reduced frequency of movement of kinocilia 
and, as a consequence, a reduction in mucociliary clearance 
[Paul, 2008; Juhn et al., 2008]. 
The process may resolve either without treatment or due to 
therapeutic measures against the causative organisms and the 
inflammation, putting an end to the occlusion of the auditory 
tube and inducing a partial involution of the mucosal metaplasia.
If the disease process progresses, the inflammation becomes 
purulent and the oxygen partial pressure decreases more and 
more. 
The continued inflammatory process with the development of 
lymph follicles, increased production of mucus by the goblet cells 
and increased secretion of the intraepithelial glands, together 
with the confines of the tympanic cavity and the auditory tube 
activates a vicious circle [Paul, 2008], in which inflammatory 
mediators play an important role [Juhn et al., 2008]. Due to 
this self-sustaining chronification of the process, massive 
proliferation of the metaplastic mucosa occurs leading to the 
development of granulation tissue and polyps [Salvinelli et al., 
1999; Paul, 2008; Juhn et al., 2008). With increasing growth, 
the polyp impinges on the eardrum, which is already affected 
by the inflammation. 
As a consequence, the tympanic membrane ruptures and 
bacterial contamination occurs. Toxins and/or applied drugs 
may damage the sense of hearing [Venker-van Haagen, 2006].
The performance of a ventral bulla osteotomy may stop the 
inflammatory process and even reverse it, although full recovery 
is not possible with this method once a sensorineural hearing 
loss has occurred [Anders et al., 2008]. 
Ventral bulla osteotomy enables surgeons to advise pet owners 
before surgery regarding the favourable prognosis and the possible 
risk of recurrence. The traction technique under optical control is a 
promising procedure, although a realistic evaluation of this method 
requires more cases as a basis for assessment. Intraoperative 
cytological examination showing ciliated metaplastic epithelium 
is a suitable tool to quickly evaluate and differentiate the tissue 
samples obtained during surgery. The bacterial component 
involved in the inflammatory process is extremely variable. In both 
cases described in this paper, the organisms were fully sensitive to 
amoxicillin-clavulanic acid. Chronic otitis media with effusion is a 
possible model for the pathogenesis of ear polyps in the cat. 
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Canine herpes virus (CHV1) infection has been reported in many European countries with the prevalence of 
antibodies against CHV1 varying from 40% to 88% in healthy dog populations in Belgium, the UK and the 
Netherlands. Although the disease occurs sporadically in Norway, its seroprevalence is unknown. In the adult dog, 
CHV1 infection causes only mild clinical signs, which are often not observed by the owner. However, in neonatal 
puppies, the virus can produce systemic fatal haemorrhagic disease. In-utero infection during pregnancy may 
cause infertility, abortion or birth of weak pups, depending on the stage of gestation when infection occurs. CHV1 
infection has also been associated with tracheobronchitis and papulovesicular genital lesions. The authors discuss 
prophylactic measures to prevent neonatal disease and infection of the bitch during pregnancy. A vaccine is licensed 
for use in the European Union to protect puppies against CHV1 infection during the first two-three weeks of life 
by transfer of maternal antibodies. The bitch is vaccinated twice during pregnancy. The authors emphasise that 
vaccination is optional and should be used only where an increased risk of neonatal CHV1 infection exists.
Key words: canine herpes virus, dog, neonatal infection, reproduction, review
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Introduction
Recently, many veterinarians and breeders have been in contact 
with the Norwegian School of Veterinary Science and the 
National Veterinary Institute concerning herpes virus infection 
in dogs. A vaccine has recently been licensed for use in several 
European countries, creating the need for increased knowledge 
of this infection.
Canine herpes virus (CHV1) infection was first reported in the 
USA in the early 1960s [1]. In neonatal puppies, the virus can 
produce systemic fatal haemorrhagic disease [2]. In the bitch, 
herpes virus infection can cause reproductive failure [3], but 
its importance in upper airway infections in dogs is unclear 
[2,4]. In adult dogs the infection is usually asymptomatic. CHV1 
infection has been reported from many European countries, 
and several serological studies indicate that CHV1 is widely 
spread in dog populations. In studies from Belgium, the UK and 
the Netherlands, the prevalence of antibodies against CHV1 
varies from 40% to 88% in healthy dog populations [5,6,7]. 
Serum samples collected from 19 of 38 kennels in the Gauteng 
province of South Africa tested positive for CHV1 antibodies [8]. 
In a Finnish study of kennel dogs with and without reproductive 
problems, a significant difference was found in the percentage 
of seropositive dogs between the two groups [9]- all dogs from 
the kennels with reproductive problems were seropositive for 
the virus. In Sweden, more than 50% of the dog population is 
expected to have been exposed to the herpes virus [10] (Lena 
Renström, the National Veterinary Institute, Uppsala, personal 
communication). In Norway, herpes virus infection was first 
diagnosed in neonatal mortality in 1973 by Bratberg et al [11]
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and over the past 20 years the infection has continued to be 
diagnosed sporadically [12,15]. The prevalence and importance 
of herpes virus infection in Norwegian dogs is still unclear. This 
article is a review of herpes virus infection in dogs.
Canine herpes virus 1
Canine herpes virus 1
CHV1 is a relatively large, enveloped doublestranded DNA 
virus belonging to the family Herpesviridae and the subfamily 
Alphaherpesviride, genus Varicellovirus (Figure 1) [16]. It has a 
relatively narrow host range, being pathogenic, in only domestic 
and wild animals of the Canidae family. This host specificity is 
caused by CHV1-specific receptors at the cell surface [17]. At 
present, only one antigen type of CHV1 has been detected. A 
relatively close genetic relationship exists between canine and 
feline herpes viruses [18,19]. The herpes virus is sensitive to 
environmental factors [2]. It is inactivated after 22 hours at 37°C 
and more quickly at higher temperatures. Freezing of samples 
to -20°C gives some reduction in live viruses, but is nevertheless 
recommended when shipping samples to laboratories [2]. 
The virus is quickly destroyed at pH levels of <5 or >8 and 
by of most disinfectants. CHV1 replication is optimal in the 
temperature range 35-37°C in vivo and in vitro, which resembles 
the temperatures in the mucosa of the upper airways and 
reproductive tract [2,16]. Replication of CHV1 occurs in the cell 
nucleus and gives rise to intranuclear inclusion bodies which are 
of diagnostic value. Typically, as for most alpha herpes viruses, 
lifelong latency follows infection. The virus enters a latency period 
during which only parts of the genome are expressed [16]. This 
virus genome is usually localised in nerve ganglia and lymphoid 
cells [20]. Using a polymerase chain reaction (PCR), Burr and 
coworkers detected DNA from CHV1 in lumbosacral ganglia and 
tonsils in 5 of 12 older dogs without a history of herpes virus 
infection [21]. Virus DNA was also found in the parotid salivary 
gland and the liver. The authors suggested an association 
between localisation of the virus and the route of shedding from 
the reproductive or oronasal mucosa. During latency, no virus 
replicates and the host cell is probably undamaged. Reactivation 
of the virus with multiplication and shedding from mucosal 
surfaces has been shown in several studies [22,23]. In bitches 
treated with prednisolone (600 mg per day for five days) who 
had a history of abortion induced by the herpes virus, CHV1 
was detected from the oronasal and vaginal mucosa and from 
the tonsils and ocular fluids [22]. Another study showed that 
repeated reactivation within one to three month intervals can 
also be induced by immunosuppressive therapy [23]. It has 
been demonstrated that stress, proestrous and gestation can 
reactivate the virus, but the mechanism by which this happens 
is not clear [2].
Pathogenesis and clinical findings
Herpes virus infection in dogs manifests itself in different ways, 
depending on age, gender, immune status, and route of virus 
transmission. 
Infection during pregnancy
If the virus reactivates or a primary infection of CHV1 occurs 
during pregnancy, there is a risk of transplacental transmission 
to the fetus [24, 25]. Viraemia in the bitch can also produce 
degenerative and necrotic lesions in the placenta [26]. The 
outcome of the pregnancy depends on the developmental 
stage of the foetus at the time of infection. Mummification of 
several foetuses has been reported in some bitches following 
intravenous virus administration at day 30 of gestation, whereas 
abortion or birth of mummified fetuses and the presence of 
dead or live pups was observed in the litters of other bitches 
[24]. Bitches inoculated at day 40 of pregnancy gave birth to 
dead and live pups one week before term. The live pups were 
weak and died shortly afterwards. With inoculation of the virus 
at days 48-53 of pregnancy, live puppies were born, but most 
of these were weak and died within two weeks with symptoms 
characteristic of herpes virus infection [25].
Naturally infected bitches experiencing reinfection during 
pregnancy often have milder disease than in primary infections 
[2]. Specific antibodies in the serum and colostrum of the bitch 
protect the fetus and offspring and consequently reduce the risk 
of abortion, stillbirth, or birth of weak puppies.
Neonatal infection
Puppies are most vulnerable to septicaemic infection during the 
first two weeks of life [1,27,28]. Virus transmission is usually 
via the oronasal route. The puppies may also be infected 
during birth if the virus is present in the reproductive tract. 
The pathogenesis of CHV1 infection is studied by challenging 
puppies of different ages. After oronasal inoculation, the virus 
replicates in epithelial cells and the tonsils [2]  then  spreads to 
the blood via monocytes. Viraemia occurs on day three or four 
after infection. The highest concentration of viruses is found in 
the kidneys, adrenal glands, lungs, liver, and spleen. Massive 
endothelial damage with necrotising vasculitis develops in 
blood vessels, leading to multiple necroses and haemorrhage in 
different organs. Systemic infection with CHV1 is often followed 
by generalised thrombocytopenia. CHV1 can be transported 
along nerve axons to the central nervous system and induce 
meningoencephalitis [29]. Neurological signs are usually not 
present because the outcome is fatal before these develop. The 
Figure 1. Canine herpes virus. (Photo: Marko Reschke, Biografix, 
Germany, copied with permission).
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Figure 4. Histo-pathology of liver section. The arrow points at an 
intranuclear inclusion body in a hepatocyte. Hematoxylin-eosin 
staining. 400x. 
Figure 2. A) Autopsy of a two weeks old rottweiler puppy that died from septicaemic herpes virus infection. B) Characteristic haemorrhages 
are seen macroscopically in the kidney (Photos in Figures 2-4 by Dr. Øyvor Kolbjørnsen, National Veterinary Institute, Oslo). 
A
A
B
B
Figure 3. A) Histo-pathology of liver section and B) Kidney section. The arrow indicates an area of focal necrosis and hemorrhages. 
Hematoxylin-eosin staining. 200x. 
retina develops during the pup’s first weeks of life and CHV1 
is associated with corneal lesions and retinal dysplasia [30,31]. 
Herpes virus infection is more serious for newborn pups than for 
six-week-old pups [32,33]. Puppies are particularly vulnerable 
during the two first weeks of life because of impaired body 
temperature regulation [34,35]. Rectal temperature is normally 
1-1.5º below adult temperature and the ability to respond to 
infection with fever is reduced [35]. Between four and eight 
weeks of age, systemic infection develops after CHV1 inoculation 
if the body temperature is artificially lowered  [2,34]. Elevation 
of the environmental temperature may reduce the severity of 
CHV1 infection in one week old pups, but not eliminate it.
The humoral immune status for CHV1 in the bitch is of extreme 
importance in the development of infection in the offspring 
[2]. Puppies nursed by a seronegative dam are at a high risk of 
developing a fatal systemic infection if they are infected, whereas 
maternal antibodies from a seropositive dam will protect the 
pups against generalised infection. Incubation time for CHV1 
infection in newborn puppies is from one to a few days and 
disease progression is often rapid with a fatal outcome. In more 
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protracted cases, poor ability to suckle, inactivity, abdominal 
pain, and a characteristic sound are observed. Diarrhoea, 
serosanguinous nasal discharge, and mucosal and ventral 
abdominal haemorrhage are occasionally seen [2]. Although 
shivering and squeaking, the juvenile puppy does not respond 
by increasing it’s body temperature. Ultimately, it becomes 
unconscious and may develop ophisthotonus and spasms before 
death occurs, mostly within 24-48 hours after the initial signs. 
Puppies who survive may develop such neurological signs as 
ataxia, blindness and balancing difficulties. Those infected from 
three weeks of age may develop eye lesions and neurological 
signs secondary to non-suppurative meningoencephalitis [29], 
or may develop a milder or asymptomatic disease.
Infection in the genital tract of adult dogs
CHV1 infection has been associated with papulovesicular lesions 
on the penis and prepuce in the male dog and in the vagina of 
the bitch, respectively [36,38]. In the male dog, the lesions may 
be accompanied by lochia. This is not observed in the bitch. The 
virus may be transmitted during copulation, but this route tends 
to be uncommon [2]. Lesions in the genital tract of the bitch 
primarily represent a risk of transmission to puppies during birth.
Infection in the respiratory tract of adult dogs
In experimental infections with CHV1, mild symptoms from 
the upper respiratory tract have been observed [39,40]. 
An unproductive cough caused by tracheobronchitis has a 
suggested association with the kennel cough complex. In a two-
year study of shelter dogs, coughing was regularly observed [41]. 
Samples from trachea and lungs revealed CHV1 with some dogs 
seroconverting three to four weeks after arrival. Conversely, 
other viral agents were also diagnosed so the exact role of CHV1 
in the progression of the disease was unclear.
In another study from two kennels in the UK, dogs were tested 
for antibodies to corona virus and CHV1 for one year. [42]. In 
this year two outbreaks of respiratory tract infection coincided 
with seroconversion against coronavirus, whereas antibodies 
against CHV1 were detected throughout the year indicating no 
association with the outbreaks. 
Diagnosis
A characteristic history and clinical findings combined with 
progression of disease are indicative of herpes virus infection 
in puppies less than two weeks old. In the neonatal period, 
differential diagnoses include bacterial infections  namely sepsis 
caused by streptococci, staphylococci and coliform bacteria. 
Diagnosis is based on post mortem findings and the detection 
of herpes virus or viral DNA in the organs of aborted, stillborn 
or dead puppies.
Post mortem findings
If neonatal herpes virus infection is suspected, post mortem 
examination is important for the diagnosis. Characteristic 
macroscopic findings include multiple haemorrhages in 
the kidneys, liver, spleen and intestinal serosa (Figure 2 
A,B) [1,26]. Congestion and oedema of the lungs is often 
present. Histopathological examination of stained sections 
reveals necrotic foci in the parenchyma, often with peripheral 
haemorrhages (Figure 3 A,B). Intranuclear inclusion bodies may 
occur in herpes virus infections (Figure 4), but are not always 
found. If the virus has been transported along the trigeminal 
or olfactory nerves, degeneration and necrosis of glia cells and 
neurons may be observed in the cerebellum. Both macroscopic 
and histological findings may reveal focal necrosis of the foetal 
part of the placenta.
Virus culturing and detection of viral DNA
Canine renal cells are used for culturing CHV1 in the laboratory 
[16]. Characteristic degenerative changes develop within 
days, shown as plaque. Samples from fresh (or frozen) organs 
are preferred. CHV1 is labile, and post mortem degeneration 
reduces the chance of virus detection. For culturing cells, the 
most appropriate course is to sample from dogs with clinical 
findings. A special transport medium ordered from the 
laboratory is important for viral detection. A small volume (0.5-
1.0 ml) is needed for each sample, and it is worth noting that 
sample tubes containing charcoal or agar as medium cannot be 
used. Sample swabs are preferably taken from the mucosa of 
the nose or the genital tract, depending on clinical findings. The 
mucosa is cleaned with physiological saline before sampling to 
reduce the risk of contamination. Samples should be sent fresh 
and cooled (or frozen to -20ºC) by courier to the laboratory. In 
DNA extracted from organ samples, PCR can be used to detect 
sequences from the CHV genome [21]. The same method may 
also be used for detection of viral DNA in formalin-fixed tissue 
samples [43, 44]. PCR is a robust and technically simpler method 
than virus isolation, and may be preferred in the future.
Serology
An immune response with production of antiviral antibodies is 
stimulated in CHV1 infections in puppies older than six to eight 
weeks and in adult dogs. Two to three weeks after exposure, 
antibodies may be detected in the serum [2]. An active infection 
gives an elevation in antibody titre, which remains high for a few 
months before it declines. A low titre may be detected for several 
years or may be induced by vaccination. Because the progress 
of the disease in puppies is acute, neutralising antibodies are 
seldom detected. During an outbreak, two samples taken from 
the same dog two to three weeks apart are used to detect  a 
rising antibody titre. Sero-epidemiological studies are used 
to indicate the prevalence of dogs exposed to CHV1. Several 
serological methods are used to detect antibodies against 
CHV in the dog. The immunoperoxidase method has a better 
sensitivity than the serum-neutralising test, which is regarded as 
the reference method [47]. It has a high specificity, but a lower 
sensitivity compared with enzyme-linked immunosorbent assay 
[5,6,48].
Therapy
In adult dogs, herpes virus infection is asymptomatic, self-limiting 
and requires no treatment. Limited experience has been acquired 
with antiviral treatment of herpes virus infection in animals in 
general [47]. No such drug is licensed for this application in 
Norway. Aciclovir has been used in cats and horses in some 
countries. A metabolite of this drug prevents viral DNA synthesis 
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in cells infected with the herpes virus and only minimally affects 
normal cell processes in non-infected cells. Aciclovir has poor 
bioavailability in the dog, but has been used experimentally in 
the dosage range of 10-20 mg/kg for a week [2,48]. A clinical 
effect was reported in a case of litter mates of puppies killed by 
herpes virus infection [48]. Even though antiviral treatment may 
save some dogs, risks of defects in the central nervous system or 
myocardium [2] still exist. Common side effects seen in aciclovir 
overdosage are anorexia and mild gastrointestinal symptoms 
[49]. Crystals are occasionally found in the kidneys, inducing 
obstructive nephropathy.
Prophylaxis
Stress and environmental factors
In latently infected dogs, the virus may be reactivated by stress 
[2]. Breeding dogs should therefore avoid long-distance travel, 
shows, competitions and stressful activities before mating and 
during gestation. Other infections may induce reactivation of 
a latent herpes virus infection, emphasising the importance 
of the dog’s general health. The most common route of 
transmission is via virus-containing droplets exchanged directly 
between dogs. Breeding dogs who are not infected should 
limit contact with risk environments to avoid CHV1 exposure 
and breeders should maintain good environmental hygiene. 
Reduced thermoregulation in newborn pups makes them 
dependant on external heat during the first two weeks of life. 
Achieving ambient temperatures of about 35-37ºC with the 
aid of a heating lamp and insulating floor is essential. The bitch 
must also have access to an area of lower temperature to avoid 
discomfort.
Colostrum
Puppies receive the majority of their maternal antibodies through 
colostrum and only small amounts are transferred to the fetus in-
utero. Colostrum intake within the first hours of life is therefore 
essential for protection against infections. The permeability of 
large immunoglobulins through the intestinal mucosa decreases 
relatively quickly after birth, and therefore puppies should 
receive adequate amounts of maternal antibodies during the 
first eight hours after birth. CHV1 infection mostly affects 
pups from a bitch that had her primary herpes infection during 
pregnancy. A previously infected bitch has specific antibodies to 
the herpes virus providing some protection for the puppy during 
the first couple of weeks. However, if the puppy has no access 
to colostrum, 1-2 ml of serum from dogs with a high CHV1 
antibody titre is reported to have prophylactic effect when 
administered before virus exposure [50].
Vaccination
A herpes virus vaccine (Eurican® Herpes 205, Merial, France) was 
registered a few years ago for use against CHV1 infection in dogs 
in the European Union [51]. This oil-adjuvanted vaccine is not 
marketed in Norway but is available following application to the 
Norwegian Medicines Agency. The vaccine contains a surface 
protein (gB glycoprotein) from CHV1 and antibodies against 
this antigen neutralise the virus. The vaccine is administered 
to pregnant bitches providing maternal immunity to the litter 
during the first two-three weeks of life through the uptake 
of maternal antibodies in colostrum. The vaccine schedule 
consists of two doses with an interval of five weeks, the first 
dose given at mating or some days after, and the second two 
weeks before the expected whelping. Revaccination follows the 
same procedure including two doses to secure high levels of 
protective antibodies in the colostrum. The vaccine has been 
tested in pregnant bitches at different times of gestation, in 
experimental studies and in the field [52]. Serious side effects 
occur rarely. Gestational abnormalities, stillbirth and perinatal 
mortality were not increased in vaccinated bitches compared 
to control animals. Local reactions at the injection site are 
common but reversible. Efficacy studies have been performed 
in kennels of varying CHV1 infection status [52]. The vaccine 
was used in pregnant seronegative bitches and in bitches with 
moderate to high levels of antibodies after natural infection. 
An increase in antibody titre was seen in the majority of dogs 
after vaccination, including those which had moderate levels in 
advance. Vaccination stimulated protective immunity in a study 
where puppies were challenged with a virulent virus and field 
observations confirmed experimental findings [53]. In this latter 
study, the vaccine also had an effect on the survival of fetuses 
in utero, because vaccinated bitches tended to have a higher 
pregnancy rate, increased birth weights and lower mortality 
from birth to weaning.
We consider the herpes virus vaccine as a non-core vaccine 
which should not be recommended for all bitches [54]. 
Moreover, vaccination of adult dogs to prevent respiratory tract 
infection or genital tract lesions is not indicated. The vaccine is 
recommended only in female breeding dogs with a perceived 
risk of CHV1 infection to prevent neonatal disease and mortality. 
The typical family dog living in a household with one or two 
dogs that has less contact with foreign dogs is probably at lower 
risk of herpes virus infection compared to one in a multidog 
household or kennels. Should there be an increased risk of 
CHV1 infection, especially before mating or during pregnancy, 
vaccination may be considered. Bitches are at risk if they have 
been in recent contact with other bitches that have aborted, 
borne weak puppies, or suffered increased neonatal mortality. 
Some veterinarians order testing of serum samples for antibodies 
against CHV1. A seropositive result indicates an earlier infection 
and a virus carrier status. In these cases, reactivation of a latent 
virus may occur followed by transmission to fetuses and puppies. 
It may be difficult to evaluate if antibody titers are sufficiently 
high to protect the litter. In such cases, one must consider 
whether vaccination should be performed to increase levels of 
antibodies in the colostrum.
Discussion
Sero-epidemiological studies indicate that CHV1 infection in 
dogs is relatively common in several countries. The association 
between virus infection and neonatal mortality is clear, but 
under debat where kennel cough is concerned. The importance 
of CHV1 infection as a cause of infertility, fetal resorption, death 
and abortion is discussed in several papers. In a Norwegian 
study of neonatal mortality (stillborns and dead puppies less 
than eight weeks old) in four large breeds, a mortality rate of 
10.9% was reported [55]. The mortality rate for puppies in their 
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first three weeks of life was 6.9%. Causes of death varied. Few 
puppies died from “fading puppy syndrome” in the first few 
weeks of life, with symptoms resembling herpes virus infection. 
Unfortunately, no further diagnostic investigations were 
performed. 
In a study carried out in Belgium, Ronsse et al studied factors 
influencing CHV1 antibody levels in kennel dogs [56]. No 
association was found between antibody levels and gender or 
breed. On the other hand, a clear relationship existed between 
antibody levels and age. Dogs less than six months old were 
seronegative for CHV1 antibodies, whereas several dogs 
seroconverted from the onset of puberty to two years of age. 
This was associated with copulation for male dogs but not for 
bitches, and indicates that venereal transmission occurs in some 
instances. Dogs from kennels with kennel cough outbreaks had 
a significantly higher CHV1 antibody titre compared with dogs 
from kennels without such a history. Additionally, there was a 
clear relationship between the numbers of dogs in the kennel 
and antibody levels, as kennels with more than six animals had 
higher antibody levels than those with fewer dogs. This was 
more prominent with poor kennel hygiene. In Norway, the most 
common type of kennel is a small facility with generally good 
hygiene and few dogs per kennel. This is expected to have a 
positive influence on the risk of CHV1 transmission between 
dogs and between kennels. In a prospective field study, Ronsse 
et al studied antibody levels throughout the reproductive 
cycle in bitches at 13 kennels [57]. The seronegative bitches 
seroconverted during the test period but, in one or two test 
samplings, 40% of the seropositive bitches seroconverted to 
antibody negative status. This finding indicates how antibody 
levels vary within the same dog and also underlines the 
problem of diagnoses based on one sample only. Differences 
in antibody levels were not observed between stages in the 
reproductive cycle, but there was a tendency to lower titres 
during metoestrus. Half of the dogs were mated and infertility 
(no puppies after mating, fetal resorption or mummification) 
was observed in 50% of these , however, no conclusions 
could be drawn regarding the association between CHV1 
infection and infertility in this study. Other studies may indicate 
an association between CHV1 infection and infertility [9,58]. 
Kennels with few breeding dogs, good hygiene and limited 
contact with foreign dogs have a lower risk of CHV1 outbreaks 
than kennels with inferior hygiene conditions. Intense coughing, 
as seen in kennel cough, can increase the risk of herpes virus 
infection through droplets if the dog is also infected with the 
herpes virus. Ronsse et al [56] suggest that vaccination against 
kennel cough caused by parainfluenza virus and bordetella 
bacteria can help prevent transmission of the herpes virus. 
Stress reduction for bitches before mating, during pregnancy 
and close to parturition helps reduce the chance of reactivation 
of a latent virus. In kennels with repeated reproductive problems 
and large neonatel losses, causal evaluation is important. If 
CHV1 infection is a probable cause, prophylactic regimes as 
mentioned above may be helpful. Additionally, care of the 
newborn puppies should include administration of colostrum 
and provision of optimal environmental conditions. Kennels 
with endemic CHV1 infections may benefit from vaccination of 
pregnant bitches. On the other hand, it should be emphasised 
that immunoprophylaxis must not replace other prophylactic 
procedures, but supplement them. The nature of the disease, 
the route of transmission, and the property of latency have 
persuaded many breeders and veterinarians to live with the 
virus, simply adding known prophylaxis to reduce the damage 
of the disease. In areas where CHV1 infection is less common, it 
may be rewarding to reduce the risk of transmission by reducing 
travelling and contact with foreign dogs.
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Objectives: To review aetiology, clinical signs and outcome of cats surgically treated for septic peritonitis (2000-
2007). 
Methods: A retrospective study. Inclusion criteria were the identification of intracellular bacteria and degenerate 
neutrophils and/or a positive culture from abdominal fluid and exploratory coeliotomy. Aetiology, clinical signs, 
haematological and biochemical parameters, surgical treatment and outcome were recorded and analysed. 
Results: Twenty-six cats fulfilled the inclusion criteria. Abdominal pain was reported in 10 (38 per cent) and 
vomiting was reported in 11 (42 per cent) of the cats. The most common aetiology was trauma (31 per cent). The 
principal source of contamination was the gastrointestinal tract. Hyperlactataemia, hypoproteinaemia and 
hyperglycaemia were reported in 9, 13 and 14 of the 26 cases, respectively. Non-survivors had significantly higher 
blood lactate concentrations than survivors (P=0.02). Nineteen cats were managed with primary closure, two with 
closed suction drains and three with open peritoneal drainage. Twelve (46 per cent) cats survived to be discharged. 
Clinical significance: In cats, lethargy, depression and anorexia were more common clinical signs than abdominal 
pain. Lactate level at the time of diagnosis may be a useful prognostic indicator in cats. The proportion of cats that 
survived was lower than previously reported and owners should be given a guarded prognosis.
summary
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Introduction
septic peritonitis is an often fatal condition encountered in 
first opinion and referral practice and can occur as a sequel to 
abdominal surgery. It is characterised by inflammation of the 
peritoneum secondary to bacterial contamination and infection. 
It is diagnosed by the identification of intracellular bacteria and 
degenerate neutrophils within abdominal fluid smears and/or a 
positive bacterial culture of abdominal fluid [staatz and others 
2002, Connally 2003, Costello and others 2004]. The condition 
is associated with high morbidity and mortality rates, with 
survival rates in cats and dogs reported to range between 32 
and 80 per cent [swann and Hughes 2000]. The prognosis in 
the cat is reported to be comparable to the dog [Costello and 
others 2004]. 
With the exception of one study [Costello and others 2004], 
previous reviews of septic peritonitis have described the clinical 
signs, aetiology, treatment and outcome in the dog, or dog and 
cat combined [King 1994, Ludwig and others 1997, staatz and 
others 2002]. It is therefore difficult to directly compare the 
results of these studies. recent reports demonstrate that cats 
with severe sepsis often have varying responses and clinical signs 
to those seen in other species. It is necessary to be aware of 
these differences to enable early diagnosis and treatment [Brady 
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and others 2000]. rapid diagnosis and surgical treatment are 
necessary in animals with septic peritonitis to prevent or minimise 
the progression of hypovolaemia, acid base disturbances and 
electrolyte abnormalities, all of which will rapidly progress and 
increase morbidity and mortality [swann and Hughes 2000]. 
The history and clinical signs of an animal with peritonitis are 
often vague and non-specific [swann and Hughes 2000]. Clinical 
signs include abdominal pain, vomiting, lethargy/depression, 
anorexia, polyuria and polydipsia. The principal difference 
reported by Costello and others [2004] was that only 62 per 
cent of cats exhibited signs of pain during abdominal palpation. 
In the dog, septic peritonitis is almost always associated with 
abdominal pain or discomfort [swann and Hughes 2000].
The most common source of abdominal contamination in 
both the cat and the dog is gastrointestinal leakage; in the cat 
being secondary to underlying neoplasia [Costello and others 
2004] and in the dog as a result of surgical wound dehiscence 
[Hosgood and salisbury 1988, Costello and others 2004]. Less 
common aetiologies include trauma and pyogranulomatous 
disease [swann and Hughes 2000, staatz and others 2002, 
Costello and others 2004]. Costello and others [2004] reported 
that in 14 per cent of cats the underlying cause of the septic 
peritonitis was not identified during surgery or postmortem 
examination which is in contrast to the situation in the dog. 
To the authors’ knowledge the study by Costello and others 
[2004], which included 51 cats, is the only large study that 
has been performed focusing primarily on the cat. Their study 
represented a population of cats in the usa and included all 
cats diagnosed with septic peritonitis based on cytological 
evaluation, microbial culture or postmortem examination 
findings. Not all of the cases reported underwent surgical 
exploration and treatment. Data regarding the aetiology, 
clinical signs and outcome of cats surgically treated for septic 
peritonitis are therefore sparse. It is also possible that population 
and management differences between the uK and usa may 
result in different features of the condition to those previously 
identified. The aims of the study reported here were to review 
the aetiology, clinical signs, outcome and prognosis of cats 
diagnosed with and surgically treated for septic peritonitis and 
to identify differences between previous reports on the cat and 
dog. results will assist in the early diagnosis and treatment of 
the condition, thereby increasing the chance of survival. 
Materials and Methods
medical records of cats referred to the royal Veterinary College, 
London, that were diagnosed with septic peritonitis between 
February 2000 and February 2007 were retrospectively reviewed. 
Criteria for inclusion in the study were the identification 
of intracellular bacteria and degenerate neutrophils within 
abdominal fluid smears and/or a positive culture from peritoneal 
fluid in association with an exploratory coeliotomy. management 
of individual cats was at the attending clinician’s discretion. 
Cats in which septic peritonitis was suspected based only upon 
compatible clinical signs and history were excluded.
Clinical records
The following information was accrued: breed, age, sex, date 
of admission, clinical signs and rectal temperature at the 
time of diagnosis, aetiology, haematological and biochemical 
parameters (see below), details of any previous related surgery, 
details of the surgical treatment performed (peritoneal lavage 
with primary closure, open peritoneal drainage or closed 
peritoneal drainage), initial antibiotic and fluid therapy, 
postoperative nutritional support (that is, placement and type 
of feeding tube), bacterial culture and sensitivity, histopathology 
results and clinical outcome.
aetiology of septic peritonitis was assigned to one of the five 
groups: traumatic, neoplastic, iatrogenic (including previous 
surgery), miscellaneous and unknown. The source of bacterial 
contamination was identified and recorded. 
When available from the medical records, selected 
haematological and biochemical parameters from blood taken 
at the time of diagnosis of septic peritonitis were recorded. 
Variables recorded were lactate, total protein (TP), albumin, 
glucose, neutrophil and band neutrophil counts. Due to the 
small sample size and non-Gaussian distribution, median values 
and ranges of the measured biochemical and haematological 
values from the whole study population were calculated. 
Cats were classified as either “survivors” or “non-survivors.” 
survivors were defined as cats that survived to discharge. Non-
survivors included cats that died or were euthanased. When 
available, the reason for euthanasia was recorded.
Statistical analysis
Descriptive analysis was performed. Data were assessed for 
normality using a shapiro-Wilk’s test (sPss 14 for windows, 
LEaD Technologies Inc., usa). Where appropriate, further 
statistical analysis was performed using sPss 14 for windows 
(LEaD Technologies Inc., usa). Ninety-five per cent confidence 
intervals (CI) of selected variables were calculated. Due to the 
small sample size and non-Gaussian distribution of the data, 
non-parametric tests were used. Comparison of data recorded 
between the “survivors” and “non-survivors” groups was 
performed using the mann-Whitney u test and Fishers exact 
test methods for continuous and discrete variables, respectively. 
a value of P≤0.05 was considered significant. 
Results
Signalment
Twenty-six cats fulfilled the requirements for inclusion in the 
study (Table 1). Breeds represented were domestic shorthair 
(DsH) (15), domestic longhair (DLH) (1), Persian (4), Burmese 
(3), siamese (1), Bengal (1) and maine Coone (1). There were 14 
neutered males and 12 neutered females, with an age range of 
6 months to 15 years (median age three years). Eighteen of the 
26 cats were less than five years old. 
Clinical signs
Lethargy/depression was observed in 25 cats [93 per cent (95 
per cent CI=74-100 per cent)], anorexia in 21 cats [81 per cent 
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Table 1. Breed, age (years), sex, aetiology, source of contamination, overview of surgical management and outcome of cats included in the 
study
Breed Age 
(years)
Sex Aetiology Source of 
contamination
Surgical management Outcome
DsH 2 Nm Trauma – rTa resulting in 
gastric rupture
stomach Open drainage Died
DsH 1 Nm Trauma – shot with air rifle External penetration 
and small intestine
abdominal lavage and primary closure survived
DsH 0.5 Nm Trauma – dog bite External penetration abdominal lavage and primary closure survived
DsH 1 NF Trauma – dog bite External penetration 
and stomach
abdominal lavage and primary closure. 
Oesophageal feeding tube
Died
Persian 3 Nm Trauma – shot with air rifle External penetration 
and small intestine
abdominal lavage and primary closure survived
Naso-oesophageal feeding tube
Burmese 7 Nm Trauma – rTa resulting in 
biliary tract rupture
Biliary tract Euthanasia Euthanasia
DsH 2.5 NF Trauma – dog bite External penetration Open drainage. Oesophageal feeding 
tube
Euthanasia
DsH 0.75 Nm Trauma – shot with air rifle External penetration 
and small intestine
abdominal lavage and primary closure Euthanasia
DLH 14 NF Iatrogenic – enterotomy 
dehiscence
small intestine abdominal lavage and primary closure survived
DsH 1 NF Iatrogenic – enterotomy 
dehiscence
small intestine and 
colon
abdominal lavage and primary closure survived
Bengal 4 Nm Iatrogenic – gastrostomy tube 
migration
stomach abdominal lavage and primary closure Died
DsH 1 Nm Iatrogenic – enterotomy 
dehiscence
small intestine abdominal lavage and primary closure survived
DsH 3 Nm Iatrogenic – enterotomy 
dehiscence
small intestine and 
colon
abdominal lavage and primary closure. 
naso-oesophageal feeding tube
survived
Persian 3 Nm Iatrogenic – enterectomy 
dehiscence
small intestine abdominal lavage and primary closure Euthanasia
DsH 3.5 NF miscellaneous – 
intussusception
small intestine abdominal lavage and primary closure Euthanasia
Burmese 5 NF miscellaneous – ruptured 
para-cystic abscess. abscess 
surrounding dorsal and left 
aspect of bladder, urethra and 
ureters
abscess Placement of closed abdominal suction 
drain. Oesophageal feeding tube
survived
DsH 0.9 NF miscellaneous – secondary to 
cholecystitis and ruptured gall 
bladder
Biliary tract abdominal lavage and primary closure survived
Persian 10 NF miscellaneous – perforated 
gastric ulcer
stomach abdominal lavage and primary closure. 
Oesophageal feeding tube
survived
Burmese 0.8 Nm miscellaneous – perforated 
gastric ulcer
stomach abdominal lavage and primary closure survived
DsH 16 Nm miscellaneous – ruptured 
duplex gall bladder
Biliary tract abdominal lavage and primary closure Euthanasia
Persian 13 NF Neoplasia – gastric perforation 
(leiomyosarcoma)
stomach abdominal lavage and primary closure Euthanasia
siamese 15 NF Neoplasia – gastric perforation 
(carcinoma)
stomach abdominal lavage and primary closure Euthanasia
DsH 8 Nm Neoplasia – duodenal 
perforation (adenocarcinoma)
small intestine abdominal lavage and primary closure. 
Naso-oesophageal feeding tube
Euthanasia
maine 
Coon
4 Nm unknown undetermined Euthanasia Euthanasia
DsH 4 NF unknown undetermined Open drainage Euthanasia
Oesophageal feeding tube
DsH 0.75 NF unknown undetermined Placement of closed abdominal suction 
drain. Gastrostomy feeding tube
survived
DsH Domestic shorthair; DLH Domestic longhair; Nm Neutered male; NF Neutered female; rTa, road traffic accident
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(95 per cent CI=51-100 per cent)], abdominal pain in 10 cats [38 
per cent (95 per cent CI=14-75 per cent)], vomiting in 11 cats 
[42 per cent (95 per cent CI=5-80 per cent)] and ascites in 9 cats 
[35 per cent (95 per cent CI=0-71 per cent)]. rectal temperature 
at the time of diagnosis ranged from 33.8 to 41.0°C (median 
38.5°C). Nine cats were considered hypothermic (less than 
38.2°C) and four were considered hyperthermic (greater than 
39.0°C).
Aetiology
The aetiology and hence the underlying nature of contamination 
was identified in 23 of the 26 cats included in the study 
(Table 1). The aetiologies were categorised as follows; eight 
traumatic, six iatrogenic, six miscellaneous, three neoplastic 
and three unknown (Fig 1). Traumatic causes included gun-
shot wounds (three), bite wounds (three) and road traffic 
accidents (two). all cases with iatro-genic peritonitis were as 
a result of complications from previous surgery performed at 
first referring veterinary practices. Three cats had dehiscence of 
small intestinal enterotomy sites and one had dehiscence of a 
colonic enterotomy site following foreign body removal. One cat 
had breakdown of a small intestinal end-to-end anastomosis site 
following removal of a foreign body and in one cat a previously 
placed gastrostomy tube migrated allowing leakage of gastric 
contents into the abdomen. Intestinal leakage secondary to 
adenocarcinoma (one), leiomyosarcoma (one) and invading 
pancreatic carcinoma (one) were seen in three cats. The 
miscellaneous causes included spontaneous gastroduodenal 
perforation (two), gall bladder rupture (one), gastrointestinal 
leakage secondary to an intussusception (one), a ruptured para-
cystic abscess (one) and peritonitis secondary to cholecystitis 
and a ruptured gall bladder (one). 
The nature of the contamination was classified as due to 
leakage of gastrointestinal contents (including biliary tract) in 16 
cats, inoculation of infection via a penetrating injury in one cat, 
leakage of purulent fluid from an abscess in one cat and both 
a penetrating injury and leakage of gastrointestinal contents in 
five cats. In the three cats with unknown aetiology there was 
no obvious primary focus of infection or disruption of intra-
abdominal viscera. 
Haematology and biochemistry
Biochemistry at the time of diagnosis of septic peritonitis 
was available for 17 (65 per cent) to 19 (73 per cent) of the 
cases (depending on parameter of interest) (Tables 2 and 3). 
Hyperlactataemia, hypoproteinaemia and hyperglycaemia was 
observed in 9 (n=19), 13 (n=16) and 14 (n=19) of the cases, 
respectively (where n equals the number of cases for which the 
biochemical parameter was available). There was a statistically 
significant difference between measured blood lactate when 
comparing survivors and non-survivors (P=0.02) with median 
lactate at the time of diagnosis of septic peritonitis being 1.4 
mmol/l (range 0.4-6.0 mmol/l) and 3.5 mmol/l (range 1.1-10..7 
mmol/l) in the survivors and non-survivors, respectively. There 
was no statistically significant difference between measured 
total protein (P=0.84), albumin (P=0.54) and glucose (P=0.32) 
when comparing survivors and non-survivors.
a neutrophilia was observed in nine cats, and a neutropaenia 
was observed in two cats (Table 2). There was no statistically 
significant difference between neutrophil count when 
comparing survivors and non-survivors (P=0.36)(Table 3). 
Thirteen cats had the presence of increased number of band 
neutrophils documented (Table 2). 
Microbial culture
Gram-negative enteric organisms were identified in 12 out of 
13 cats that had a bacterial culture performed [Escherichia coli 
(nine cases), Enterococcus faecalis (two cases) and Pasteurella 
(one case)]. In one cat Corynebacterium species was cultured.
 
Intraoperative findings and surgical management
at the time of surgery, 19 cats were managed with copious 
abdominal lavage and primary closure (Table 1). Two cases were 
managed with a closed suction drain (Jackson Pratt type drain) 
and three with open peritoneal drainage. Feeding tubes were 
placed in nine cats following surgery; naso-oesophageal (three), 
oesophageal (five) and gastric (one). 
Two cats were euthanased at the time of surgery. In one case 
the cause of the septic peritonitis could not be identified and in 
view of the poor prognosis the owner elected for euthanasia. 
In the second case ruptured hepatic ducts were identified. 
The owner declined further treatment due to the cat’s clinical 
condition and poor prognosis. 
unfortunately, there were insufficient animals in treatment 
groups to draw pertinent conclusions on the association 
between treatment methods and outcome.
Antibiotics and fluid therapy
all cats received perioperative and postoperative intravenous 
fluids and antimicrobials at the attending clinician’s discretion. 
all cats received crystalloids (Hartmann’s solution). Eight cats 
received colloids. Of those, three cats received oxyglobin 
(Biopure Cor-poration, usa) and two received oxyglobin as well 
as a blood transfusion. None of the cats receiving oxyglobin or 
blood transfusions survived to discharge. Of the three cats that 
were administered pentastarch, one survived to discharge. 
31%
23%
23%
12%
12%
Traumatic
Iatrogenic
Miscellaneous
Neoplastic
Unknown
FIG 1. Aetiologies of cases of septic peritonitis.
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at the time of diagnosis various antimicrobials were used either 
alone or in combination: cefuroxime (14), metronidazole (13), 
enrofloxacin (10), amoxicillin/clavulanate (5) and ampicillin (18). 
Continuation of antibiotic therapy was based on culture and 
sensitivity results with antibiotics being stopped or changed 
following test results. 
Outcome
survival to discharge occurred in 12 of the 26 cats (46 per 
cent). median duration of hospitalisation for survivors was 
seven days (range 4-20 days). Fourteen of the 26 cats died, 
which included 11 that were euthanased. all cases where 
euthanasia was performed were reported to have been due 
to deterioration of the cat’s condition. None were reported to 
have been euthanased due to financial reasons. No statistical 
difference was observed when comparing survival of cats with 
septic peritonitis originating from traumatic or iatrogenic causes 
(P=0.59).
Discussion
results from this study suggest that the prevalence of clinical 
signs seen in cats with septic peritonitis differ to those seen 
and previously reported in the dog [swann and Hughes 2000]. 
abdominal pain and vomiting, which are typically seen in 
dogs with peritonitis, were observed in only 10 and 11 cats, 
respectively (43 and 48 per cent). This is also less than the 62 
per cent previously reported in the cat [Costello and others 
2004]. Lethargy/depression and anorexia were more consistent 
findings, being seen in 96 and 82 per cent of cats, respectively. 
These clinical signs are non-specific to the condition of septic 
peritonitis. Variability between the frequencies of specific 
clinical signs observed in this study to that reported previously 
may in part be due to differences in case inclusion criteria. Here, 
we included only cases of septic peritonitis that were surgically 
treated. abdominal pain and vomiting may be more commonly 
observed in patients that do not survive to become surgical 
candidates. It is however important to note that the absence 
of vomiting and abdominal pain should not be used to rule out 
the diagnosis of septic peritonitis in the cat. It is also important 
to note that the variability in the frequencies of clinical signs 
reported here compared with other studies could be due to the 
small sample size. The presented 95 per cent CIs demonstrate 
that the differences could be due to random variation and 
chance due to the small sample size. 
This is the first study where trauma has been identified as the 
most common primary cause of septic peritonitis, responsible 
in 8 of the 23 cats (35 per cent). Trauma has previously been 
reported as the underlying aetiology in only 16 per cent of 
animals [Costello and others 2004]. The most common cause 
previously reported was gastrointestinal tract (GIT) leakage as 
a result of neoplasia in the cat [Costello and others 2004], and 
as a result of surgical wound dehiscence in the dog [Hosgood 
and salisbury 1988, swann and Hughes 2000]. similar to 
previous studies in both the cat and the dog, the primary source 
of abdominal contamination in our population was from GIT 
leakage [Hardie and others 1986, swann and Hughes 2000, 
Costello and others 2004]. The inclusion of only surgical cases 
in this study may have resulted in a reduction in the number 
of cases that were reported to be secondary to neoplasia. a 
diagnosis of neoplasia may have influenced the decision to elect 
for surgical treatment, hence excluding the case from the study. 
The difference in reported underlying aetiologies may also go 
some way to explaining the difference in clinical signs observed 
when comparing studies. 
In the study by Costello and others [2004], the median age of 
the cat population was five years. In our study the median age 
of the cats was three years with 17 cats (74 per cent) being 
Table 2. Biochemical and haematological parameters from the whole study population
Mean value Standard deviation Median Range Reference range
Glucose (mmol/l) n=19 8.6 3.8 7.6 2.4-14.9 4.2-6.6
Lactate (mmol/l) n=19 3.1 2.7 1.9 0.4-10.7 0.6-2.5
albumin (g/l) n=17 23.8 6.5 21.0 16-39 28-42
Neutrophils (×109/l) n=19 17.7 14.1 10.7 0.6-47.2 2.5-12.5
Bands (×109/l) n=13 2.6 2.2 1.8 0.5-6.3 0-0.3
Total protein (g/l) n=16 54.2 9.9 52.5 40.3-73.5 61-80 
median values and ranges of the measured biochemical and haematological values are presented along with parameter reference ranges
Table 3. Biochemical and haematological parameters for survivors and non-survivors 
Survivors Non-survivors
Reference 
range
n Median Range n Median Range
Glucose (mmol/l) n=19 4.2-6.6 9 9.5 3.7-14.6 10 7.2 2.4-14.9
Lactate (mmol/l) n=19 0.6-2.5 9 1.4 0.4-6 10 3.5 1.1-10.7
albumin (g/l) n=17 28-42 7 22.4 17.2-39 10 21.0 16-39
Neutrophils (×109/l) n=19 2.5-12.5 9 8.7 2.1-35.2 10 17.8 0.6-47.2
Bands (×109/l) n=13 0-0.3 5 4.9 0.56-6.29 7 0.92 0.5-3.8
Total protein (g/l) n=16 61-80 7 51 40.3-73.5 9 54 42.1-71.2
median values and ranges of the measured biochemical and haematological values are presented along with parameter reference ranges
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under five years of age. This small age difference may partly 
explain the differences seen in aetiologies when comparing 
studies. Behavioural differences of a younger population may 
increase the risk of trauma. It is interesting to note that in three 
cats the cause of septic peritonitis remained unidentified despite 
extensive investigation. septic peritonitis of unknown origin has 
previously been described in the cat [mueller and others 2001, 
Costello and others 2004], and has recently been reported 
in the dog [Culp and others 2009]. It may be that bacterial 
translocation from the GIT could trigger peritonitis. However, in 
the three cases described, there was no evidence of underlying 
GIT pathology. 
Consistent with previous studies, serum glucose concentration 
at the time of diagnosis was variable [King 1994, Costello and 
others 2004]. Hyperglycaemia was the most common finding. 
This may have been a result of a stress response. Blood glucose 
patterns are also influenced by the time course of the infection 
[miller and others 1980, Hardie and others 1986]. There was no 
significant difference between glucose levels when comparing 
survivors and non-survivors. It has previously been reported 
that the blood to peritoneal fluid glucose concentration ratio 
is a reliable diagnostic indicator of septic peritoneal effusion in 
the cat [Bonczynski and others 2003]. unfortunately, due to the 
retrospective nature of our study peritoneal fluid glucose levels 
were not available for any of the cats. 
a statistically significant difference was identified when 
comparing blood lactate between survivors and non-survivors, 
with measured lactate being higher in the non-survivor group. 
This suggests that lactate level at the time of diagnosis may be 
a useful prognostic indicator. In human medicine blood lactate 
is used as a prognostic indicator for critically ill patients [Bakker 
and others 1991]. Hyperlactaemia has also been associated 
with a higher mortality rate among dogs in an intensive care 
unit [Lagutchik and others 1998]. Interestingly, Levin and 
others [2004] identified that in the dog peritoneal fluid lactate 
concentration and blood to fluid lactate differences are accurate 
tests for detecting septic peritoneal effusions. This relationship 
was not however demonstrated in the cat. unfortunately, in our 
study peritoneal fluid lactate levels were not available for any of 
the cats and this relationship could therefore not be examined. 
Hypoalbuminaemia is a common finding in cats with sepsis 
[Brady and others 2000] and was observed in 14 of 17 cats 
where bio-chemistry results were available. Fluid therapy before 
diagnosis of septic peritonitis may have resulted in decreased 
albumin values in some cats. This would vary between individuals 
due to management variation between cats. Hypoalbuminaemia 
in animals with septic peritonitis can also result from a series 
of pathophysiological mechanisms including increased loss of 
albumin into the abdominal cavity [Brady and others 2000].
In the present study Gram negative enteric organisms were 
identified in all but one of the cats where culture was performed. 
This reflects the high incidence of gastrointestinal rupture as 
an underlying cause and is consistent with previous studies 
[Hardie and others 1986, swann and Hughes 2000, staatz 
and others 2002]. In one case Corynebacterium species was 
cultured. Despite careful and thorough physical examination 
and surgical exploration, the source of contamination remained 
undetermined. This bacterium can be found in the oral mucosa 
of cats [Gruffydd-Jones 1991] suggesting a cat bite could have 
been a possible underlying cause.
The overall mortality rate in this study was 54 per cent. This 
does fall within the range previously reported of 20-68 per cent 
[swann and Hughes 2000], however is greater than that of 
more recent studies in the cat [Costello and others 2004]. Cats 
that were euthanased due to septic peritonitis were classified 
as having died of septic peritonitis, as the proportion of 
euthanased animals in the study sample was so high, omitting 
these would have resulted in an extremely small sample size. 
Limitations of this method are acknowledged [Hosgood and 
scholl 2001]. Due to the retrospective nature of the study it 
was not possible to accurately classify reasons for euthanasia 
further (that is, such as disseminated intravascular coagulation 
and systemic inflammatory response syndrome), as information 
required for such classification was not available from the 
records. Neoplasia was identified in three of the cases of septic 
peritonitis. The outcome in these cases would likely have been 
partly determined by the underlying neoplasia of the condition 
and not by sepsis alone. This should therefore be considered 
when interpreting overall survival rates presented in this study. 
as with all retrospective studies, interpretation of the data is 
complicated by the large number of variables that cannot be 
controlled including, variability in management both before and 
upon admission to the hospital, the absence of haematology 
and biochemistry from some cats and the timing of euthanasia. 
Euthanasia can be affected by a combination of factors 
including disease progression, financial constraints, the owner 
and the veterinarian and so bias can be introduced. None of the 
cats included were reported to have been euthanased due to 
financial reasons. In all cases the reported reason for euthanasia 
was due to a grave prognosis and/or failure to respond to 
therapy. a prospective study would be helpful to examine and 
control for these varying factors; however, septic peritonitis is 
a multi-faceted condition and does not lend itself well to this 
type of study. Our study is also limited by the small number of 
cats. This is expected given the nature of the condition. The 
small sample size allows only the detection of large differences 
between survivors and non-survivors. small differences present 
in this study may therefore result in type II statistical errors. It 
is important to note the differences in inclusion criteria of cats 
included in our study when comparing our results to the only 
other large study of septic peritonitis in the cat [Costello and 
others 2004]. In their study, only 23 out of 51 cats had surgery, 
which was our criterion of inclu-sion. This, as well as other 
differences discussed, demonstrates the difficulty of comparing 
results from multiple studies. 
In conclusion, our results reveal that the survival rate in this 
group of cats with septic peritonitis was 46 per cent. Clinical 
presentation of septic peritonitis differed from that previously 
reported in both cats and dogs, with fewer cats exhibiting 
pain on abdominal palpation. In contrast to previous studies, 
trauma was the most common aetiology. If septic peritonitis is 
confirmed the cat owner should be given a guarded prognosis. 
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EJCAP special issue on Dentistry 
The ECJAP special issue 2010 is devoted to Dentistry. The papers 
are all written by some of the leading experts in Europe, and 
include the following titles: 
•  The evaluation of dentition and occlusion in dogs 
•  Management of tooth fractures 
•  The importance of dental radiology  
•  Periodontal disease from the whole body perspective 
•  Oral proliferative lesions in the dog and cat 
•  Myths and ethics in small animal dentistry 
The articles can be downloaded from the FECAVA website 
www.fecava.org free of charge. 
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Objective: Objective interpretation of dental disease in rabbits, guinea pigs and chinchillas with the use of 
anatomical reference lines.
Material and methods: Skull radiographs (laterolateral and dorsoventral view) of 528 small mammals (204 rabbits, 
151 guinea pigs and 173 chinchillas) were measured and analysed exactly in connection with a thorough intra- 
and extra-oral clinical examination. 464 animals showed variable signs of malocclusion whereas 64 animals had 
a normocclusion. The clinical and radiographic changes of 224 individuals (52 rabbits, 41 guinea pigs and 131 
chinchillas) were additionally compared with post mortem findings. 
Results: Particularly the comparison of the prepared skulls with the radiographs of the identical animals enabled 
the acquirement of species specific anatomical reference lines, that facilitate the objectice assessment of the severity 
of dental disease in elodont species.
Conclusion and clinical relevance: Using these reference lines the extent of malocclusion in rabbits, guinea pigs 
and chinchillas can be acquired more exactly and the results are reproducible by different examiners (staging). In 
addition to this these special lines facilitate to accurately monitor the progress of dental changes and thus to predict 
a probable long-term prognosis. The reference lines are absolutely applicable for daily use in practice.
Key words Malocclusion, normocclusion, radiography, assessment, long-term prognosis, staging
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Introduction
Dental diseases in rabbits and rodents are very common and 
often pose a challenge for the attending veterinarian. In this 
context, there have been numerous publications within the 
last two decades describing species pathological changes 
seen in the different species [1–45]. Many of these point out 
the importance of a tho rough radiographic examination of 
the skull using multiple views and give some helpful advice 
on the treatment, but they rarely describe objective methods 
to ascertain the degree of pathological changes such as tooth 
elongation. Thus it has not been possible to accurately monitor 
the progress of these changes. This paper, however, illustrates a 
range of radiographic anatomical landmarks for the examination 
of rabbits, guinea pigs and chinchillas. With the help of these 
landmarks specific reference lines can be defined which enable 
the veterinarian to discern the specific pathological changes 
and perform accurate measurements for long-term monitoring 
if necessary. Use of these anatomical reference lines greatly 
simplifies explanation of oral problems to the animal’s owners, 
as they can clearly see the extent of changes. This permits them 
to better understand the treatment recommendations and any 
associated complications. 
A specific reference line which demonstrates extraoral maxillary 
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cheek tooth elongation (apical intrusion) in chinchillas was 
published by Crossley in 1995 and 1996 [8, 10]. Five years later, 
Boehmer mentioned a similar basic reference line for rabbits and 
guinea pigs [1]. These three lines turned out to be so helpful in 
objectively illustrating extra-oral maxillary cheek tooth problems 
on laterolateral radiographs that studies were extended to include 
dorsoventral views. On the basis of numerous measurements 
performed on radiographs of 528 lagomorphs and rodents with 
and without pathological dental changes (Table 1), additional 
reference lines were acquired (Table 2).
The reference lines presented in this paper represent those that 
have survived validation by clinical and radiographic follow-
up plus post-mortem examinations performed on previously 
radiographed patients (Table 1).
Radiographic screening
Whilst the presence of some dental problems can be determined 
by physical examination, the bulk of the teeth is embedded in 
the jaw. In order to detect whether or not a rabbit, guinea pig 
or chinchilla suffers from tooth elongation or other changes in 
dental morphology, it is best to initially obtain two radiographic 
views of the skull (laterolateral and dorsoventral). These screening 
views can normally be achieved using light sedation. It helps to 
Radiographic Examinations
Rabbit Guinea pig Chinchilla Total animals
With dental disease 183 132 149 464
Clinically healthy  21  19  24  64
Totals 204 151 173 528
Post mortem Examinations
Rabbit Guinea pig Chinchilla Total animals
Skull dissection  52  41 131 224
Table 1 Radiographic (laterolateral and dorsoventral view each) and post-mortem examinations
Rabbit Guinea pig Chinchilla
Lateral 
projection
Dorsal limitation of 
maxillary tooth apices 
(white line)
Proximal end of the nasal 
bone to occipital 
protuberance
Rostral end of the nasal 
bone to dorsal notch of 
the tympanic bulla (about 
three quarters of its 
height)
Dorsal margin of the 
maxillary incisor to middle 
of the tympanic bulla
Occlusal plane (yellow line) Rostral end of the hard 
palate to one third of the 
height of the tympanic 
bulla
Rostral surface of the 
mandibular incisor (normal 
length) to the notch of 
the tympanic bulla (about 
three quarters of its 
height)
Tip of the upper incisors to 
the tympanic bulla (about 
three quarters of its height) 
Ventral limitation of 
mandibular tooth apices 
(blue line)
No penetration of the 
ventral mandibular cortex
No penetration of the 
ventral mandibular cortex
No penetration of the 
ventral mandibular cortex
Mismatch of the cheek 
tooth arcade (reliable 
sign of significant 
malocclusion) (red lines)
No regularity Rostral displacement of 
the mandible
Caudal displacement of 
the mandible
Dorsoventral  
projection
Lateral limitation of the 
maxillary tooth arcade
Lateral margin of the 
maxillary first incisor’s tip 
to medial edge of the 
mandibular ramus
Mesial border of the 
maxil lary incisor to the 
most caudolateral part of 
the ipsilateral mandible
Medial tip of the maxillary 
incisor to caudal extremity 
of the ipsilateral 
mandibular ramus
Medial limitation of the 
maxillary tooth arcade
Lateral rim of the 
contralateral maxillary 
incisor to the lateral 
border of the tympanic 
bulla
– –
Table 2 Reference lines (overview)
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obtain the latero lateral view with the mouth open a couple of 
millimetres as sepa ration of the cheek teeth improves definition 
of the occlusal line. Additional views are usually indicated after 
screening but positioning for these is more complicated, so 
they are best obtained once the animal is fully anaesthetised 
[1, 2]. When obtaining radiographs after placement of an 
endotracheal tube in rabbits, its location has to be taken into 
consideration as superimposition over the area of interest can 
obscure anatomy and pathological changes. Therefore the use 
of injectable anesthetic agents should be pre fered. The technical 
requirements for an adequate radiographic examination of the 
skull and hints for an optimal positioning in different species had 
been described in detail in a previous two-section paper [1, 2].
Rabbit
Normal radiographic anatomy of the skull
In clinically healthy animals no dental structure should extend 
dorsal to a reference line that connects the proximal end of the 
nasal bone with the tip of the occipital protuberance on the 
lateral view (Fig. 1a). In rabbits without pathological changes of 
the skull or teeth, another reference line runs parallel to the one 
previously mentioned, beginning at the rostral end of the hard 
palate (yellow line) mostly immediately caudal to the second 
incisor and extending caudally to pass through the tympanic 
bulla at approximately one third of its height. This line matches 
the occlusal plane in healthy rabbits. Although in this species 
six maxillary cheek teeth occlude with five mandibular ones, 
the maxillary and mandibular dental arcades are approximately 
the same length (red lines in Fig. 1a). Additionally, the apices 
of the mandibular cheek teeth should not penetrate the 
ventral mandibular cortex which should have a near even 
thickness beneath the first three cheek tooth apices (blue line). 
Remodelling of the ventral cortex adjacent to the tooth apices 
indicates that there is retrograde elongation of the lower cheek 
teeth. Furthermore the palatine and mandibular bone plates 
should slightly converge rostrally in normal rabbits (green lines 
in Fig. 1a) the amount of convergence varying somewhat with 
breed skull type.
There are also some relevant reference lines on the dorsoventral 
view of the skull which add to the information obtained from 
lateral views. The first line connects the lateral margin of the 
maxillary first incisor’s tip with the medial edge of the mandibular 
ramus on the same side caudally. Another line, which diverges 
slightly from the previous one, runs from the lateral border of 
the tympanic bulla to the lateral rim of the contralateral maxillary 
b) b)
c)
Fig. 2 Rabbit, 8 years, advanced stage of dental disease. See main 
text for explanation. a) Laterolateral view; b) dorsoventral view.
a)
Fig. 1 Radiographic anato mic reference lines of a clinically healthy 
rabbit. See main text for explanation. a) Laterolateral view; 
b) dorsoventral view; c) intraoral radiograph of the maxilla.
a)
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incisor (Fig. 1b). With the exception of the tips of the apices of 
the significantly curved maxillary second and third cheek teeth 
(see arrows in Figure 1c), no part of any tooth should be located 
outside these two lines. The two blue lines in Figure 1b indicate 
the medial cortex of the mandible. This should be almost 
straight, smooth and even. The maxillary premolar anatomy is 
shown in Figure 1c without superimposition of the mandible 
and its associated teeth.
Dental disease
The applicability of these anatomical reference lines is 
demonstrated in Figures 2 and 3 which show radiographs 
of two rabbits with advanced dental disease. In Figure 2a, a 
distinct retrograde apical elongation of multiple maxillary cheek 
teeth can be seen, as indicated by the white arrows. Additional 
findings are a malocclusion of the incisor teeth with penetration 
of the palatal bone cortex by the apex of at least one of the 
maxillary first incisors (green arrow). There is also considerable 
bone loss in the mandibular incisor region suggestive of an 
intra-bony abscess (blue arrows).
Even if laterolateral radiographs are imperfectly positioned the 
reference lines can be approximated and remain valid as shown 
in Figure 2a. Although the second reference line in yellow 
cannot be drawn as precisely, it still shows that the occlusal 
plane is close to normal rostrally, but there is slight elongation of 
the clinical crowns of the maxillary molars. 
The dorsoventral view of this rabbit (Fig. 2b) objectively 
demonstrates pathological changes of the maxillary cheek 
teeth. The retrograde root elongation is distinctly seen to be 
primarily affecting the right side. Both the lacrimal and maxillary 
zygomatic processes have been deeply penetrated and overlain 
by the intruded root apices of elongated teeth. All but the last 
maxillary cheek tooth of this side show laterally displaced apices 
which are more radiodense than normal and have lost the 
normal apical structure. On the left side, the maxillary second 
molar is displaced medially (Fig. 2b, green arrow). On the right 
side the medially displaced apex of the mandibular first cheek 
tooth (premolar 1), is also seen (Fig. 2b, blue arrow). 
Examination of the laterolateral and dorsoventral views in this 
case indicate that, as in many cases, additional radiographs 
are required for more accurate localization of the pathological 
changes. At least two oblique views (right and left side mirror 
image views) plus an intraoral image of the mandible are 
required in this case to ascertain whether the mandibular first 
cheek tooth is involved in the lesion affecting the mandibular 
incisor.
The reference lines drawn in Figure 3a highlight the distinctly 
intruded apices of the maxillary cheek teeth in another rabbit. 
The second to fourth maxillary cheek teeth (premolar 2 to molar 
1) are affected (white arrows). In addition, the bony part of the 
lacrimal duct is pathologically distended (red arrow) and the 
palate is remodelled to accommodate the intruding apices of 
the maxillary first incisors (green arrow). The occlusal plane is 
uneven and there is a significant mismatch in its length between 
maxilla and mandible (red lines). In addition to this, a deformity 
of one of the mandibular second cheek teeth can be seen, 
accompanied by a broadening of the caudal interdental space 
(blue arrow), despite superimposition of the two sides.
The dorsoventral view (Fig. 3b) illustrates a distinct pene tration of 
the zygomatic and lacrimal processes by marked retrograde tooth 
elongation of four teeth on the left side (white arrows) whilst 
just three maxillary cheek teeth are affected on the right (green 
arrows). The yellow arrows indicate a medial displacement of 
the apices of the first and second mandibular cheek teeth (right 
side). Care is required in order to distinguish radiographically 
between intermandibular retrograde tooth displacement (yellow 
arrows) and intraoral lingual spur formation (blue arrow) so a 
tho rough intraoral examination is essential at the same time as 
radio graphy. As with the previous case, an intraoral mandibular 
and two oblique radiographs are indicated to further distinguish 
the pathology.
Guinea Pig
Normal radiographic anatomy of the skull
Anatomical reference lines are also useful in guinea pigs. One 
connects the rostral end of the nasal bone with the dorsal notch 
of the tympanic bulla, about three quarters of the height of 
the bulla (Fig. 4a). In young guinea pigs the nasal bone forms a 
nearly straight line with the dorsal skull (orange line), whereas 
in older guinea pigs the two meet at a slight angle creating a 
dorsal concavity where they meet (orange line in Figures 5a and 
6a). 
As the occlusal surfaces of guinea pig cheek teeth are strongly 
a)
b)
Fig. 3 Rabbit, 3 years, 
advanced stage of dental 
disease. See main text for 
explanation. 
a) Laterolateral view; 
b) dorsoventral view.
a)
b)
51
EJCAP - Vol. 21 - Issue 1 April 2011
angled the occlusal plane does not present as a clear line on 
the laterolateral skull view (certain vagueness because of 
superimposition of the medial occlusal part of the upper and the 
lateral occlusal part of the lower cheek teeth), but it is mostly 
sufficiently visible to allow comparison with the next reference 
line. This is drawn from the point on the rostral surface of the 
mandibular incisor where it is crossed by a line projected cranially 
from the mandibular bone plate (green line), to the notch of the 
tympanic bulla (yellow line in Fig. 4a). This second reference line 
runs straight along the occlusal line of the mandibular cheek 
teeth. If the teeth are truly healthy it should also run through the 
wear surfaces of the maxillary and mandibular incisors when the 
mouth is closed, but this is rarely seen in practice as most guinea 
pigs have at least a minor degree of clinical crown elongation as 
seen in this case. 
As in rabbits, the ventral mandibular cortex (blue line) should not 
be penetrated by any of the cheek tooth apices which should 
be distinctly radiolucent. If thinning, distortion or penetration 
is evident (dark blue arrows), retrograde tooth elongation is 
present. The guinea pig’s oral profile differs from that of rabbits, 
the palatal and mandibular cortices converge noticeably rostrally 
when the mouth is closed (green lines). The greater the degree 
of intraoral tooth elongation the less obvious this becomes in 
guinea pigs. The maxillary and mandibular tooth arcades are 
each formed by four cheek teeth, the maxillary and mandibular 
arcades being of matching lengths (red lines). A discrepancy 
between arcade lengths is an indicator of significant dental 
problems in this species.
On the dorsoventral skull view the most informative reference 
line runs from the mesial border of the maxillary incisor to the 
most caudolateral part of the ipsilateral mandible, which lies 
at the level of the temporal zygomatic process (red arrows in 
Fig. 4b). In guinea pigs without any significant tooth elongation 
only the radiolucent apical bulla of the maxillary first cheek 
tooth (the premolar) extends beyond this line (white arrows). 
More caudally the prominent nearly crescent shaped bone 
structure crossing this line (blue arrows in Figures 4b, c and d) 
is the masseteric ridge of the mandible, where the deep part 
of the masseter muscle originates. The blue lines in Figure 4b 
indicates the medial cortical borders of the mandibles.
Dental disease
A mature guinea pig (see the angulation in the orange line) with 
advanced dental changes is shown in Figures 5a to 5d. The dorsal 
reference line clearly demonstrates a retrograde displacement of 
the reserve crown and apices of the third and fourth maxillary 
cheek teeth (white arrows in Fig. 5a). Dorsocaudal to that area, 
the radiograph of the skull shows radiodense bone formation 
that is clearly seen on the dissected skull from this animal (green 
arrow in Figures 5a and 5c). 
Fig. 4 Reference lines of a 
clinically healthy guinea 
pig. See main text for 
explanation. 
a) Laterolateral view; 
b) dorsoventral view; 
c-d) prepared skull.
a) b)
c)
d)
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The rostral point of origin for the second reference line is less 
precise in this animal due to changes in the mandibular bone 
plate and rostral tipping of the incisors; however, the line clearly 
shows an intraoral elongation of the mandibular molars (yellow 
line). Additionally the apexes and reserve crowns of all the cheek 
teeth on one side have penetrated the ventral mandibular cortex 
demonstrating marked apical elongation (light blue arrows in 
Figures 5a, c and d). Superimposed over this, cortical thinning 
and remodelling is clearly seen around the apices of the teeth 
in the other mandible (dark blue arrows in Figures 5a and d). 
Mismatch of the cheek tooth arcade lengths is clearly visible (red 
lines in Figure 5a). This is a very reliable sign of significant dental 
disease, particularly in this species. The mouth can clearly be 
seen to be in the fully open position in this animal as the rostral 
mandible and palate are almost parallel.
On the dorsoventral view (Fig. 5b) the reference lines reinforce 
Fig. 5 Guinea pig, 
4 years, advanced stage of 
dental disease. See main 
text for explanation. 
a) Laterola teral view; 
b) dorso ventral view. 
An incidental finding on 
this dorsoventral view is 
thickening of the bone of 
the left tympanic bulla. 
c) Skull lateral view of 
the left side; 
d) rostrocaudal view.
a) b)
c) d)
Fig. 6 Guinea pig, 7 months, early stage of dental disease. See main text for explanation. 
a) Laterolateral view before; b) immediately after trimming the teeth.
a) b)
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the findings from the lateral view: a distinct and generalized 
retrograde displacement of the reserve crowns and apices of 
both the mandibular and maxillary cheek teeth is evident (left 
side > right side). The elongated mandibular molar apices extend 
beyond the reference line laterally (light and dark blue arrows). 
The apices and elongated reserve crowns of the maxillary 
premolar and first molar also cross the reference line in the 
area of the infraorbital canal (white arrows in Figure 5b), with 
penetration of the bone cortex on the left side as confirmed 
from the dissected skull of this guinea pig (white arrows in 
Figures 5c and 5d). The light blue arrow in Figure 5d points 
at the mandibular left fourth cheek tooth which has extreme 
retrograde elongation and deviation. The second reference line 
along the medial cortex of the mandible, re presented by the blue 
lines in Figure 5b, is crossed medially by some tooth substance 
(red arrows). This correlates with a combination of probable 
rostral displacement of the mandible, as occurs accompanying 
intraoral tooth (clinical crown) elongation in many guinea pigs, 
and the overlong reserve crowns of the caudal maxillary molars 
of both sides.
The anatomical reference lines can be very helpful in interpreting 
post-treatment radiographs. As mentioned above, it is typical 
for the mandible to be forced rostrally in guinea pigs with intra-
oral tooth elongation (Fig. 6a). The yellow reference line in 
Figure 6a shows that the animal’s lower cheeck teeth are far 
too long. Extensive shortening and recreation of normal occlusal 
angulation is necessary for all the mandibular teeth including the 
incisors, the maxillary teeth then requiring occlusal adjustment 
to match the mandibular teeth. The goal of treatment is to reach 
as near to normal occlusion as possible. 
In this case the teeth were elongated without other significant 
changes so the teeth could be returned to near normal as 
shown by the reference line in Figure 6b. Following tooth 
trimming, the occlusal plane is at near normal height and the 
maxillary and mandibular tooth arcades are opposite each other 
and of approximately the same lengths. Critically judged the 
lower incisors are still a bit too long (white line) and miss typical 
chisel-shaped tips. Despite a good dental outcome such animals 
will have some problems chewing in the post-treatment period 
as the jaw muscles take time to readapt to a shorter working 
length during which time supportive feeding may be required.
Chinchilla
Normal radiographic anatomy of the skull
The most important reference line in chinchillas connects the 
dorsal margin of the maxillary incisor with the middle of the 
tympanic bulla, which is very large in chinchillas (Fig. 7a). In 
healthy animals the radiolucent soft tissue at the apices of the 
maxillary cheek teeth should be on this line, with no calcified 
tooth structures extending dorsal to it. As most pet chinchillas 
have retrograde displacement of the cheek tooth apices, it is 
uncommon to find animals without any abnormalities here. 
The second reference line begins at the tip of the upper incisors 
and extends caudally to pass through the tympanic bulla at 
approximately three quarters of its height. It runs almost parallel 
to the palatinal bone and passes through the occlusal surfaces 
or tips of both the incisors when they are of normal length and 
occlusion (yellow line in Fig. 7a). This position will need to be 
estimated in a manner similar to finding the point of origin on 
the rostral surface of the mandibular incisor in guinea pigs if 
the teeth are significantly elongated (green line). The reference 
line (yellow) coincides with the normal occlusal plane. Due to 
the physiology of normal chewing the occlusal plane should be 
horizontal and quite even in this species, resulting in a distinct 
straight line on laterolateral radiographs of clinically healthy 
chinchillas. 
The third reference line runs near parallel to the occlusal line 
extending caudally from the most ventral part of the mandibular 
incisor and corresponds with the ventral mandibular cortex 
below the apices of the first three cheek teeth (blue line). The 
ventral border of the mandible should be smooth and even 
without any thinning or distortions associated with intruded 
apices.
Reference lines on the dorsoventral view are not as accurate in 
identifying changes as those for guinea pigs, but are still useful. 
Lines can be drawn between the medial tip of each maxillary 
incisor and the caudal extremity of the ipsilateral mandibular 
ramus (white lines in Figure 7b) to mark the lateral limit of 
cheek teeth in clinically healthy animals. A transverse line drawn 
through the points where the first lines cross the rostral edge of 
Fig. 7 Reference lines in a healthy chinchilla. See main text for 
explanation. a) Laterolateral view; b) dorsoventral view.
a)
b)
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the maxillary zygomatic processes (green line Figure 7b) indicates 
the most rostral extent of clinically healthy cheek tooth apices.
Dental disease
Although the radiograph in Figure 8a does not show major 
pa thological changes, the reference lines clearly indicate that 
there is significant change present in this chinchilla. The upper 
line de monstrates an advanced stage of retrograde tooth 
elongation of all the maxillary cheek teeth (white arrows). The 
mandibular molar clinical crowns are elongated (broken yellow 
line and yellow arrows in Figure 8a) and need to be shortened. 
In order to be able to determine the correct rostral end of both 
yellow lines the length of the upper and lower incisors has to 
be corrected first (white lines – compare with Figure 7a). Note 
that the increased divergent curvatures rostrally and caudally 
have elongated the occlusal surfaces. The ventral cortex of the 
mandible is penetrated by the apices of the second and third 
cheek teeth (blue arrows). As such apical changes cannot be 
reversed, ongoing dental problems are expected even if the 
occlusal surfaces are returned to normal alignment.
Contrary to the situation in guinea pigs with dental disease, 
where the lower jaw moves rostrally, the mandible typically 
shifts caudally in chinchillas. This is scarcely visible in Figure 8a. 
Chinchillas with this incongruity have significant dental 
problems, the degree of mandibular displacement closely 
correlating with the extent of clinical crown elongation. It 
represents the combined effects of tooth curvatures and the 
resultant “open mouth” jaw alignment due to clinical crown 
elongation. The dental arcades are often displaced by as much 
as half (red arrows in Figure 8b) or even the whole width of a 
cheek tooth (red arrows in Figure 8c).
Dorsoventral views often permit easy detection of changes in 
dental morphology which can be clearly seen as irregularities of 
tooth structure and alignment. The blue arrows in Figures 8d and 
8e point at the intruded apices of the caudal mandibular molars. 
The white arrows mark the apices of the first two maxillary 
cheek teeth (premolars) which extend beyond the rostral 
reference line. Typically, they elongate in an arc and penetrate 
the maxillary bone in this area, obstructing or obliterating the 
nasolacrimal ducts. It is important to distinguish clinical crown 
from apices on this view: the yellow arrows in Figure 8d indicate 
the intraorally and buccally elongated first cheek tooth on both 
sides in this animal. The clinical crowns appear more lucent 
compared with the intra-alveolar parts of the cheek teeth which 
appear relatively radiodense, being surrounded by alveolar bone 
and soft tissues.
Fig. 8 Chinchillas with different stages of dental disease. 
See main text for explanation. 
a) Chinchilla 11 years, early stage of dental disease (laterolateral view); 
b) Chinchilla 5 years, more advanced dental disease (laterolateral view); 
c) Chinchilla 2 years, advanced dental disease (laterolateral view); 
d) Chinchilla 3 years, advanced dental disease (dorsoventral view); 
e) Chinchilla 5 years, advanced dental disease (dorsoventral view).
a)
c)
d) e)
b)
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As in guinea pigs, the reference lines permit checking for correct 
shortening of the cheek teeth. Figure 9a shows the laterolateral 
view of a chinchilla with excessive intra- and extra-oral tooth 
elongation. The two yellow lines approximate the normal 
occlusal lines and clearly indicate how much tooth substance 
has to be removed (area in between the lines). This is up to 
one third of the maxillary tooth substance. The corresponding 
reference line on the post treatment image (Fig. 9b) shows that 
the shortening was not entirely successful. The last mandibular 
molar is still somewhat too long (yellow arrow), but in general 
the occlusion is much better. It is often difficult to remove 
sufficient length of tooth as the gingiva has usually grown 
to cover part of the elongated clinical crowns, so repeated 
occlusal adjustment should be scheduled before there is further 
significant elongation to make further adjustments. In cases 
with gross clinical crown elongation it is preferable to stage 
treatment, only removing about two third of the measured 
excess tooth length initially, scheduling completion of treatment 
2–3 weeks later. This permits better muscle re-adaptation to the 
shorter working length and gives time for the gingiva to recede 
exposing enough crown for more effective occlusal correction.
As the animal had to be euthanized a year later, the dissected 
skull of this chinchilla was examined (Figs. 9c and 9d). This 
demonstrates the generalized intra- and extra-oral elongation 
of all teeth along with the associated bony changes that were 
evident on the previous radiographs: retrograde displacement of 
all the maxillary cheek tooth apices, the accompanying maxillary 
bone penetration (black arrows), apparent caudal dislocation 
of the mandible (red arrow) and the ventral distension of the 
mandibular cortex (blue arrows).
Conclusion
Anatomical reference lines adapted to the particular anatomy 
of the species enable the veterinarian to more accurately assess 
and evaluate aspects of dental disease in rabbits, guinea pigs 
and chinchillas. Reference lines provide an objective measure 
of tooth elongation which can be demonstrated to owners, 
permit assessment of prognosis, appropriate treatment planning 
and assessment of success of treatment for clinical crown 
elongation. They make it easier for veterinarians to help their 
elodont patients.
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Objective: To report long-term clinical outcome and radiographic results in dogs diagnosed with partial bicipital 
rupture and treated by arthroscopic tenotomy.
Materials and methods: The medical records of dogs that had undergone arthroscopic tenotomy were 
retrospectively reviewed. Inclusion criteria for this study were: performance of an arthroscopic tenotomy between 
August 1999 and July 2007, availability of arthroscopic records data for review, and ability to obtain follow-up data 
for more than 1 year after arthroscopic tenotomy. In all cases, owners were interviewed at re-check appointments or 
via telephone to determine perceived outcome after surgery.
Results: Forty-seven arthroscopic tenotomies were performed on 40 dogs without any major surgical complications. 
Long-term follow-up examinations ranging from 12 months to 48 months (mean 26 months) after the tenotomy 
were obtained for 24 dogs (25 shoulders).  Clinical outcome was excellent in 22 shoulders (88%), with each dog 
showing a full return of limb function. A total of 10 dogs (11 joints) were evaluated radiographically and revealed 
no progression of pathology in 6 joints (55%). Five joints (45%) showed a limited progression of pathology 
radiographically.
Conclusion: Arthroscopic tenotomy in the treatment of bicipital tendon partial rupture yields favourable long-
term clinical results and a high degree of owner satisfaction. The feasibility of this technique and the long-term 
clinical and radiographic outcome from our study indicate that this technique can be considered a reliable and safe 
treatment for partial bicipital rupture.
summary
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Introduction
Tendon and ligament conditions are becoming more frequently 
recognised as a cause of shoulder lameness [1-5]. according to 
Bardet [5], the most commonly reported conditions affecting 
the bicipital tendon are partial or complete tears at its origin. 
The aetiology of partial or complete ruptures and the associated 
tenosynovitis is complex [6-9]. 
The disease occurs primarily in large or medium-sized dogs 
of middle-age or older. Clinical signs are usually chronic and 
progressive [9-11].
Typical clinical findings are a positive biceps test and, when 
a complete bicipital rupture is present, hyperextension of the 
elbow along with flexion of the shoulder [1]. Diagnostic imaging 
for a partially or completely ruptured biceps tendon includes 
radiography, arthrography, ultrasonography and arthroscopy. 
Primary radiographic signs are changes at the supraglenoid 
tubercle, such as osteophytosis, osteosclerosis, a radiolucent 
area and deformation of the tubercle and calcification and 
osteophytosis within the tendon sheath. secondary arthrosis 
develops with chronicity of the lesion [11]. Confirmation of the 
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diagnosis can be made with ultrasound showing a changed 
structure of the proximal part of the biceps tendon as well as 
defects or a complete rupture. an increased amount of fluid 
within the tendon sheath is often seen as a secondary sign of 
synovitis within the joint [12- 13]. arthrography can also be used 
to confirm the diagnosis by demonstrating a changed delineation 
of the biceps tendon and its sheath [14-16]. arthroscopy allows 
direct inspection of the biceps tendon, showing thickening of 
the tendon, ruptured fibres  and hyperplastic remnants [17-18]. 
recently, mrI has shown great potential as a diagnostic tool 
in the evaluation of canine shoulder disease, including partial 
bicipital rupture [19]. a correct diagnosis is crucial for obtaining 
the desired treatment result. 
The stabilising function of the biceps tendon in the shoulder 
remains controversial therefore treatment varies widely 
among surgeons, ranging from non-operative management 
to bicipital repair, tenotomy or tenodesis. surgical treatment 
is recommended for dogs that do not respond to medical 
treatment. according to the veterinary literature, good and 
excellent result have been obtained with both tenotomy and 
tenodesis [20-22], however, the ultimate outcome was based on 
preliminary results and long-term clinical results are unavailable. 
The purpose of this study is to evaluate the long-term clinical 
outcome and radiographic results in dogs diagnosed with partial 
bicipital rupture treated by arthroscopic tenotomy. 
Materials and methods 
Inclusion criteria 
The medical records of dogs that underwent arthroscopic 
tenotomy as treatment for partial rupture of the biceps tendon 
(PrB) were retrospectively reviewed. Inclusion criteria for this 
study were: performance of an arthroscopic tenotomy between 
august 1999 and July 2007, availability of arthroscopic records 
data for review, and ability to obtain follow-up data for more 
than 1 year after the arthroscopic tenotomy. 
For this study, diagnosis of PrB was based on the presence 
of definitive forelimb lameness localised to the shoulder, 
filling defects of the biceps brachii tendon sheath, abnormal 
delineation of the tendon seen on a positive contrast arthrogram 
or an amorphous, inhomogeneous, hyperechoic biceps brachii 
tendon on ultrasonographic examination and confirmed by 
arthroscopy. retrieved data included, age, gender, breed, 
activity status, orthopaedic examination findings, arthroscopic 
findings and follow-up examinations. 
Arthroscopy
shoulder arthroscopy was performed in a standardised manner 
for all dogs using craniolateral and caudolateral portals (Wolf 
2.7 mm, 30° fore-oblique arthroscope) (richard Wolf GmbH, 
Knittlingen Germany) [18]. The joint was explored using a 
standard compartmental approach. The presence of a partial 
bicipital rupture was assessed by visual examination and probing 
the tendon while extending and flexing the elbow. Transection 
of the tendon was achieved by an arthroscopic hook scissor 
(richard Wolf Gmbh, Knittlingen, nr. 98487.04). at the time of 
arthroscopy, digital images of each structure were obtained for 
subsequent evaluation and data recording. 
Post-operative care 
The instructions for initial post-operative care that were given 
to owners included short leash walks, or restriction of the dog 
to a small room when unobserved, for 6 weeks after surgery. 
In addition, analgesics were administered for 3 weeks however 
physiotherapy was not performed. When there was no evidence 
of pain at the 6 week re-check, a progressive return to full 
activity and non-concussive activities were encouraged over the 
subsequent 6 weeks. unrestricted activity was allowed after 12 
weeks of convalescence. 
Outcome 
In order to evaluate the treatment outcome the owners were 
asked to present their dogs for a clinical and radiological re-
examination (Group 1). If the owners could not present the 
patient to the clinic again the treatment was evaluated by 
means of functional results reported by the owner through 
a questionnaire (Group 2). The extent of the remaining 
complaints and complications were of special interest. all of the 
dogs presented were observed and video recorded walking and 
trotting on leash, in a straight line and in a circle (2 directions). 
Two investigators independently assigned an individual lameness 
score for each forelimb of each dog. The lameness score was 
based on a 5-point scale: 0 = no detectable lameness, 1 = 
mild weight-bearing lameness, 2 = moderate weight-bearing 
lameness, 3 = marked weight-bearing lameness, 4 = non-
weight-bearing lameness. The evaluation of the treatment’s 
success was based on the findings of the clinical examination 
and on the owners’ reports (questionnaires). The outcome was 
rated ‘excellent’ when no lameness was observed or reported in 
all activities without the use of anti-inflammatory medication. 
The outcome was rated ‘good’ in dogs with occasional 
lameness or exercise intolerance sensitive to anti-inflammatory 
medication. all other outcomes were rated ‘poor’. radiographs 
from the initial examination and the follow-up examination 
were evaluated and compared with respect to subchondral bone 
sclerosis, remodelling, osteophytosis and enthesiophytosis. The 
joint was then subjectively graded based on the severity of the 
radiographic arthrosis (Fig. 1). 
Results 
Patients 
47 arthroscopic tenotomies were performed in 40 dogs, but 
only 24 dogs met the inclusion criteria due to lack of follow-up. 
Nine dogs were no longer living at the time of owner contact 
and so no interview was performed. Contact data were not 
available for 7 other dogs because of address change. all of the 
dogs were large breed and included: Bernese mountain Dog 
(7), Newfoundland (2), Golden retriever (3), Border Collie (3), 
Crossbreed (2), rottweiler (1), american staffordshire Terrier (1), 
Labrador retriever (1), German shepherd (1), Irish Wolf Hound 
(1), Beauceron (1), and Nova scotia Duck Tolling retriever (1). 
The dogs’ ages ranged from 6 months to 10 years (mean: 
42 months). The group included 10 intact females, 1 spayed 
female, 9 intact males, and 4 castrated males. 
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Clinical and arthroscopic findings
The degree of lameness varied among the dogs (n=24), ranging 
from subtle, chronic intermittent lameness to permanent non–
weight-bearing lameness. The duration of lameness ranged 
from 3 weeks to 3 years (mean: 3.5 months). Only in half of 
the cases, was there a history of trauma and acute onset of 
lameness. Orthopaedic examination findings include, atrophied 
shoulder muscles (92%), a painful shoulder in extension (20%), 
a positive biceps test ( 88%) and hyperextension of the elbow 
(8%). Besides the ruptured aspect of the biceps tendon, the most 
consistent arthroscopic findings were synovial hypertrophy and 
hyperaemia (88%) and fibrillation of the medial glenohumeral 
ligament (32%). Other findings included fibrillation of articular 
cartilage of the humeral head (12%), fibrillation of the 
subscapularis muscle (8%) and a partial rupture of the medial 
glenohumeral ligament (4%).
Outcome and radiographic evaluation 
Long-term follow-up examinations were obtained for 24 dogs 
(25 shoulders) and ranged from 12 months to 48 months (mean: 
26 months). No complications related to the tenotomy were 
reported. The follow-up exam consisted of a second clinical 
and radiological examination of the affected dogs (Group 1; 
n= 10 dogs (11 shoulders)) or a questionnaire answered by the 
patient’s owner (Group 2; n=14 dogs (14 shoulders). In Group 1, 
81% (9/11) showed an excellent result, with relief of symptoms 
at a mean time of 3 weeks. The dogs had no abnormalities on 
clinical examination, were without lameness at the time of the 
long-term follow-up examination, and did not show any signs 
of lameness after exercise. The result for one dog was rated as 
‘good’ (lameness score 1). This dog showed no signs of lameness 
most of the time, however, after hard exercise or when running in 
circles, a low degree lameness was noticed. One result was rated 
Grade 0 Grade 1 Grade 2 Grade 3
Grade 0: No radiographic abnormality
Grade 1: Sclerosis at the glenoid rim and medial trochlea of the biciptal sulcus
Grade 2: Osteophytosis less than 3mm at the caudal rim of the humeral head
Grade 3: Osteophytosis more than 3 mm at the caudal rim of the humeral head 
Figure 1. Joints with PBR with different degree of arthrosis
Table 1: Clinical, radiographic and follow-up findings of the dogs that were represented for clinical and radiographic re-evaluation (Group 1).
Clinical outcome and radiographic data for Group 1
Breed Age at first 
presentation
Pre-op radio-
graphic arthrosis
Post-op radio-
graphic arthrosis
Clinical 
outcome
Time to 
follow-up
Newfoundland 6 years, 1month Grade I Grade I excellent 14 months
Beauceron 6 years, 11 months Grade I Grade II poor 32 months 
Bernese mountain Dog 4 years, 4 months Grade II Grade II excellent 22 months
Border Collie 4 years, 5 months Grade I Grade II excellent 22 months
Border Collie 4 years, 6 months Grade I Grade I excellent 20 months
Border Collie 3 years, 9 months Grade II Grade III good 31 months
Bernese mountain Dog 10 months Grade I Grade II excellent 43 months
Bernese mountain Dog 1 year, 11 months Grade I Grade I excellent 14 months
Bernese mountain Dog 3 years, 9 months Grade I Grade I excellent 24 months
rottweiler 3 years, 7 months Grade I Grade II excellent 31 months
Irish Wolf Hound 6 years, 6 months Grade I Grade I excellent 13 months 
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as ‘poor’, as the dog suffered from permanent low to moderate 
lameness. a second arthroscopic examination revealed fibrous 
tissue originating from the supraglenoidal tubercle running in 
the inter-tubercular groove. The lameness did not improve after 
the second arthroscopic transection of the fibrous tissue. Despite 
the latter case, none of the dogs developed an abnormal gait 
or an inability to flex the elbow. In Group 2, 92% (13/14) of the 
results obtained via the questionnaire were rated as ‘excellent’; 
one report was rated as ‘good’. No cosmetic deformities were 
noticed in Group 1 or in Group 2. a total of 10 dogs (11 joints) 
were evaluated radiographically and revealed no progression of 
pathology in 6 joints (55%). Five joints (45%) showed a limited 
progression of pathology. The median progression was 0 (Table 
1). 
Discussion 
The goal of surgical treatment in partial bicipital rupture is to 
eliminate movement of the tendon in the inflamed tendon 
sheath. This can be accomplished with either tenodesis or 
tenotomy. Initially, biceps tenotomy was criticised based on 
bio-mechanical data and a lack of long-term clinical results [22-
24]. The biceps muscle-tendon unit is one of many structures 
in the canine body to cross two joints. In the elbow, it serves 
as a flexor and supinator. Whilst its function at the elbow is 
clear, its role in the shoulder remains controversial. an in vitro 
study by sidaway [24] has confirmed that the biceps tendon 
contributes to the passive shoulder stability, particularly in 
the neutral and flexed positions. However, scapulo-humeral 
stability after bicipital tenotomy should be comparable to that 
after a traditional bicipital tenodesis. If significant instability had 
been present after tenotomy, we would have expected clinical, 
and eventually radiographic signs after a longer period of time, 
which did not occur in this study. It seems clear that the biceps 
tendon does not have a primary stabilizing function in the 
shoulder but has multiple secondary roles instead. Therefore, 
as no primary function can be isolated it is not surprising that 
there is no single reliable clinical test or single treatment in 
biceps pathology. 
In human medicine, tenodesis was initially advised to re-
establish the resting muscle length and thereby maintain the 
length-tension relationship, prevent muscle atrophy, avoid 
cramping pain, maintain elbow flexion and supination strength 
and avoid cosmetic deformity (Popeye sign) [25]. Currently, 
tenotomy is becoming more popular than tenodesis [26-28]. 
mariani et al. [29] compared 30 patients with spontaneous 
rupture of the long head of the biceps treated non-operatively 
with 26 patients who underwent early biceps tenodesis. They 
found only a 13% difference in the biceps’ supination strength 
between the two groups and no difference at all in elbow 
flexion strength. However, in patients who are concerned 
about potential cosmetic deformity and associated dysfunction, 
tenodesis might be advantageous. It is important to note that 
none of the dogs in this study developed an abnormal gait, a 
cosmetic deformity or the inability to flex the elbow. 
Pre-operative clinical findings in this study are similar to 
those reported in the literature however in 2 patients (8%) 
hyperextension of the elbow was possible despite the fact that 
the biceps tendon was not completely ruptured. 
Clinical outcome was excellent in 22 shoulders (88%), with 
each dog showing a full return of limb function. symptoms 
disappeared rapidly in the majority of the dogs at a mean time 
of 3 weeks. since most dogs showed immediate pain relief it is 
likely that tenotomy eliminates the painful traction forces that 
are exerted on the non-ruptured part of the affected biceps 
tendon and its attachment to the supraglenoid tubercle. In 
one case, the dog had a recurrence of symptoms six weeks 
after surgery and suffered from low to moderate permanent 
lameness for 24 months. after other joint problems were ruled 
out, the dog underwent a second arthroscopic examination 
which revealed the presence of fibrous tissue at the normal 
location of the bicipital tendon. The authors believed that this 
was the result of an incomplete tenotomy of the biceps tendon 
in the initial arthroscopy. During arthroscopic tenotomy, the 
tendon does not always retract clearly in its groove which 
can make it difficult to judge whether or not the tendon is 
completely transected, particularly in chronic cases. However, 
even after the second tenotomy the owner could still see no 
improvement 10 months post-operatively. another explanation 
could be that the initial diagnosis was incorrect. This stresses 
the importance of a complete diagnostic work-up that carefully 
rules out other pathologies. Fibrillation of the mGHL present 
in 32% (8/25) and a partial rupture of the mGHL present in 
4% (1/25), were regarded as secondary findings. Post-operative 
exercise restriction could have contributed to the recovery 
of these structures. None were surgically treated and the 
outcome was rated ‘excellent’ in all affected dogs, therefore, 
we recommend caution in interpreting such findings as a 
primary clinical problem, because, in our opinion, some could 
be coincidental findings of no clinical significance. although 
it was limited, degenerative joint disease was present pre-
operatively in all dogs from Group 1. We could not demonstrate 
a correlation between presence of increase in grade and the 
clinical outcome, however, all dogs with post-operative grade 
I (5/11) had excellent clinical outcomes. Dogs showing clinical 
signs for more than 5 weeks were associated with higher post-
operative grades, which suggests that early recognition and 
treatment could produce better clinical outcomes. The number 
of radiographic cases is not large enough for statistical analysis.
 
a major limitation of our study is that tenodesis (open or 
arthroscopically) was not evaluated as an alternative treatment. 
Because no comparison was made, tenotomy cannot be 
considered superior to tenodesis based on the available data, 
however data from the present study indicate that tenotomy 
results in good to excellent long-term outcome. Long-term 
studies designed to evaluate a more complex treatment 
(tenodesis) have not yet been made. another limitation is 
that dogs from Group 2 were evaluated only by a subjective 
questionnaire, however the results achieved in both groups were 
consistent, and the overall clinical outcome for both groups was 
rated ‘excellent’ in 88% of cases. Force plate analysis, computed 
tomography and arthroscopy would have contributed important 
data to this study, but they were beyond the scope of this work 
for financial reasons and the desire not to tax the goodwill of 
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the owners. Indeed, owners are not inclined to come for an 
additional examination if no problems are present. This could 
have affected our results − even positively − because, for the 
majority of the dogs, the short-term results (which are not 
included in this study) were rewarding. 
Variables in our study were epidemiologic aspects and the 
different functions, environments and pre-surgical management. 
Only one dog from Group 1 was a working dog – nevertheless, 
outcome was excellent after bilateral arthroscopic tenotomy. 
We conclude that arthroscopic tenotomy in the treatment of 
bicipital partial rupture yields favourable long-term clinical results 
and a high degree of owner satisfaction. although it cannot be 
considered superior to tenodesis, the feasibility of applying this 
technique and the long-term clinical and radiographic outcomes 
from our study suggest that this technique can be considered a 
safe, reliable treatment for partial bicipital rupture.
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This article provides an overview of diabetes in dogs and cats in general and details the importance of chromium 
action in the therapy of diabetic patients. In the final section, results of chromium supplementation in 17 diabetic 
dogs are described.  The levels of glycaemia of all animals initially treated with insulin only are statistically 
compared to glycaemic levels after adding bioactive chromium to the therapy.  A statistically significant positive 
effect of chromium supplementation to diabetic dogs treated with insulin is documented. The decrease of glucose 
level may be explained by elevated insulin activity or as reduction of insulin resistance, mediated by means of 
chromium supplementation.
Key words: diabetes mellitus, chromium, therapy, dog
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Introduction
Diabetes mellitus is a relatively frequent endocrine disturbance 
of dogs and cats. The incidence in both species is approximately 
1:100 to 1:500 [1]. Typically diabetes affects older dogs 
between 7-9 years and cats between 9-11 years. The occurrence 
of juvenile diabetes in dogs and cats before the first year of age 
is uncommon [1].
Blood glucose measurement should be a routine part of the 
emergency database, preoperative assessments, and preventive 
geriatric programmes. Additionally, levels of glycaemia and 
glycosuria should be one of the basic laboratory parameters 
measured in the differential diagnosis of polyuria/polydipsia. 
These screening tests can enable the early diagnosis of diabetes. 
The need for injectable insulin is the basis for the current 
classification of diabetes in dogs and cats. In animals, the 
nomenclature insulin dependent diabetes mellitus (IDDM) and 
non insulin dependent diabetes mellitus (NIDDM) is preferred to 
the human subdivision of Type I and Type II diabetes [1].  However, 
diabetes in dogs and cats may not fall within this preferred 
classification. Some patients with NIDDM, particularly cats, have 
varying insulin requirements throughout disease progression [1]. 
This is due to increasing insulin resistance and varying insulin 
production in the damaged beta cells of the pancreas [1]. A 
range of pathological processes in the pancreatic islet cells, 
either progressive or static, can vary from mild to severe [1]. 
The severity of the pathological process contributes to the stage 
of the disease, as it affects the ability of the islets to produce 
insulin, resulting in a reducing insulin secretion with time and 
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disease progression. Therapeutic success is determined by the 
tissue response to insulin, which in turn depends on concurrent 
inflammatory, infectious, neoplastic, or hormonal disorders, and 
therefore the need and dosage of insulin [1].
 
IDDM is characterized by permanent hypoinsulinaemia and the 
need to provide exogenous insulin to maintain normoglycaemia 
[2] Aetiology of diabetes is multifactorial, (see Table 1).
However, an increased risk of diabetes is seen in some breeds 
(Australian terrier, Schnauzer, Bichon Frise, Pomeranian, Fox 
terrier, Poodle, Yorkshire terrier, Maltese and others) [2].
The most common cause of IDDM in dogs is probably the 
autoimmune destruction of the pancreatic islet in combination 
with genetic predispositions and environmental factors [1].
 
Clinically NIDDM is seen more frequently in cats than in dogs, 
and it is commonly caused by pancreatic islet amyloidosis. 
Like insulin, amyloid peptides, or amylin, are secreted from 
pancreatic beta cells and act predominantly postprandially as 
neuroendocrine hormones with additional gluco-regulatory 
effects synergic to insulin. Chronically increased insulin and 
amylin secretion, which occur in obesity or other insulin resistant 
states, leads to aggregation and formation of amylin deposits. 
Amylin is cytotoxic to the pancreas leading to apoptosis of islet 
cells, and subsequently a reduction in insulin secretion. The 
stage of this pathologic process determines if diabetes is insulin 
dependent (in a cat with complete islet destruction) or non 
insulin dependent (in a cat with a partial islet destruction). If the 
process of amyloid deposition in cats is progressive, it gradually 
results in the conversion of NIDDM to IDDM. The presence and 
range of insulin resistance in cats with partial islet destruction is 
variable and affects the clinical stage of the disease.  As insulin 
resistance increases so does the need for insulin secretion. With a 
higher degree of insulin resistance, and a larger loss of functional 
islets, the probability of hyperglycaemia increases. Persistent 
hyperglycaemia can consequently suppress the function of 
the remaining beta cells and cause hypo-insulinaemia thereby 
increasing levels of hyperglycaemia. 
Causal factors of NIDDM in cats are obesity, chronic pancreatitis, 
acromegaly, hyper-adrenocorticism and long term treatment 
with glucocorticoids or megoestrol acetate. 
In dogs NIDDM usually manifests as a result of concurrent disease 
antagonising insulin or as a result of medicaments, particularly 
glucocorticoids [1]. A typical example of hyperglycaemia is in the 
intact bitch during dioestrus [1].
 
Diagnosis of diabetes in dogs and cats is based on the presence 
of hyperglycaemia and glycosuria while fasting [1). In dogs IDDM 
is the most common type, so all of these patients should be 
treated with insulin where an underlying condition antagonising 
insulin secretion is not suspected [1]. In cats it is important to 
try to differentiate IDDM from NIDDM, because of the higher 
probability of NIDDM or transient type diabetes.  Measuring 
serum insulin levels to differentiate IDDM and NIDDM does 
not appear to be reliable. If serum insulin levels are higher than 
normal (mean concentration above 12 μU/l), functional beta 
cells are likely and there is a possibility of NIDDM [1]. However, 
reliable differentiation of IDDM and NIDDM in cats is only 
possible retrospectively, by the assessment of the response to 
insulin after several weeks of treatment. The initial decision to 
use insulin or oral anti-diabetics is dependent on the clinical 
symptoms, the presence of ketoacidosis, the health status of 
the cat, and also the compliance of the pet-owner [1].
 
As a consequence of a relative or absolute lack of insulin 
secretion, hyperglycaemia is caused by decreasing the utilisation 
of glucose, amino acids, and fatty acids in peripheral tissues, 
and increasing hepatic glycogenolysis and gluconeogenesis. 
Additionally glucose absorbed from food increases the level of 
hyperglycaemia.   Hyperglycaemia saturates renal tubular function 
preventing reabsorption of glucose back from glomerular 
ultrafiltrate, leading to glycosuria. This osmotic diuresis leads to 
polyuria and compensatory polydipsia to prevent dehydration. 
The decreased ability of peripheral tissues to utilise absorbed 
glucose leads to weight loss. The body tries to compensate 
this “peripheral starving” by increasing appetite. Polyphagia 
and the feeling of hunger occur despite hyperglycaemia by 
blocking the entrance of sufficient amounts of glucose to cells 
of the hypothalamic centre [1]. The situation of uncontrolled 
hyperglycaemia leads to diabetic ketoacidosis.  This is caused by 
the oxidation of non esterified or free fatty acids in the liver, and 
their use as a source of energy for tissues with a lack of glucose. 
These free fatty acids are mobilized from triglycerides from fat 
deposits, and also from the adjustment of the lipid metabolism 
from synthesis to oxygenation and ketogenesis.  Insulin is a 
powerful inhibitor of lipolysis and oxidation of free fatty acids. 
dog cat
Genetic disposition Pancreatic islet amyloidosis 
Pancreatitis Obesity
Immune mediated insulinitis Pancreatitis
Obesity Other endocrinopathies
- hyperadrenocorticism
- acromegaly
- hyperthyreosis
Other endocrinopathies
- hyperadrenocorticism
- dioestrus-induced increased 
levels of growth hormone 
- hypothyreosis
iatrogenic
-glucocorticoids 
- megoestrol acetate
iatrogenic-glucocorticoids Infection
Infection Other diseases
- renal insufficiency
- heart diseases
Other diseases
- renal insufficiency
- heart disease
Hyperlipidaemia
Hyperlipidaemia Genetic disposition
Pancreatic islet amyloidosis Immune mediated insulinitis
Tab.1 Potential aetiologic factors of IDDM (modified from 
Ettinger)1
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When insulin is defi cient, lipolysis increases the availability of 
free fatty acids for the liver, predisposing it to ketogenesis. 
Insulin reduction contributes to the increased loss of electrolytes 
and water from the kidneys, resulting in a decrease in the 
circulating blood volume. Subsequently hypoperfusion and pre-
renal azotaemia develop.  Increasing levels of ketones leads to 
progressive exhaustion of buffer mechanisms and metabolic 
acidosis. Vomiting and diarrhoea further exacerbate the water 
and electrolyte loss, increasing the acidosis and dehydration. 
The blood volume continues to decrease leading to further 
concentration of glucose and ketones. Subsequently, blood 
osmolality increases and water moves to the extracellular space 
leading to cellular dehydration and eventually coma [1].
Mechanism of chromium action in the organism and its 
relationship to diabetes
Chromium is an essential element involved in saccharide and 
lipid metabolism. Chromium is an ultra trace element, making 
its serum level practically impossible to analyse exactly. In 
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Fig.1 Apo-chromodulin obtains  4 x Cr3 +  from trasferin. 
Apo-chromodulin transfers to active chromodulin.
Fig. 2 Chromodulin binds to the inner part of the insulin receptor. 
Chromodulin fully activates the insulin receptor. The effect of  
tyrosinkinase increases 18x and together with fosfotyrosin-fosfatase 
the adequate glucose metabolism is reached.
Fig. 3 After fi nishing the glucose metabolism, the inactivated 
insulin is released from the receptor bond. Similarly chromodulin 
bound with 4 atoms of Cr3  is excreted to urine. The new 
apochromodulin appears in the cell.
Fig. 4 The full saturation  with chromium.
Fig. 5 Insuffi cient saturation with chromium.
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humans, metabolic signs of the lack of chromium are fasting 
hyperglycaemia and hyper-insulinaemia, disturbed glucose 
tolerance, decreased number of activated insulin receptors, and 
the increased concentration of cholesterol and triglycerides. In 
healthy people chromium is excreted by the kidneys and about 
85-95% is reabsorbed back through the tubules. In human 
patients with Type II diabetes excessive loss of chromium 
through the urine is seen, the cause of which has only recently 
been discovered.  Increased loss is associated with foods rich 
in saccharides, which can increase insulin resistance even 
during insulin therapy [7]. Only a small per cent of chromium is 
absorbed from food.  Absorption is influenced by the chemical 
form of chromium [2].
Current model for the effect of chromium
After the trivalent chromium is absorbed, it is transported to 
cells bound to the plasma protein transferin. Insulin initiates 
chromium transport into cells where it binds to an oligopeptide 
apochromodulin, which together with 4 molecules of trivalent 
chromium makes the active chromodulin (this low molecular 
oligopeptide was isolated from the canine liver in 1983).  After 
binding to insulin receptors, which are activated by the bond of 
insulin, tyrosinkinase (part of the intracellular side of the insulin 
receptor) activity increases and glucose metabolism is activated 
[2]. As a result of the reduction of blood insulin concentration, 
chromodulin is released from the cell and excreted via kidney. As 
chromium binds to the chromodulin, it cannot be recirculated. 
This may be one explanation, why foods rich in calories and 
carbohydrates contribute to chromium depletion. (see figures 
1-5) [3].
Materials and Methods
Seventeen diabetic dogs were included in the study. Blood 
glucose was measured regularly for a prolonged period. 9 
dogs were suspected to suffer from IDDM and 8 bitches were 
suspected to suffer from NIDDM. Blood glucose was monitored 
previously for weeks to months from the beginning of the 
therapy and was measured directly after blood sampling in the 
consulting room of the clinic by a glucometer (One touch ultra). 
Cases of hyperglycaemia were initially treated with medium-
long acting biosynthetic human insulin (Insulatard HM 100 IU/
ml) injected subcutaneously (1-1, 5 IU/kg). Blood glucose levels 
were always measured while fasting in the period of maximal 
effect of insulin, 6-8 hours after the morning injection by the 
owner. When blood glucose fell below 15 mmol/l, and at least 
two sequential fixed levels of blood glucose on an unchanged 
dose of insulin were achieved, bioactive chromium (Bioaktivní 
Chrom Dia, 100 μg Pharma Nord, Vejle, Denmark) in the form of 
cellular bound chromium yeast (ChromoPrecise® Yeast Pharma 
Nord Vejle, Denmark) was added to the diet (100 μg per day).
In all bitches, after stabilizing glycaemia below15 mmol/l with 
the insulin monotherapy, ovariohysterectomy was performed .In 
this group of diabetic animals bioactive chromium was initiated 
after this procedure. 
For the statistical assessment of the efficacy of bioactive 
chromium, dogs remained on the same dose of insulin as before 
the supplementation, and two sequential measurements of 
blood glucose during the first and second week after initiating 
the supplementation were used during regular checkups of the 
animals treated with the combination of insulin and bioactive 
chromium. 
Results 
Table 2 shows successive measurements of blood glucose. The 
first 9 rows represent the patients (male dogs) with suspected 
IDDM.  The numbers from 10-17 the patients (bitches) with 
suspected NIDDM. Column 0 represents the original glucose 
value without therapy, column 1 and 2 represent the two levels 
of glycaemia during monotherapy with insulin and column 3 and 
4 represent the two subsequent levels of glycaemia during the 
unchanged therapy with insulin supplemented with bioactive 
chromium.
The columns with insulin monotherapy (column 1 and 2) were 
statistically analysed without the initial hyperglycaemia (column 
0). Analysis was performed by double selective Wilcoxon´s 
test (Mann-Whitney U-test). Values in columns 1 versus 3 and 
columns 2 versus 4 were compared. The hypothesis tested was 
that column 1 and 3 came from the same distribution with 
the same medians. The alternative hypothesis tested was that 
columns 1 and 3 did not come from the same distribution nor 
Initial 
glycemia
Glycemia within 
insulin therapy 
Glycemia 
within insulin + 
chromium therapy
Number 
of column
..................
patient
0 1 2 3 4
1 15.5 9.9 11.3 3.3 6.7
2 9.4 12.9 14.2 10.1 12.5
3 11.8 14.1 13.4 9.2 4.5
4 26.4 18.4 18.0 3.7 10.4
5 22.4 10.9 13.2 10.2 8.6
6 25.4 14.8 11,5 7.6 10.8
7 21.6 14.4 11.0 9.8 5.0
8 17.8 15.6 17.8 6.4 6.4
9 24.8 14.1 7.1 7.2 3.5
10 16.6 17.5 9.3 11.2 10.8
11 28.4 13.9 9.6 11.6 5.4
12 16.3 13.1 11.2 4.1 3.6
13 24.1 4.7 9.1 4.6 4.3
14 24.3 14.4 11.2 6.6 11.2
15 28.5 28.6 20.6 11.7 9.0
16 over 40 15.5 6.4 2.1 5.2
17 over 40 25.4 18.0 5.1 9.7
Table 2: Tested levels of glycaemia of the dogs treated with 
insulin and consequently with insulin and bioactive chromium 
supplementation.
66
Diabetes mellitus in dogs and cats – clinical experience with bioactive chromium supplementation... - P. Muzˇík et al
did they have the same medians. Results of the test negate 
the hypothesis on the level of relevancy p = 2.1992e-006 (or 
0.0000021992).  This means that we can conclude that the 
medians differ very significantly. The presumption (p-level), that 
this statement is not valid, is smaller than or equal to 2.1992e-
006 (approx. 2 millionth). 
The comparison of column 2 and 4 is based on the hypothesis, 
that both come from the same distribution with the same 
medians. The alternative hypothesis is that columns 2 and 4 
do not come from the same distribution nor do they have the 
same medians. The test is again performed by double selective 
Wilcoxon´s test (Mann-Whitney U-test).
The results of the test negate the hypothesis on the level of 
relevancy p = 7.6788e-004 (0.00076788). In practise this 
means that we can conclude that the medians differ very 
significantly. The presumption (p-level), that this statement is 
not valid, is smaller than or equal to 7.6788e-004 (approx. 8 
ten-thousandth).
Discussion
Our clinic has a long-term positive experience of treating diabetic 
dogs and cats with human insulin. We prefer this choice due to 
a subjectively good therapeutic effect (over a prolonged period) 
and relatively good financial sense for owners. In patients we 
currently recommend the initial dose of insulin at 1 IU/kg of 
body weight once daily, however, in some patients a divided 
dose is more effective. When the reduction in blood glucose 
is not sufficient we increase the dose to a maximum of 2 IU/
kg of body weight. In tested patients a single daily dose was 
given. In entire bitches with suspected NIDDM the response to 
exogenous insulin is usually insufficient due to the hormonally 
mediated peripheral tissue resistance. For this reason we perform 
ovariohysterectomy in these patients as soon as possible. 
This procedure should be performed once the blood glucose 
is stabilized, or after correction of a metabolic ketoacidosis, if 
insulin therapy fails to produce an adequate decrease in glucose 
levels. In patients with higher levels of glucose for a longer time 
despite insulin therapy, dietary chromium supplementation was 
recommended.  
In humans, chromium supplementation increases glucose 
tolerance and some parameters of lipid metabolism. The lack of 
chromium can contribute to insulin resistance and hyperlipidemia. 
In rats fed a chromium-free diet, all symptoms of diabetes, 
paradoxically resistant to insulin, were manifested. After adding 
the trivalent chromium to their food, the glucose tolerance was 
restored and all symptoms vanished [2). A similar development 
of symptoms was observed in human patients on intravenous 
nutrition without chromium. After addition of chromium 
to the infusion all abnormalities resolved [4]. Several long-
term scientific studies in human patients with Type II diabetes 
mellitus have confirmed that chromium supplementation led to 
a statistically significant decrease of hyperglycaemia and hyper-
insulinaemia [2].
 
Supplementation of bioactive chromium is recommended to 
diabetic patients with insufficient response to insulin therapy, 
or when repeatedly measured blood glucose levels tend to vary 
markedly. In our animals an organic complex of chromium bound 
to bakery yeast (Bioaktivní ChromDia 100 μg, Pharma Nord, 
Vejle, Denmark) in the form of chromium bound yeast (Chromo 
Precise® Yeast Pharma Nord Vejle, Denmark) is supplemented, as 
this form can be easily absorbed [2].
Large variations in absorption of differing compounds of 
chromium were described, even among species [2].  
In healthy people the effects of chromium supplementation 
have not been confirmed, but in individuals with a chromium 
deficit, supplementation has a demonstrable effect.  In 
patients with insulin resistant Type II diabetes, an increased 
loss of chromium through the kidneys is suspected advocating 
chromium supplementation. Insulin resistance often precedes 
the manifestation of clinical symptoms of diabetes, therefore 
early chromium supplementation can prolong the period before 
the symptoms of diabetes are displayed. No side effects of 
supplementation have been described [2]. 
The classic subdivision of human diabetes into 2 basic types 
(Type I-insulin dependent and Type II-insulin resistant) is not 
completely without exceptions. In Type II diabetes the insulin 
secretion persists, and in most cases hypersecretion occurs. 
In this phase chromium supplementation increases the effect 
of this secretion and the use of insulin is not usually required. 
Exogenous insulin is required in advanced stages of Type II 
diabetes, when the endogenous insulin secretion decreases, 
and probably the low chromium saturation persists. According 
to the so far unpublished information, in these human patients 
chromium supplementation combined with insulin therapy 
enables the reduction of the dose of insulin [3]. On the basis 
of our long-term observation, we suppose the same principle 
applies in canine diabeties with NIDDM. 
The results of our study have shown that addition of chromium 
to the diet has a positive effect in decreasing blood glucose 
levels of diabetic dogs already on treatment with insulin.
In the experimental group 20 animals were monitored. From 
this group 9 were male-dogs with suspected IDDM, 8 were 
bitches with suspected NIDDM, and 3 were cats. The 3 cats 
have not been included in the statistics. The reasons for this 
exclusion from the statistical assessment was that only a small 
number of feline patients were treated with insulin, stress-
induced hyperglycaemia in cats, and thirdly we supplemented 
cats with a lower dose of chromium relative to dogs (30 μg 
to cats versus 100 μg to dogs). Despite these facts a positive 
effect of supplemented chromium was seen during long-term 
monitoring.  Statistically the levels of glycaemia were analysed 
without differentiation of patients to IDDM and NIDDM type. 
To be able to analyse both groups separately the number of 
patients in each group has to be increased.
Conclusion
Supplementing chromium yeast to the diet in diabetic dogs 
already treated with insulin produced a statistically significant 
decrease in blood glucose levels. Large variations in the absorption 
of differing compounds of chromium were described, even 
among species. In our patients an organic complex of cellular 
bound chromium yeast (ChromoPrecise® Yeast Pharmanord, 
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Vejle, Denmark) was used, as this form of chromium can be 
easily absorbed.  From this study we can conclude, that in 
addition to the decrease in insulin production, hyperglycaemia 
in dogs was also caused by increased tissue resistance to insulin 
in patients with IDDM and NIDDM. We suppose that chromium 
supplementation led to a natural increase of the tissue glucose 
tolerance, which is a more physiological and safer way to 
decrease hyperglycaemia in treated diabetic dogs than just 
increasing the dosage of insulin.
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A 6-month-old entire female Beagle was presented for investigation of acute onset paraparesis and hindlimb ataxia. 
After neurological examination a multifocal neurological localisation was suspected. Magnetic resonance imaging 
scans of the dog’s cervicothoracic region revealed an intradural/extramedullary spinal cord lesion between the 
T8 and T9 vertebral segments; in addition, another lesion adjacent to the dorsal aspect of the first cervical vertebra 
which infiltrated mainly the epaxial muscles was visualised. A mild prolongation of prothrombin time was 
detected. A genetic polymerase chain reaction assay to confirm the presence of factor VII deficiency was carried out 
and indicated a homozygous condition for the defective gene. Factor VII deficiency as well as other coagulopathies 
should be considered as a differential in dogs with neurological deficits.
Keywords: Beagle, factor VII deficiency, ataxia, paraparesis, magnetic resonance imaging
summary
NEurOLOGy
Introduction
Factor VII (FVII) is a vitamin K-dependent glycoprotein synthesised 
in the liver and secreted into the circulation as a zymogen that, 
once activated, plays a vital role in the initiation of coagulation 
[1, 2]. FVII deficiency in humans is a rare autosomal recessive 
coagulopathy [3]. Hereditary FVII deficiency has been previously 
reported in research colonies of Beagle dogs as well as in the 
companion animal population [4, 5, 6, 7, 8] and recently it has 
also been described in alaskan Klee Kai dogs [9]. FVII deficiency 
is an autosomal recessive trait in the Beagle and affected dogs 
are homozygous for this mutation [10]. There are reports of mild 
to severe bleeding in affected dogs [5, 7, 8, 9, 11] but to the best 
of the authors’ knowledge there is no data available regarding 
FVII deficiency associated with a neurological involvement. 
suspected spinal and muscle haemorrhage associated with 
a coagulopathy caused by a FVII deficiency in a Beagle is the 
subject of this case report.
Case history
a 6-month-old entire female Beagle was referred for 
investigation of acute onset paraparesis and bilateral hindlimb 
ataxia. On neurological examination the dog appeared subdued; 
cranial nerve function was normal. an ambulatory paraparesis 
and spinal ataxia were noted. Hopping deficits were observed 
in the hindlimbs and proprioceptive positioning was absent 
in both hindlimbs. Deep pain perception was preserved in all 
four limbs. moderate pain could be elicited during palpation 
of the thoracolumbar paraspinal muscles and during lateral 
movements of the dog’s neck towards both the left and the 
right side. The panniculus reflex was bilaterally absent caudally 
to the cranial thoracic region. Neurolocalisation indicated a 
lesion of the cervicothoracic region. Thoracic and abdominal 
radiographs were normal. magnetic resonance imaging (mrI) 
scans (Vet-mr Grande, Esaote s.p.a., Genoa, Italy) of the dog’s 
thoracic and neck regions were obtained in three planes of 
orientation before and after the intravenous administration of 
(1) Chester Gates Animal Referral Hospital, Unit F, Telford Court, Chester, Cheshire GB-CH1 6LT
(2) Carmichael Torrance Diagnostic Services, BlacksmithsForge, BrookfieldFarm Selby Road, Garforth, Leeds, GB-LS251NB 
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0.1 mmol/kg gadolinium (magnevist®, schering, Germany). a 
C-shaped solenoid coil was used. slice thickness was 3.5 mm 
and slice interspace gap was 0.3 mm. On T2-weighted (T2W) 
(repetition time (Tr): 2000 ms, echo time (TE): 80 ms) and 
short-tau inversion recovery (sTIr) (Tr: 1500 ms, TE: 15 ms, 
time to inversion: 120 ms) sequences there was an intradural/
extramedullary hyperintense region between the T8 and T9 
vertebral segments on the right side (Fig. 1). The lesion appeared 
hypointense on gradient echo (GE) (Tr: 1200 ms, TE: 22 ms, flip 
angle: 45) sequence (Fig. 2) and slightly hyperintense on pre-
contrast T1-weighted (T1W) (Tr: 700 ms, TE: 18 ms) sequence. 
after the intravenous injection of the contrast medium a slight 
enhancement was visualised (Fig. 3, Fig. 4). These findings were 
considered compatible with a recent intradural/extramedullary 
spinal cord haemorrhage. In addition, another lesion was 
visualised involving and infiltrating the epaxial muscles dorsally 
to the atlas. This lesion was hyperintense on sTIr, 
Fig (1) Dorsal STIR and Fig 
(2) transverse GE images 
of the spinal cord at T8/
T9. There is an intradural/
extramedullary irregular 
lesion invading the right 
side of the spinal cord 
parenchyma (white arrows). 
On STIR image the lesion is 
homogeneously hyperintense 
whereas on GE image it 
contains a hypointense 
central focus surrounded by 
a hyperintense rim.
Fig(3) Dorsal pre-contrast 
T1W and Fig (4) dorsal 
post-contrast T1W images of 
the thoracolumbar vertebral 
segments. The lesion appears 
mildly hyperintense on T1W 
pre-contrast image and is 
slightly enhancing.
T1W and T2W pre-contrast images (Fig. 5) and was interpreted 
as a recent muscle haemorrhage or a myositis. since the neck 
lesion was close to the foramen magnum and a coagulation 
disorder was suspected, cerebrospinal fluid (CsF) sampling was 
considered inadvisable. The dog was hospitalised and as the 
findings of the clinical examination and imaging were considered 
consistent with either haemorrhage or inflammation, the dog 
was given a course of oral prednisolone (Prednidale®, Dechra, 
shrewsbury, united Kingdom) at 1 mg/kg once a day. serology 
for Toxoplasma Gondii and Neospora Caninum was undertaken 
by immunofluorescent antibody tests and gave negative 
results. Faecal analysis by Baermann flotation was negative 
for lungworm larvae. routine haematology (Vet aBC analyser, 
abaxis, usa), serum biochemistry (IL 650 biochemistry analyser, 
Instrumentation Laboratories, united Kingdom), and serum 
electrolytes (IL 650 biochemistry analyser, Instrumentation 
Laboratories, united Kingdom) were analysed and coagulation 
tests were undertaken. The red cells appeared normocytic and 
normochromic with no evidence of increased polychromasia or 
anisocytosis and platelet morphology and numbers appeared 
normal. a moderate prolongation of prothrombin time (PT) 
was detected (28.5 seconds; reference 5 to 12 seconds) using a 
dried recombinant human tissue factor (Dade Innovin, siemens, 
united Kingdom). Partial thromboplastin time (PTT) (Dade 
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action Fs activated PTT reagent, siemens, united Kingdom) 
was within normal limits. Both the PT and PTT assays were 
determined manually in duplicate with the reported results being 
the mean of the two measured clotting times. The extended 
PT with normal PTT was considered likely to reflect a defect in 
the extrinsic coagulation pathway. Given the signalment further 
testing for the inherited coagulopathy associated with FVII 
deficiency previously reported in this breed was undertaken. 
a genetic polymerase chain reaction (PCr) assay similar to the 
one previously validated in this breed [10] (primers and probes 
upon request) to confirm the presence of this condition was 
carried out (Laboklin  GmBH & Co.KG, Germany) and indicated 
a homozygous condition for the defective gene. During the next 
four days the dog’s neurological status improved dramatically and 
the steroid treatment was slowly tapered down. Three months 
later the dog was presented for neurological re-evaluation; 
the owners reported that the dog was improving and that her 
quality of life was now good. On neurological examination she 
appeared bright and alert with normal gait, spinal and cranial 
nerve reflexes and no hopping or proprioceptive deficits. No 
pain could be elicited during manipulation of the neck and 
palpation of the paraspinal muscles.
Discussion
FVII is a vitamin K-dependent serine protease coagulation factor. 
It is synthesised in the liver and secreted into the circulation 
as a single-chain zymogen that, following vascular injury, is 
converted to the activated form. This, in combination with 
the membrane protein tissue factor, cleaves factors IX and X 
(FX) to their activated forms. Once activated, FX participates 
in the prothrombinase complex consisting of FX and the 
activated factor V. This complex, in the presence of calcium 
and phospholipids, catalyses the conversion of prothrombin to 
thrombin [1, 2] (fig. 6). 
FVII deficiency in humans is a rare autosomal recessive 
coagulopathy, with an estimated frequency of 1:500,000 
[3]. Naturally occurring hereditary FVII deficiency has been 
previously reported in Beagle and in other breeds [4, 5, 7, 8, 9, 
11]. FVII deficiency is an autosomal recessive trait in the Beagle 
and affected dogs are homozygous for this mutation. The 
molecular basis of hereditary FVII deficiency in the Beagle breed 
is a G to a missense mutation in exon 5, resulting in substitution 
of glycine 96 by glutamic acid in the epidermal growth factor-
like 2 domain [10]. There are reports of mild to severe bleeding 
in dogs with FVII deficiency, although in most research Beagle 
colonies FVII deficiency has been noted incidentally when routine 
coagulation screens performed prior to experimental studies 
revealed prolonged PT [4, 7]. Pre- and postpartum uterine 
haemorrhage [7, 8], excessive bleeding after routine castration 
[5] and spontaneous severe bruising and haematomas [9, 11] 
have been reported in dogs affected by FVII deficiency. In the 
case under study the initial neurological signs were compatible 
with a disease process of vascular origin. This disorder is 
characterised clinically by an acute onset of non-progressive and 
often focal signs. In this particular case the regression observed 
after a short period of time may be attributable to diminution 
of the mass effect secondary to haemorrhage and/or oedema 
resolution [12]. To the best of the authors’ knowledge this is the 
first report of FVII deficiency associated with neurological signs. 
Fig (5) Dorsal STIR image of the brain and cervical 
epaxial muscles. A diffuse ill-defined hyperintensity 
can be noted involving and infiltrating the epaxial 
muscles at the dorsal aspect of the atlas.
Fig (6) The extrinsic or cellular injury pathway is mediated by the binding of the 
FVIIa to TF. The FVIIa-TF complex in turn activates both FX and FIX. In the 
intrinsic or contact system, coagulation is initiated through HMWK, PK, and FXII 
activation, which in turn activates FXI, which then catalyses the conversion of FIX 
to FIXa. FVIIIa functions as a cofactor and significantly accelerates activation of FX 
to FXa by FIXa. Once activated, FXa participates in the prothrombinase complex 
(FXa-FVa), which, in the presence of Ca2+ and PL, converts PT to thrombin.
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The pattern of the spinal cord lesion visualised on mrI in the 
present case were consistent with recent haemorrhage. acute 
neural haemorrhages commonly appear as hyperintense areas 
on T2W and sTIr images and are characterised by isointensity 
or subtle hyperintensity on T1W images [13, 14, 15, 16, 17]. 
GE sequence is highly sensitive for detection of blood products; 
haemorrhages tend to demonstrate low signal intensity 
regardless of the time from the onset vascular accident, the 
source of its location or the magnetic field strength [18]. 
However, hypointensity on GE sequences is not a specific feature 
of haemorrhage and may also be seen with mineralisation, gas, 
iron deposits or fibrous tissue [19]. In the present case, after 
the intravenous administration of gadolinium a slight contrast 
enhancement was visualised and this has been reported to be 
caused by the leakage of contrast medium through the damaged 
blood brain barrier [20]. The lesion involving and infiltrating 
the epaxial muscles dorsally to the atlas was hyperintense on 
T2W, sTIr and T1W pre-contrast images. These mrI features 
were thought to represent recent muscle haemorrhage [21] 
or myositis [22]. The characteristic pattern of abnormalities on 
routine coagulation tests, however, alerted the authors to the 
possibility of a coagulopathy involving the extrinsic pathway. 
This was confirmed to reflect an inherited breed associated 
abnormality on genetic testing. 
most dogs with vascular accidents affecting the CNs recover 
with time, as occurred in this case. management of bleeding 
in dogs because of a FVII deficiency may be achieved by local 
control (e.g. compression, cautery) and/or administration of 
fresh-frozen plasma or plasma cryosupernatants. The latter have 
been successfully used to control moderate to severe bleeding 
[9]. Prevention or treatment of bleeding episodes in human 
patients with FVII deficiency now is frequently achieved by 
administration of recombinant human activated FVII (rhFVIIa) 
[23]. studies are needed to determine whether rhFVIIa can be 
used safely and cost effectively to supplement or replace plasma 
components for controlling clinical bleeding in FVII-deficient 
dogs.
In conclusion, inherited FVII deficiency as well as other bleeding 
disorders should be considered as a differential in dogs with 
neurological deficits and mrI features suggestive of underlying 
vascular disease. 
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Telemedicine provides veterinarians with a means to efficiently acquire specialist support for the management of 
complex clinical cases and can be offered to pet owners by the clinic as an additional service. Online consultation 
is preferable when transmitting large amounts of data or high resolution images. It allows a complete presentation 
of patient history and clinical findings. Queries by veterinarians are facilitated by online questionnaires that 
guide veterinarians regarding key clinical information. This approach saves both veterinarians and specialists 
time by minimising exchanges needed to obtain a medical background on the patient. Telemedicine reports can 
be complemented by e-mail or phone exchanges. In using telemedicine, the main considerations are image format 
and quality, report quality by the provider and access to a multidisciplinary specialist group. Telemedicine can 
be implemented as a chargeable service to the pet owner by offering it as an integral part of the clinic’s services. 
The benefits of telemedicine for the veterinarian, clinic and owner include efficiency in the management of more 
complex clinical cases, a means of continuing education for the veterinarian, and an economic benefit from 
continued in-house case management due to diagnostic tests, treatments and extended contact with the client.
Keywords: telemedicine, referral, practice management, specialists
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PraCTICE maNaGEmENT
Introduction
The economic crisis has yielded a buzz of exchanges in our 
society on how to do more with less, how to cutback and 
explore new ideas to improve on the old way of doing things. as 
this affects all walks of life, veterinarians have not been exempt 
from its impact.
Time management is perhaps one of the toughest challenges in 
any business. When confronted with a challenging clinical case, 
we are often limited by the time required to consult the literature 
or to track down a specialist by phone in order to narrow down 
a diagnosis or orient treatment. Telemedicine is beneficial to 
practices that seek to enhance their time management and 
constitutes an additional service that can be offered to pet 
owners. In this article, the focus will be on telemedicine as the 
consultation between the referring veterinarian attending a 
patient and the remote specialist, rather than on the broader 
definition, which includes remote consultation between pet 
owner and veterinarian and is subject to very different legal and 
ethical considerations [1].
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Telemedicine as a case and time 
management tool for the veterinarian
remote consultation of a case with a veterinary specialist has 
been around since the dawn of medicine. However, most of the 
scant literature on veterinary telemedicine has been published 
in the last decade [2]. Telemedicine has traditionally been 
based at academic institutions and, more recently, is now being 
offered by referral centres or telemedicine providers exclusively 
dedicated to this activity. In past decades consultations have 
taken the form of telephone or e-mail requests.  advances in 
telecommunication technology has allowed a new approach, 
that of online consultation. Online queries allow the veterinarian 
to make consultations more efficiently, communicating greater 
detail regarding a patient, and allowing images of large file size 
to be joined to a query or sent directly from a digital imaging 
system to the remote server used by the specialist [3]. Online 
telemedicine provides veterinarians with a written report 
usually within a short time, with tailored advice for diagnosis, 
therapeutic management of a case, or imaging interpretation 
regarding a patient.  a study comparing personal vs remote 
specialist consultation when managing aggressive behaviour in 
dogs demonstrated that both methods were equally effective in 
assisting case management [4]. The benefit of a written when 
compared with a verbal report is that it can be shared with the 
owner and filed electronically or as a paper copy with the patient 
records. all information that has gone into the consultation such 
as the request, report and any files or images submitted are also 
stored as a copy by the telemedicine provider. This is important 
as digital image archiving by clinics that do not adopt a complete 
imaging solution when they make the switch to digital, is often 
an unsatisfactory and unaddressed problem. With online 
telemedicine, high resolution images eg. X-rays, CT, mrI, (Fig. 1) 
and other patient data, including video files, eg. ultrasound, can 
be sent with relative ease and speed, compared to a few years 
ago [5] (Fig. 2). although radiology has been the most popular 
discipline for remote consultations, telemedicine extends to 
most areas of medicine for example, surgical consultations or 
pathology and comment on microscopic images [6,7].
Telemedicine as a service to the pet 
owner
although online consultations save time and money, a few 
points should be considered to make the use of telemedicine 
more effective. Telemedicine is still a relatively new concept to 
sell to the pet owner as a service and consequently it is used in 
different ways by different clinics. It can be offered as an option 
in the form of a premium service that owners can choose if they 
wish for their animal to continue to receive treatment at their 
primary clinic, enabling a presumptive diagnosis to be confirmed 
or information interpreted. On the other hand, it may form part 
of the practice’s management system. For example, all or most 
imaging examinations may be sent electronically to a board 
certified radiologist for a report. some veterinarians hesitate 
to divulge to clients that they are seeking a second opinion, 
because they fear it may be viewed by pet owners as a lack of 
skill or knowledge. However, integrating telemedicine into the 
array of a practice’s services can help address how it is viewed 
by the client.
The need for structured consultation 
requests
If a case exceeds the veterinarian’s knowledge and skill, it has 
always been considered ethical to consult a more experienced 
colleague.  Frequently it is what the veterinarian does not see on 
the radiograph –errors of omission – that can hinder diagnosis. 
Informal consultations are free of charge and can provide varied 
opinions (eg. via a forum). They are good for situations when 
limited information is exchanged: a sampling of images of 
small file size; when confirming a doubt or seeking alternative 
treatment options. This does not readily allow a report to be 
stored in the patient’s record thus making the information solely 
verbal in nature. Disadvantages of e-mail or telephone requests 
Figure 1. Advances in telecommunications technology and 
digital imaging, such as this CT of a dog’s head, enables 
electronic transmission of large file sizes, facilitating telemedicine 
consultations between veterinarians and specialists. 
Figure 2. Telemedicine can be applied to most medical disciplines 
and is especially useful for imaging. Here, a cardiologist is 
interpreting images from echocardiography in a cat. High image 
quality is paramount in getting the most out of a telemedicine 
consultation.
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is the difficulty one often has in reaching 
a colleague, and a variable turnaround 
for a response. more importantly, these 
consultations risk leaving out information, 
in the initial query and consequently, in 
the specialist’s response. 
In some disciplines (eg. internal medicine) 
consultations are usually more complex 
than for radiology. although e-mails or 
phone calls are useful for follow-up in 
case discussions, they are not the best 
modality for an initial query since the 
submitted patient information may be too 
incomplete to provide a tailored response. 
Frequently, the specialist will need to 
request further information in addition 
to an initial e-mail or phone query, thus 
delaying the final recommendations. 
more detailed information and varied 
types of files (X-ray, laboratory data) can 
be attached to an online request along 
with a detailed history of clinical signs, 
previous treatments and case evolution. 
some telemedicine services address the 
need to submit a complete case history 
by providing a step-by-step questionnaire 
(Fig. 3) that is a memory aide and guides 
the veterinarian as to what information to 
include and for the specialist to provide 
a tailored reply.  For these reasons, an 
online telemedicine consultation provides 
the most accurate means of transmission 
of patient information to a specialist and 
is the most cost- and time effective approach.  also, an online 
telemedicine request is generally quicker to complete than an 
email or phone call. 
With a chargeable telemedicine service, a written report is 
provided that can be shared with the owner and in part justifies 
a fee for the service. It is recommended that the telemedicine 
service be explained beforehand to clients as an integral part 
of the clinic’s services and their consent be obtained. In this 
way, the owner becomes part of the decision-making process 
and telemedicine is part of the working ethos of the clinic, as a 
valuable resource but also to educate clients and veterinarians 
[8]. The veterinarian can be viewed as working in partnership 
with specialist colleagues. alternatively in clinics which already 
employ specialists, access to a remote team expands on their 
existing multidisciplinary team. Instead of trying to locate a 
specialist by phone or via a lengthy email, veterinarians can 
focus their time on attending cases in the practice. a veterinary 
assistant can partially fill in the patient data in the  telemedicine 
request forms, further saving time.  In this way, telemedicine 
can be implemented either as a premium service option or used 
routinely (eg. radiology).  an example of the latter is that pet 
owners may be advised that the consultant radiologist reading 
fee is incorporated in the X-ray cost prior to taking a radiograph 
if the practice elects to manage their radiology department 
in this way. Finally, although the high cost of referral is often 
used to justify telemedicine as an alternate route, telemedicine 
is not meant as a substitute for referral. Instead, it provides 
a supportive resource to manage clinical cases alone. The 
attending veterinarian is in the best position to judge when a 
telemedicine consultation is relevant or when patient referral is 
most indicated, depending on the resources and skills at hand. 
In this regard, should an owner be reluctant to have their pet 
referred, telemedicine can be a first course of action giving the 
veterinarian the support he/she needs to manage the case in-
house. 
Choosing a telemedicine service
There are 3 main aspects to consider in selecting a telemedicine 
provider: (1) image formats and the quality of data or 
image transmission; (2) report quality; and (3) access to a 
multidisciplinary specialist group.
(1) Image formats and the quality of data or image transmission.
The most important aspect in sending images to a remote 
specialist for a second opinion is adhering to official medical 
standards for data and image transmission. Imaging standards 
such as DICOm (Digital Imaging and Communications in 
medicine) set guidelines and requirements for image transmission 
and ideally should be adhered to although some telemedicine 
providers accept radiographs in JPEG format.  The DICOm 
standard is evolving constantly and not all imaging equipment or 
Figure 3. For online telemedicine consultations, an internal medicine questionnaire 
(partially illustrated) serves as a memory aide for the requesting veterinarian to provide 
a complete medical history. This increases the speed and completeness of the specialist’s 
response.
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software is DICOm compliant, so this needs to be checked by the 
veterinarian when purchasing new equipment.  Even if devices 
are compliant, they may not incorporate the most recent updates 
to the standard (eg. DICOm version x.x; http://medical.nema.
org/dicom/).  When shopping around for imaging equipment, a 
practice should ask about the devices’ DICOm compliance, the 
possibility to easily archive images remotely in order to backup 
the practice’s images, and whether the software (worklist or 
PaCs) allows the primary care veterinarian to configure different 
destinations so the clinic can flexibly choose a telemedicine 
provider or remote archive for storage. 
For the specialist responding to a query, the challenge lies in 
the quality and completeness of the information provided, 
a selected subset of the information available regarding the 
patient. Is it appropriate to interpret information sent by a 
requesting veterinarian even if the images and/or data provided 
are suboptimal?  although suboptimal samples or requests 
cannot always be avoided, it is the role of the specialist or 
telemedicine provider to inform veterinarians regarding the 
minimal requirements for patient information needed and 
provide further guidance in order to improve future submissions. 
This is akin to quality assurance in the diagnostic laboratory and 
should be part of the telemedicine provider’s policy. 
some techniques in diagnostic imaging lend themselves less 
well to remote image interpretation.  abdominal ultrasound 
interpretation requires a trained and knowledgeable driver - the 
sonographer - for proper evaluation and interpretation by the 
specialist.  many telemedicine service providers do not offer 
interpretation of ultrasound imaging for this reason, be it for 
still images or videoclips.  Veterinarians using a service that 
does advise on such images should ask themselves if they really 
benefit from submitting them. Videoclips of the whole animal 
are very valuable in consulting the specialist and can be used in 
neurology consultations, assessing behavior or gait problems. 
(2) Quality of the report 
a high quality report does not only require a quick turnaround 
time but should also be subject to scrutiny (eg. peer review). 
Furthermore the consultants have to be trained in improving 
submissions by providing appropriate recommendations. 
High report quality that provides useful recommendations for 
the veterinarian is as important as, if not more so, than the 
turnaround time provided.
(3) Access to a multidisciplinary specialist group
The advantage of a dedicated telemedicine provider is that a 
large pool of qualified specialists in several disciplines is available 
to the clinic, ensuring short turnaround times, coverage for 
holidays or other leave by specialists, and makes use of a 
common, easy-to-use online platform.  It also handles the billing, 
which can be centralised for a group of clinics, data storage and 
publicity.  sometimes, a practice may wish to work only with 
consultants they know personally which some providers respect 
and cater for.
Discussion
There are several benefits to incorporating telemedicine as a 
service in the clinic:
(1) Efficiency in case management – this minimises trialling 
therapies or performing diagnostic tests that may not be 
indicated;
(2) Competence is demonstrated by working with a remotely 
located multidisciplinary specialist team;
(3) Continuing education through working alongside a specialist 
colleague; 
(4) an economic benefit from continued in-house case 
management due to additional diagnostic tests, treatments and 
contact with the client. 
The online telemedicine consultation allows high quality images 
and detailed patient information to be exchanged quickly and for 
the veterinarian to receive a prompt response from a specialist. 
It also provides the veterinarian with a tailored approach to case 
management and the nuggets of wisdom from a specialist who 
has been exposed to a large number of complex cases, and the 
possibility to continue to interact with one or more specialists, 
as needed, if several disciplines are covered by the telemedicine 
provider.
Conclusions
There are a growing number of telemedicine service providers 
making online specialist support more accessible to veterinary 
practices. Telemedicine is an affordable additional service that 
practices can offer pet owners, especially if there are financial 
constraints regarding referral or if time is of the essence.  The two 
main attributes of telemedicine are that it provides veterinarians 
the multidisciplinary support they might otherwise lack in a 
practice team and a means to managing cases more efficiently 
by improving the quality and speed of diagnostic and therapeutic 
decision-making.  If used properly, more complete information 
is passed on to the specialist using this form of query, resulting 
in useful advice that enhances the quality of veterinary medical 
care in the practice, especially for more complex cases.  Clients 
most easily accept it if it is implemented as part of the practice’s 
services, showing pet owners that the practice has access to, 
and works with, a team of specialists.   
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Focus in this and the following article will be on practising veterinarians as professional and self-employed 
business people, and the major challenges facing the profession – business succession in practices, with the next 
generation of veterinarians seeking leadership and new forms of organisation, at the same time as practising 
veterinarians experience declining faith in their professional judgement, and increased regulatory control. The 
trend is paradoxical in many ways, as it is accompanied by increasing social significance for veterinarians and other 
professions. Specialisation is on the ascendancy.
Danish practising veterinarians are facing a major paradigm shift in terms of their self perception. Regulatory 
control and the centralisation of power are forcing veterinarians into a new role, where public service functions 
may end up dominating professional veterinarian autonomy. At the same time, rationalisation of agricultural 
production, declining veterinarian student intakes, fewer graduates entering into rural practices, are demanding 
new approaches. Meanwhile, society is keenly watching the veterinary profession, as it are still expected to fulfil its 
classic virtues and champion animal welfare.
Based on in-depth interviews with senior veterinarians – practice owners – a health examination has been 
carried out for the Danish veterinarian profession. How are the new operating conditions impacting on practising 
veterinarians, and how is the desired business succession being achieved?
INTRODUCTION
This paper originally appeared in:
Dansk Veterinærtidsskrift (2009)*  23:6-11 (Part I) 
16-18 Part II
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PRACTICE MANAGEMENT
Anamnesis
Practising veterinarians tell a story of change. The self perception 
– or professional identity – of practising senior veterinarians is 
closely linked to being a free agent, with authority grounded in 
their professional expertise, and autonomy in organising their 
work. These key identity factors have come under pressure from 
greater administration and control, and increasingly aggressive 
market forces.
Factors in Figure 1:
Regulatory authorities 
Practice owners report a trend over the last 30 years towards 
greater control from regulatory authorities. The government has 
(1) Fuglebakken 17, Strib DK-5500 Middelfart   E-mail:jo@ddd.dk, josterbye@gmail.com
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changed the framework within which 
large-animal veterinarians operate. Their 
relationships with colleagues in the Danish 
Veterinary and Food Administration are 
under strain. The authorities are seen as 
rigid rule enforcers who have forgotten 
the role of professional judgement. 
The conflict between professional 
autonomy and greater control is seen 
in the tension between regulatory 
authorities and professional pride. 
Increased administration is seen as a 
barrier to work satisfaction,  succession 
in practice, and survival of the profession. 
Current practice owners are finding that 
requirements and regulation can conflict 
with the desires of new assistants for 
professionalism and autonomy. 
Changed business conditions 
Business conditions are linked to 
the government and political arena 
– conditions which impact on the 
operation of a veterinary practice as an 
independent business. The veterinarians’ 
professional association is expected to 
play a role in this area through lobbying 
and strategic, proactive engagement in 
national politics. Veterinarians point to 
the current veterinary accord as evidence 
that their association is not working 
proactively. They concede that there is a 
certain signal value in standing outside 
the accord, but this achieves nothing and 
is seen as weak opposition. Rather it is 
the agricultural organisations which are 
seen as the strong players – the ones who 
have set the framework and changed the 
conditions for work in practices.
New generation of veterinarians 
Veterinarians view their employees 
from their position as self-employed 
businessmen. Assistants are seen as 
employees who need to be trained – 
the farmers know more than a new 
veterinarian straight out of college. 
Assistants are also seen as not pulling 
their weight , until such time as they have 
bought into the practice as partners. 
Many practice owners feel that their 
assistants have favourable conditions. As 
a whole, they go one step further and 
describe the new generation as unwilling 
to invest and tie up capital in a future 
as a partner – due to concerns about 
family and leisure time, and because the 
entrepreneurial spirit senior veterinarians 
see in themselves is not very evident in 
the following generations. 
Changed market conditions 
These are the factors which together 
provide the external context within 
which the practice must operate. The 
changed business conditions are leading 
to greater competition, which may in 
future lead to the formation of first and 
second class practising veterinarians. 
Emergencye work will become less 
frequent, and consultation work in large-
animal practices will be given greater 
focus. New regulatory requirements will 
make it quite an art in future to juggle the 
roles of inspector and consultant. There 
are also new conditions in relation to 
recruitment and business succession. The 
new generation of veterinarians can no 
longer be expected to simply follow the 
tradition of taking over the practice after 
two to five years as an assistant. They 
want a guarantee of professional content 
and financial security – and expect 
leadership and professional development 
during their time as employees, and 
later as a partner in the practice. The 
practices capable of meeting these new 
expectations will survive, according to 
those interviewed. 
Legal considerations in relation to 
business succession 
Many practices have enshrined future 
business succession within a strict legal 
and economic framework, as opposed to 
Figure 1 shows the development of the change process which becomes evident after working 
through notes from the in-depth interviews (see box). 
Figure 1 has been derived using data from the qualitative interviews and shows the process 
of change taking place in veterinary practices, interaction with the outside world, and 
the possible outcomes of the process. Leadership has been given its own diagram (blue 
background). Assistants and practice owners agree that leadership will play a vital role 
in the final outcome. Leadership could, like an enzyme, serve as a catalyst for a faster, less 
resource-intensive and more deliberate path through the necessary process.
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operating within a loose framework. 
Specialisation and economic 
considerations 
The trend towards greater specialisation 
in livestock practice is mirrored in all 
professional areas, and may lead to the 
desire to invest in diagnostic equipment 
such as scanners, digital x-ray machines, 
dental equipment, etc – equipment 
which can require significant investment. 
In the larger affiliated practices and mixed 
practices, where several professional 
groups work together, all interviewees 
report increasing tension between 
solidarity with the practice as a whole, 
and solidarity with other specialists. 
Economic considerations are fuelling this 
tension. Actual and desired investments 
are often greatest within the companion 
animal and equine sectors, whereas 
livestock veterinarians can manage with 
the equipment which can fit in their 
work vehicle. There are concerns as to 
whether these investments are yielding 
the desired returns, as well as conflicts 
over whether groups are pulling their 
weight or freeloading. This is a central 
aspect in some affiliated practices, and 
the business organisation is structured 
around the economic framework. 
Commission-based remuneration 
systems are developed, time studies 
are carried out, and fee committees are 
appointed. Depreciation on equipment 
is being made personal. This is a clear 
break with practice structures in earlier 
times, where there was always trust that 
everyone was pulling together. 
Change in level of activity 
Administrative work accounted for a 
major proportion of daily activities for all 
interviewees. See Figure 2. In less than 
a generation, there has been a change 
in the distribution of tasks, from clinical 
towards more desk work and increased 
administration. Several practices report 
that regulatory control measures have led 
to stress and illness among partners. This 
quickly leads to a vicious circle of extra 
work and an ever increasing backlog. 
Many practices have also seen a decline 
in profitability due to the changes in the 
distribution of work. Where it used to be 
possible to manage several visits during a 
duty shift, administrative work now has 
to be taken into account. 
Changes to groupings 
A possible consequence of increased 
specialisation is the formation of new 
groups, centred around specialist fields 
and decision processes. Where decisions 
in the past used to be made via a 
democratic process involving all partners, 
the trend now is to delegate responsibility 
to a leadership group, such as a business 
committee or board of directors. In 
some practices there is a gradual slide 
away from large democratic meetings 
towards appointment of smaller groups 
to make decisions and implement them. 
Veterinarians report that bonds exist 
within these groups. The same is evident 
in the professional associations. One 
consequence of this change in focus 
may be the loss of team spirit within 
the businesses. This differentiation is 
expected to become more pronounced, 
with practice owners predicting that 
companion-animal veterinarians will 
be split into general practitioners and 
specialists. James Herriot, as an icon of 
the all-round practising veterinarian and 
symbol of the mixed practice based on 
democratic principles, will thus finally be 
laid to rest as a figure of the past.
The future
This issue covers initiatives being 
considered and current actions in 
response to changes in internal and 
external conditions:
•	 	New	 interdisciplinary	 alliances	 and	
plans for national consultancy centres 
providing both health and consultancy 
elements – meeting professional 
development requirements and the 
desire for “one-stop shopping” among 
livestock owners of the future. 
•	 	Amalgamation	of	livestock	veterinarians	
into a joint company which manages 
the administrative component of 
the work, ongoing training, and 
marketing, to ease future recruitment 
and ensure continual development 
within these fields. This would permit 
a professional community to shoulder 
the burden of the detrimental 
consequences of external challenges, 
while also responding to the desire for 
professionalism and work satisfaction. 
Veterinarians would retain their local 
practices, whilst also being members 
of a nationwide professional network.
•	 	Merging	 practices	 and	 employing	
internal leaders frees up more time for 
professional work. It also generates 
profit which can be used to employ 
more staff for the administrative 
component of the work. Leadership 
within the individual professional 
communities is a result of this trend. 
Professional Man: Motivated by a sense 
of duty and the desire to maintain good 
professional standards. Relationships 
between people are based on professional 
standard practices.
Illustrations: Lars Hauritz
Figure 2. Informants were asked to draw a pie chart showing how they spend their time in 
their practices. Administration accounts for an average of 24 per cent of informants’ time.
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The aim is to ensure communication 
with board members/managers, and 
to prevent a breakdown in solidarity 
within the wider practice.
•	 	Reflection	on	the	role	of	management,	
and changes to the organisation such 
that the managing director is no longer 
a partner, but an employee.
•	 	Fixed	term	employment	for	assistants,	
and linking additional shareholders to 
the company will counter the lack of 
commitment from senior assistants 
and help ensure the desired business 
succession takes place. 
•	 	Students	 are	 being	 invited	 to	
participate in job training within 
businesses, and foreign veterinarians 
are being employed to meet future 
recruitment needs and a possible 
increase in competition. 
•	 	Employing	external	veterinarians	to	do	
duty shifts, so the management and 
permanent staff can work as efficiently 
as possible during the day.
•	 	Commission-based	remuneration,	time	
sheets and investment agreements 
are being used to counter concerns 
about economic inequality within 
practices, and the tension between the 
respective professional groups.
Management/Human Resources 
Management
All interviewees agreed that leadership 
was necessary. They have all witnessed 
the transition from the time of 
entrepreneurs with short chains of 
command. When companies grow it 
becomes necessary to have leadership. 
Leadership in this context is seen as a 
kind of “rocket science” – difficult to 
master. Problems with cooperation and 
poor team spirit are attributed to a lack 
of leadership. Several companies have 
met the challenge and appointed leaders 
within the various specialist groups who 
also serve as part-time veterinarians. 
Other companies have gone all the way 
and employed full-time leaders . The 
challenge is to be able to lead one’s peers 
where cordiality among partners can be 
a barrier to a critical approach by the 
leadership. 
Symptoms
Three leadership types have arisen as 
a symptom of changes within Danish 
practices. These are archetypes, and 
elements of the three leadership types 
and the quotations used have been drawn 
from in-depth interviews with senior 
practice owners. Examining the various 
leadership characteristics in relation to 
business succession in practices helps 
magnify and clarify how they are tackling 
the internal and external challenges. This 
will allow leaders of practices to make 
comparisons and assess the process of 
change and strategic readiness in their 
own businesses. 
Economic Man
Motivated by material gain, and with a 
contractual approach to relationships:
“Things aren’t going very well anywhere 
in Denmark. 85-90 per cent of fee 
income is paid out in assistant salaries. 
Our practice is a business, and we have 
to earn money wherever we can”. 
There is a fight for market share, and the 
enemy are the competitors:
“As long as an assistant is profitable, 
things are OK. If we are losing money on 
an assistant, this is unsustainable. Either 
the assistant has to go elsewhere, or do 
less”.
This type of leader wants to make their 
own decisions without interference from 
others. There is a focus on business 
development and competitiveness. They 
are highly active, willing to take risks, and 
invest time and energy in good business 
acumen. They feel the regulatory 
authorities are giving veterinarian 
practices completely unreasonable 
conditions under which to operate a 
business. The authorities are continually 
inventing new regulations, and snuffing 
out the desire of veterinarians to run 
a business. They see the greatest 
future challenge as lying in this area. If 
veterinarians were simply left in peace 
to be enterprising and create jobs, 
business succession and survival would 
be ensured. 
Economic Man is therefore a true 
reflection of the New Public Management 
initiatives which characterise the 
government’s neoliberal reform agenda. 
Individual contribution-based reward 
formulas are being introduced in the 
affiliated practices, and there is a focus 
on the market. The veterinarian is a 
professional consultant. There is mistrust 
of the government and its control 
systems, and trust between colleagues 
is maintained through contracts. There is 
an ambivalence towards leadership. It is a 
necessary evil if the practice is to survive. 
The solution is to employ managers to 
lead the various professional groups, 
to maintain solidarity and ensure 
communication upwards to the board of 
directors. 
Economic Man: 
Motivated by material gain and 
relationships between people are 
contractual.
New Professional Man: Motivated by 
professionalism and doing the right thing 
towards others – whether related parties 
or society in general. Relationships 
between people are based on dialogue and 
convenience.
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Professional Man
Motivated by a sense of duty and the 
desire to maintain good professional 
standards. Relationships between people 
are governed by professional standard 
practices:
“Being able to perform an operation in 
peace and quiet is wonderful. We had two 
displaced abomasums yesterday. There 
has to be time for coffee afterwards. 
There is half an hour of consultation, and 
an hour of coffee time. This shouldn’t be 
changed”.
“They are given a free rein, we have 
pretty much equal status. We do not 
set the assistants any tasks which are 
assistant work as such. They can speak 
their mind. We sometimes praise their 
efforts”. 
This group is fighting for conditions 
under which they can work professionally 
and independently, and the enemy is 
bureaucracy.
Professionals are doing much the 
same as they always have. There is no 
fundamental desire to change things. 
Each veterinarian has their own niche 
within the practice, which they stick to, 
even if market conditions change. They 
take a reactive approach to the market. 
There is no great desire to see growth 
or development outside the scope of 
the strictly professional elements within 
their niche. Contact with the market and 
peers has traditionally been via the local 
associations, which are reaching the end 
of their useful life. 
It is important to this group that the 
business has a stable economy. They 
are averse to risk. Regulatory controls 
and increased administration are seen as 
nuisances, as they limit the time available 
for professional work and generally 
disrupt the routines veterinarians have 
developed. 
New Professional Man
Motivated by professionalism and doing 
the right thing towards others – whether 
related parties or society in general. 
Relationships between people are based 
on dialogue and convenience.
“We sometimes look at each other’s 
papers and ask, ‘why do it this way when 
it would be easier to do it that way in 
terms of the technical elements’. We 
discuss treatments with each other. We 
also do ‘second opinion’ visits. If one 
person has a problem and is not making 
progress, we might send out someone 
else”.
This group is fighting to find the common 
ground that makes sense, and the enemy 
is a lack of pluralism.
“Even though you are working in a small 
practice, you can still be part of the 
nationwide specialist community. We talk 
about recruitment for livestock practice 
in this forum. I personally find it very 
satisfying working with livestock. These 
reports help you to see correlations that 
you had no idea existed”.
The group has a pragmatic attitude to 
the authorities and increased controls. 
As long as it makes sense professionally 
and for society, it is not completely 
futile. However, inflexible inspectors 
who stubbornly stick to their guns cause 
frustration, as New Professional Man 
feels that their colleagues in the Danish 
Veterinary and Food Administration 
should be more just and keep the aim of 
the controls in mind.
New Professional Man sees that market 
conditions are changing dramatically, 
and that it is therefore necessary to find 
new opportunities in terms of services 
and suppliers, as well as in terms of new 
alliances. He has a proactive approach 
to the market. He has many formal and 
informal contacts with others in private 
practice, and is happy to work with 
others across the established practice 
community. In other words, New 
Professional Man sticks to the primary 
practice community and services which 
work and are a source of job satisfaction, 
but also looks outside and reflects on the 
changes to life and working conditions 
within new communities. As the owner 
of a small business, New Professional 
Man can see that it is necessary to find 
new collaborative partners to ensure 
survival. 
Diagnosis
Based on the anamnesis and symptoms 
we can identify the following tensions:
•	 Government	versus	Market
•	 Altruism	versus	Consultancy
•	 	Market	approach	–	Reactivity	versus	
Proactivity
•	 	Practice	Community	versus	
Professional Community
•	 Control	versus	Trust
•	 Leadership	versus	Autonomy
Figure 3. Economic Man’s position 
between the poles of the various tension 
areas
Figure 4. Professional Man’s position 
between the poles of the tension areas.
Figure 5. New Professional Man’s position 
between the poles. 
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Therapy
The aim of this check has been to 
investigate the state of health in Danish 
practices in relation to succession in 
business. A business succession that can 
ensure practices survive – either in the 
traditional sense or in a completely new 
form. The proposed therapy consists of 
strategic recommendations. The various 
leader types find themselves attracted 
to one or the other pole in the various 
tension areas, depending on their 
perceptions of reality. The therapy will 
therefore depend on where they sit in 
relation to these tension areas.
Economic Man
The therapy aims to ensure employees 
have the right core skills in relation to 
the market. Focus group interviews 
with assistants reveal that the younger 
generation of veterinarians do not 
give a central place to clients and a 
market-oriented approach in their 
interpretation of future practice. New 
work routines will therefore be required 
which give focus to clients within the 
organisational structure. Sustainable 
financial results are achieved through a 
balance between professionalism, client 
service, responsiveness to changes in the 
market and financial common sense. The 
goal for Economic Man must be a better 
balance in priorities. A one-sided focus 
on profit and individual contributions can 
create detrimental behaviour patterns. 
Focus group interviews show that 
professional focus and pride among the 
younger generation are well-established 
and reminiscent in many ways of the 
original altruism. A purely economic 
value set may therefore have a directly 
demotivating effect and potentially derail 
the business succession.
Professional Man 
The therapy targets holistic 
organisational considerations, taking 
into account the desire of assistants 
for social satisfaction outside working 
hours, and making allowance for the 
professional communities. Professional 
Man is the successor to James Herriot 
– the traditional veterinarian with 
altruism, professional autonomy and 
pride. His core focus is the primary 
professional expertise, making these 
businesses fairly successful in attracting 
the new generation. Solidarity within the 
practices is based on trust, and everyone 
pulling together. However, the problems 
arise in relation to organising the work. 
The older generation has often been 
used to everyone taking care of their 
own responsibilities, and this attitude 
does not support the new generation’s 
demand for professional development 
and expectation of ‘apprenticeship’ or 
a mentor. External leadership may be 
able to achieve the complex challenge 
of grafting employees into the business, 
given that there is no team spirit to draw 
on. Such leadership can also set a more 
strategic and proactive approach to the 
market. The situation may arise in these 
businesses that time stands still in relation 
to development; a form of stagnation. 
     
New Professional Man 
The therapy and strategic 
recommendations target two areas: 
the future leadership, and the tension 
between professional communities and 
the original practice communities. With 
respect to leadership, veterinarians in the 
communities should consider employing 
an external leader, as leadership within 
a professional collective often makes real 
leadership impossible. There is a danger 
of repeating behaviour patterns linked to 
the traditional profession’s ideologies of 
equality and practice operations. 
Given specialisation and generally 
increasing level of education within 
the profession, veterinarians should 
consider whether it is possible in the 
long term to be effective members of 
both the practice community and the 
new professional community. They 
should consider whether external and 
market conditions point towards new 
organisational structures, where focus 
can be given internally to the training and 
professional development of assistants 
and partners. A new organisational 
structure may meet the desire of the new 
generation to develop their expertise 
within a framework which also allows 
time for other social commitments, 
through efforts to provide contemporary 
services to the market. 
The interdisciplinary approach which 
some of these new communities 
already pursue can counter the harmful 
aspects of the competition and rivalry 
between, for example, consultants and 
veterinarians. This could in turn have an 
influence on the power struggles within 
the political arena, where new alliances 
could pave the way for a new perception 
based on trust rather than control. 
Prognosis
Changes within the deregulated 
knowledge society are impacting 
on the identity and future forms of 
practice for the veterinarian profession. 
The practising veterinarian, as an 
institution, is undergoing change. 
Throughout this process, the image of 
the veterinarian stands as an unclear mix 
of obsolete authority, the long arm of the 
government, and a local businessman. 
This unclear mix also results in a loss 
of legitimacy – in terms of what is 
“desirable, proper and appropriate” – in 
other words, credibility. If the necessary 
future business succession is to take 
place, and the profession is to survive, 
there is an acute need for reflection and 
change.
This change can take place gradually, 
or through revolutions. The change can 
be brought about proactively by the 
veterinarians involved, before others 
go behind their backs due to lack of 
initiative. The change can be created 
locally and only influence a few involved 
parties, or it can spread and impact 
others, and possibly even society as an 
institution.
Identity and image can blend together 
to shape a professional consultant 
who offers his professional insight and 
experience on market terms, in interaction 
with the client. New Professional Man 
could become the focal point for the 
necessary change in practices. 
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New norms and new directions
What key factors will lead the coming generation of veterinarians 
to become partners in the practice community?
Johanne Østerbye 
The way work is organised is critical to 
how assistants perceive their role in 
clinical practice. Work segregation and 
procedures have dramatic effects on 
dedication and motivation. This was 
the general message from assistants 
who participated in a number of focus 
group interviews aimed at investigating 
conditions for business succession in 
Danish veterinarian practices in 2009 
(see box). According to these assistants, 
reorganisation can be used to lever 
improvements in other areas. 
For example, practices can facilitate the 
difficult harmonisation of family and 
working life by restructuring the working 
day. By focusing on specialisation 
and professional development, and 
moving towards larger units1 with 
more employees and an appropriate 
organisation design, new values can be 
introduced into practices. This should 
ideally be guided by an overall vision, 
with professional leadership directing 
and catalysing the ongoing process.
“A high degree of specialisation, so you 
don’t have to be good at everything”. 
“A good working environment – able 
to delegate and know precisely who is 
responsible for each task”.
The justification in relation to the 
impending business succession and 
the current practice owners is that 
workplaces which can offer full 
professional development through 
knowledge sharing with colleagues will 
attract the new partners of the future. The 
challenge for some practices is to effect 
a personnel policy and organisational 
structure which allows assistants to 
retain their professional identity, and sets 
new standards for harmonising family 
and working life.
It will be up to leaders to serve as role 
models and “walk the talk” in their daily 
work, so the assistant can see a future 
as a partner in the practice. Efforts to 
improve the organisation will impact on 
values, and if leaders go home at 5:00 
p.m. each day and ask staff to switch off 
their mobile phones, this expresses basic 
conflicting values in terms of the priority 
of work in each veterinarian’s life.
Changes to practices and their 
conditions
The focus group interviews also revealed 
that changes in operating conditions for 
practices, along with  new structures and 
procedures affect behaviour and can 
lead to unexpected negative side-effects. 
Increased administration requirements 
resulting from greater regulatory control 
are managed in some practices as extra 
work which assistants and partners 
simply have to find time for during their 
working day – or in their leisure time. 
Assistants’ attitudes to 
successful business succession
Five focus group interviews with 
assistants from various forms of 
practice throughout Denmark 
provide the basis for the analysis 
and subsequent conclusions 
presented in outline in this article. 
Thanks to The Danish Veterinary 
Practitioners Association and 
Capacent  for good teamwork 
and subsequent access to in-
depth analysis of notes from the 
interviews. Thanks to the Danish 
Veterinarians Insurance Association, 
under Codan/SEB, for kindly 
supporting the master’s thesis 
entitled, “A new direction? Analysis 
of the veterinary profession – social 
conditions for business succession 
in Danish veterinary practices in 
the new millennium” by Johanne 
Østerbye, MPM, veterinarian.
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capable of reporting to a managing 
director?”. 
Even so, assistants seek professional 
leadership in their daily work.
“An administrative person should be 
employed. I don’t feel our education 
has prepared us to be leaders – at least 
not the way I see things now. It is the 
veterinary work I find appealing. I should 
be spared from all administration”.
Thus faith and vision are left up to the 
leadership. The assistants basically want 
to be left in peace to be practitioners– 
even when they become partners. The 
leadership has to create the desired vision 
for the future, and communicate this to 
employees and peers. The leadership 
challenge will be threefold:
•	 	The	leader	has	to	integrate		employees	
and peers into the organisation, 
without having solidarity or a loyal 
work ethic to fall back on.
•	 	The	 leader	 also	 has	 to	 open	 the	
practice to the outside world and get in 
touch with the interests of clients and 
livestock owners in the marketplace..
•	 	The	 leader	 must	 know	 each	
employee and peer so well that client 
requirements can be met in a way that 
fully exploits the available potential.  
The question is, who is going to meet 
the leadership challenge in Danish 
veterinarian practices in the future ?
The focus groups refer to leadership 
as a hypothetical concept and not an 
existing reality2, and we might ask 
where this leadership mantra comes 
from. Veterinarians have traditionally 
been autonomous within a professional 
hierarchy at the clinics, without the need 
for additional supervisory coordination. 
The logic can be recognised as one 
of the key arguments in New Public 
Management3 regarding leadership: 
“There is a focus on professional, 
entrepreneurial leadership with a vision 
and a mission, which can be held 
responsible for implementation of new 
initiatives. Leadership is moving away 
from the administrator and professional 
focus, towards leadership teams which 
function as strategic forums”.
Business succession and the future 
shape of practices
The change currently taking place 
in society, and among practising 
support the necessary market focus – that 
attitudes to organisation, professionalism 
and basic faith and values among 
assistants in Danish veterinarian practices 
are disconnected from an appreciation 
of the market. The assistants write the 
clients out of the equation!
The self perceptions of most young 
veterinarians are primarily linked to 
the expertise, professionally grounded 
authority, and autonomy in arranging 
work which has historically been 
associated with the profession. A self 
perception which belongs to the original 
altruism, and which they carry with them 
from their time of study at the Faculty of 
Life Sciences at Copenhagen University.
Social factors and the leadership 
challenge
It is surprising how little reference is made 
to social factors in the focus groups. 
The young assistants seek professional 
guidance from their supervisors, but 
apart from experiencing a lack of basic 
apprenticeship, they make no mention of 
a desire for group dynamics, loyalty, or 
“esprit de corps”. 
Social aspects are expressed in the desire 
for a change in organisation which permits 
leisure time for social relationships with 
family and friends. One could argue that 
the desire to belong is expressed when 
they seek involvement and transparency 
in financial matters, but this could also 
be interpreted as a desire for utility and 
material gain, or a fear of not knowing all 
the risks before making a decision.
The autonomy enjoyed by practitioners 
sets the scene for the “leadership 
challenge” in the future predicted by 
assistants. Professional judgement – 
drawing on a combination of experience 
and theoretical knowledge, often without 
reflecting on it at the time – has not 
created a basis or tradition for reflecting 
on one’s actions and their consequences 
for affected parties, including staff and 
peers. 
This professionally grounded authority 
is carried over, unnoticed, into other 
relationships of life, and it can be difficult 
for a veterinarian with a traditional 
self-perception to accept and openly 
acknowledge that they make mistakes. 
This factor makes it a significant leadership 
challenge to lead or advise autonomous 
veterinarians in their daily work.
“But these seven leaders – are they 
Other practices reorganise their daily 
operations to take into account the extra 
administrative workload.  
New wage and evaluation systems can 
be designed with the best intentions, 
targeting increased efficiency and the fair 
distribution of income in line with effort, 
but such systems can lead to mistrust and 
unintended behaviour patterns among 
employees. In some cases, assistants have 
resigned as a consequence.
“I was told brusquely that I had hardly 
earned enough to cover my salary over 
the last few years. I resigned immediately! 
Because they did not appreciate the other 
ways in which I had contributed. They 
were only interested in the financial side”.
Paradoxes and areas of tension
The assistants in the focus group 
investigation all agreed that sufficient 
earnings are the foundation for everything 
else. A healthy economy makes it possible 
to employ others to perform the tasks 
which lie outside the purely professional 
area, reducing working hours for 
veterinarians, thereby leaving room for 
reflection and development. 
A vicious circle will quickly arise in 
practices where veterinarians perform 
all the tasks themselves, do not pursue 
professional development because of 
time pressures, and are forced to focus on 
price instead of quality as a competition 
parameter.. The practice will degenerate 
into an economic prison which  assistants 
describe as the worst imaginable scenario 
in a future as a partner.
It therefore seems paradoxical that clients 
who are the source of the desired income 
are viewed as a burden and a problem by 
assistants. 
“I think it is very important to agree on 
how to manage the clients, because then 
it happens automatically, and there is a 
united front. This is what works. There 
are major differences from practice 
to practice in terms of how clients are 
trained”.
The majority of assistants do not see it 
directly as their job to link developments 
in the market and developments in 
practices. Skilled employees who are 
responsive to feedback from the recipients 
of their services will therefore be a key 
resource among those striving to ensure 
practices remain in the marketplace. 
There is much to suggest that work 
routines, perceptions and values do not 
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veterinarians, is reflected in the new 
generation and their desire for change 
in practices. The regulatory structures 
resulting from the neoliberal forms of 
control – most recently in the form of the 
veterinary accord – may lead to changes 
in ethics and practice among the coming 
generation of veterinarians. 
Such a control strategy may force the new 
generation of veterinarians to give up 
their professional autonomy, given that 
it is difficult to support. It is conceivable 
that repeated patterns of behaviour will 
eventually lead to new norms and values, 
such that the current form of practice 
is changed. One possible scenario 
might be that practising veterinarians 
become part of the public health sector. 
This will require a paradigm shift for 
practitioners, away from their original 
status as an independent profession. 
Another possibility is that veterinarians 
construct an alternative form of practice 
which decouples the fixed rules from 
professional judgement, and renegotiate 
their autonomy.
The question, then, is whether the 
profession should sit by and let New 
Public Management and neoliberal forms 
of control provide inspiration and set the 
agenda for others, including civil servants 
within the Danish Veterinary and Food 
Administration. Should we let them have 
the initiative and set a new direction 
for the profession under the cover of 
the process of change? Or should we 
identify it ourselves, and let our own 
entrepreneurs lead the way, by choosing 
a strong organisational value base built 
on professionalism and trust? 
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the thesis entitled: “A new direction? Analysis of the veterinary profession – social conditions for business succession in Danish veterinary practices 
in the new millennium” on the website of the Danish Veterinary Association: www.ddd.dk > PDA > Management og ledelse).
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The FECAVA Hygiene and 
Antimicrobial Resistance Symposium 
was held during the FECAVA / WSAVA 
Congress in Geneva last June. As this 
is an issue of global concern we were 
happy to invite some of the world s´ 
most well know speakers on the 
subject. The Symposium was attended 
by a large number of delegates and the 
lectures were very much appreciated.
A nosocomial infection is an infection, 
not present or incubating on admission 
but acquired in the hospital. The 
transmission of a pathogen can occur 
through the environment, between 
staff and patient or between patients, 
through direct or indirect transmission. 
This is an increasing problem not only 
in human hospital settings but also 
in small animal practice. One of the 
most serious nosocomial transmissions 
is that of infections caused by antimicrobial resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and 
methicillin-resistant Staphylococcus pseudintermedius (MRSP). Infections caused by pathogens resistant to antimicrobials can cause 
serious disease in both humans and animals.
Effective implementation of hygienic measures is essential to prevent and contain the transmission of nosocomial infections 
to animals and humans both within veterinary settings and in the community.  Every veterinary practice, no matter what its 
size, should have a person responsible for infection control. There should be hygiene guidelines posted and adherence to basic 
hygiene routines should be an integrated part of all clinical work.
Appropriate selection and usage of antimicrobial drugs in veterinary settings is also vital to maintain the efﬁ cacy of 
antimicrobial treatments in companion animals and to constrain antimicrobial resistance that can seriously compromise animal 
health and welfare and can have negative implications for public health.
As veterinarians we all play an important role in the prevention and treatment of diseases in small animals but also have a 
responsibility in the education of animal owners. Communication with pet owners is essential to raise awareness of potential 
health risks and to ensure their active involvement in the prevention of bacterial, viral and parasitic diseases and their 
compliance to prescribed therapy to pet animals.
To publish papers in EJCAP based on the lectures given at the FECAVA Hygiene and Antimicrobial Resistance Symposium is 
an important part of the continued work to increase awareness on this emerging matter. All the papers will be posted on the 
FECAVA website (www.fecava.org) together with the poster “FECAVA Key Recommendations for Hygiene and Infection Control 
in Veterinary Practice”. This poster (above) shows the different key elements in basic hygiene within veterinary settings. It is free 
to download. The appropriate printing size is A2. Translations into different languages are available on request. 
Alexandra Vilén, DVM, FECAVA Director of SSAVA, Chair of the FECAVA Working Group on Hygiene and the use of Antimicrobials in 
Veterinary Practice
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Methicillin-resistant Staphylococcus aureus (MRSA) has caused much concern among health-care professionals, 
considerable fear among the general lay public, and a large number of newspaper headlines touting a “superbug”. 
Why has this pathogen received so much attention? 
S aureus –whether resistant or not –  is first of all a human commensal, asymptomatically colonising the anterior 
nares and moist areas of the skin of 30% of humans [1]. But S aureus can also cause invasive infections.  The skin 
is most commonly affected. Skin and soft tissue infections can be relatively trivial and superficial (impetigo), or 
more serious and invasive (cellulitis, abscesses). Infections of deep-seated structures such as the lungs or bones are 
often complicated and difficult to treat. At the most serious end of the spectrum, S aureus causes bacteraemia and 
endocarditis, life-threatening infections that few patients survived prior to the advent of antibiotics.
Based on the clinical presentation of a patient it is impossible to predict with certainty whether an infection is 
caused by MRSA or MSSA (methicillin-sensitive S aureus). While methicillin-resistance does not render S aureus 
more pathogenic per se, it seriously limits treatment options. In addition, antimicrobial resistance seems to be 
preferentially acquired by S aureus strains that are “successful” epidemiologically [2].
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Historical perspective
The advent of penicillin in the 1940s revolutionised the treatment 
of S aureus infections and considerably improved the outlook 
for affected patients [3]. However, penicillin-resistant strains 
emerged rapidly, and by the middle of the 1950s penicillin had 
lost much of its usefulness as an anti-staphylococcal agent. Much 
of this was due to one strain, the 1950s equivalent of today’s 
MRSa: a penicillin-resistant S aureus clone designated phage-
type 80/81 that was particularly virulent and highly transmissible 
and that caused difficult to control hospital outbreaks [4].  In 
one Boston Hospital the mortality associated with S aureus 
bacteraemia increased almost five-fold between 1947 and 1957 
due to the spread of antimicrobial resistance while the mortality 
from pneumococcal bacteraemia was falling [5].
In 1959, methicillin, a new penicillinase-fast semi synthetic 
antibiotic promised renewed control over S aureus. In fact, 
around the same time phage type 80/81 started to disappear. 
However, it took less than two years from the introduction 
of methicillin that the first MRSa was isolated. Soon, MRSa 
became a significant clinical problem, particularly in europe. In 
countries like Denmark and Switzerland up to 30% of S aureus 
isolates from blood cultures were methicillin-resistant in the 
second half of the 1960s. By the 1980s these archaic MRSa 
strains had vanished into thin air. It is unclear whether this was 
due to successful infection control measures, introduction of 
new antibiotic agents, or other reasons [6]
In the meantime a second wave of MRSa was underway. a 
number of strains – different from the ones seen in the 1960s 
– spread in hospitals and long-term care facilities all over the 
world. In england, for example, over 40% of all S aureus blood 
culture isolates were MRSa in 2000. Different geographic 
regions are affected by different strains of MRSa, which may 
in part explain the hugely variable success of MRSa in different 
countries.
Why is MRSA a problem?
S aureus is a virulent organism that causes considerable 
morbidity and mortality. The MRSa strains that became endemic 
in hospitals since the 1980s share this property. In addition they 
appear to be particularly well adapted to the contemporary 
hospital population and environment. They are associated 
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with older age, more co-morbidities, previous hospitalisations, 
surgery, and invasive devices. Due to their antimicrobial resistance 
they have a selective advantage over other microorganisms 
in the face of widespread use of broad-spectrum antibiotics. 
Hospital MRSa strains are highly transmissible and spread within 
and between health care facilities. Finally, resistance to first line 
antibiotics may necessitate the use of more expensive second or 
third-line agents, increasing the cost of treatment [7-8]
Particularly well adapted to hospitals, hospital MRSa strains are 
a very common cause of health-care acquired infections. Figures 
from the United States implicate S aureus in 30% of surgical site 
infections (49% of isolates MRSa), 24% of ventilator-associated 
pneumonia (54% MRSa), and 10% of central-line-associated 
blood stream infections (57% MRSa) [9]
How can MRSA be controlled in 
hospitals?
The control of MRSa in health-care facilities demands a multi-
pronged approach, similar to other health-care associated 
infections. First, the problem needs to be measured, described 
and defined. Surveillance leads to increased awareness and 
helps to focus minds. Second, steps have to be taken to reduce 
transmission, including consistent hand hygiene with alcohol-
based hand rubs for staff and isolation or cohorting of MRSa-
colonised patients [10]. Third, patient-level risk factors need to 
be tackled. examples include managing the risk from central 
lines by adhering to evidence-based care bundles and reducing 
the risk of surgical site infections through best practices in skin 
preparation, antimicrobial prophylaxis and surgical technique. 
Fourth, ecologic factors have to be addressed, such as reducing 
and optimising antimicrobial consumption and cleaning. a 
strategy aimed at identifying MRSa carriers on admission by 
universal screening has contributed to the Dutch success in 
keeping MRSa rates minimal, [11] but its merit has not been 
conclusively judged in settings where MRSa is endemic [12-13]. 
Targeted screening is useful in both endemic and non-endemic 
settings. 
The success of these measures has been demonstrated, and the 
incidence of MRSa infections in hospitals has been falling in 
several countries in recent years [14]
A new threat – community-associated 
MRSA
The fight against the MRSa strains commonly found in 
hospitals has been facilitated by the fact that transmission of 
these strains largely occurred within health-care facilities, and 
endeavours to curb their spread could be focused accordingly. 
Unfortunately, since the 1990s strains of MRSa have emerged 
that primarily circulate in the community (Ca-MRSa) [15-18]. 
These community-associated clones appear to have a higher 
biological fitness than hospital strains and are often more 
virulent. as a result, they also affect young, healthy individuals 
in whom they cause serious skin and soft tissue infections and, 
more rarely, pneumonia. In many US emergency departments, 
the majority of adults presenting with staphylococcal skin and 
soft tissue infections are affected by Ca-MRSa [18]. Compared 
with the “conventional” hospital MRSa strains, Ca-MRSa are 
usually resistant to fewer classes of antibiotics. Oral drugs such 
as clindamycin, tetracyclines and co-trimoxazole frequently 
remain active. However, alarming trends of increasing resistance 
have been noted [19]. Control of these strains is much more 
challenging as they are not limited to health-care facilities. as 
time goes by, the borders between hospital- and community-
associated MRSa are becoming more blurred, and Ca-MRSa is 
increasingly becoming endemic in hospitals in several countries, 
such as the United States, greece, algeria, India, and Taiwan 
(among others).
The role of animals in human MRSA 
infection
Pets have anecdotally been implicated as reservoirs for human 
MRSa infection [20].  More recently, livestock has been shown 
to act as a source of MRSa. a novel strain, ST398 has been 
found to be highly prevalent in pigs and calves in europe and 
North america [21-22]. Persons who are in direct contact with 
livestock frequently become carriers of this MRSa strain that is 
typically resistant to tetracyclines – a commonly used class of 
antibiotics in pig farming. like other strains of S aureus, ST398 is 
capable of causing serious infections in humans [23]. 
For the time being, livestock-associated MRSa does not seem to 
be well adapted for human-to-human spread and is therefore 
mostly limited to individuals with direct contact with colonised 
animals [24]. Nevertheless, smaller hospital outbreaks have 
been reported, [25] and ongoing vigilance seems warranted.
Conclusion
MRSa is not a single entity, but represents a variety of clones 
of antibiotic-resistant S aureus with different epidemiological 
and clinical characteristics. Much progress has been made in 
controlling the hospital-associated strains that have plagued 
health-care facilities in many countries since the 1980s. 
Community-associated MRSa strains are a cause for concern, as 
these strains are associated with higher virulence and biological 
fitness. animals can play a role in the epidemiology of human 
MRSa infection.  Risk factors that promote the spread of MRSa 
in animals have to be identified and addressed.
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INTRODUCTION                                           
GENERAL
Antimicrobial resistance issues in small 
animal practice
Antimicrobial resistance (AMR) is a global public health concern 
and it is associated with antimicrobial usage in both human 
and veterinary medicine. Currently, information is scarce on the 
extent and the patterns of antimicrobial usage in companion 
animals and on prescribing practices by veterinarians. Little 
is known about the role of companion animals, particularly 
dogs and cats, in the epidemiology of AMR, although there 
is growing evidence of antimicrobial resistance in pathogens 
with zoonotic potential in these species. Previous research has 
shown that companion animals can act as potential sources of 
infection for humans in veterinary practices. Also, at community 
level, companion animals can transfer resistant pathogens and 
AMR determinants to humans through social interactions and 
by sharing common areas [1, 2]. 
Veterinary surgeons, generally, are aware of the possible 
occurrence of adverse reactions when administering or 
prescribing antimicrobials. Allergic reactions to certain 
antimicrobial groups (e.g. penicillins) and growth abnormalities 
(e.g. fluoroquinolones) are well documented in the veterinary 
literature [3-6]. However, practitioners often fail to consider 
AMR as an adverse reaction and to consider it when selecting 
antimicrobials for animal therapy (Fig. 1) [7]. 
Surveillance of antimicrobial usage and 
of antimicrobial resistance (AMR) in 
companion animals
Knowledge of the extent and patterns of antimicrobial usage in 
companion animals is vital to the understanding of the context 
in which AMR occurs in these species. Data on antimicrobial 
usage at practice level can be used in risk assessment and risk 
management of AMR. Surveillance systems are important to 
gather data at both national and international level. However, 
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Antimicrobial resistance is nowadays a major public health issue. Misuse of antimicrobials is one of the risk factors 
associated with the development and spread of antimicrobial resistance in humans and animals. Furthermore, it is 
also linked to the occurrence of nosocomial infections in humans and it is becoming more frequently detected in 
veterinary practices. Monitoring and surveillance of antimicrobial consumption and resistance trends are important 
to inform policy makers and veterinarians for the development of guidelines and practice protocols, respectively. 
Stewardship of antimicrobials, together with infection control and hygiene programs are essential in veterinary 
practices to ensure and maintain efficacy of existing antimicrobials. Furthermore, responsible use of antimicrobials, 
hygiene and infection programmes  are essential to contain antimicrobial resistance and nosocomial infections.  
This paper will focus on the development and implementation of stewardship programmes for the responsible use 
of antimicrobials and hygiene protocols in small animals practices.
Fig. 1 Aims and objectives of antimicrobial stewardship programs.  
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most of the currently available surveillance systems in different 
European countries are mainly focused in food-producing 
animals and gather very little information on companion animal 
species, especially when assessed by the level of wholesale sales 
of medicines. [8-10]. Recent studies evaluated antimicrobial 
usage through the analysis of clinical electronic practice 
databases or through postal survey of veterinary surgeons and 
identified widespread use of broad-spectrum antimicrobials, 
particularly of beta-lactams, fluoroquinolones and macrolides 
[11-16]. In the UK, the Royal Veterinary College in association 
with the University of Sydney are currently developing a system 
for the surveillance of diseases in companion animals in the 
UK, known as VEctAR (Veterinary Electronic Animal Record) 
(http://www.rvc.ac.uk/VEctAR/) [17]. This system will use, 
retrospectively, clinical data from electronic patient records of 
participating veterinary practices to assess disease prevalence 
but will also use research studies focused on pharmacovigilance 
and investigations of the  efficacy of antimicrobial therapy [12, 
18].   
The European Medicines Agency (EMA) has recently 
implemented the European Surveillance for Veterinary 
Antimicrobial Consumption (ESVAC). This system monitors 
antimicrobial sales at the level of the pharmaceutical companies 
for the different veterinary species [19]. Nevertheless, most 
European countries have, currently, only a limited surveillance or 
monitoring of antimicrobial usage in small animals. Researchers 
in Denmark have referred to the importance of monitoring AMR 
in indicator bacteria (Enterobacteriaceae and Enterococcus 
spp.) in dogs, after observing that the use of fluoroquinolones 
and cephalosporins in this species was higher than in food-
producing animals. These bacteria can be a source of AMR to 
human pathogens [20]. 
Currently, most of the AMR reported in companion animals 
refers to diseased animals monitored at practice level [1, 21-
26]. Nonetheless, there is evidence that AMR also occurs within 
healthy companion animal populations and that pathogens 
with zoonotic potential are often involved [27-29]. Surveillance 
of such AMR in companion animals is important to assess 
the potential risk for public health and to identify areas for 
intervention, particularly for targeted antimicrobial stewardship 
programs.
Aims and objectives of stewardship of 
antimicrobials
Stewardship of antimicrobials is important in companion animal 
practice to prevent the loss of efficacy of antimicrobials due 
to the emergence of AMR and to prevent the emergence of 
antimicrobial resistance in pathogens relevant to animal and 
public health. Furthermore, stewardship programs are important 
to reduce morbidity, mortality and additional cost associated 
with resistant infections and therapeutic failure (Fig 1) [30]. 
Antimicrobials are used routinely in practice and are important 
tools for the prevention and therapy of infectious bacterial 
diseases in pet animals. However, veterinarians working with 
companion animals may not be aware of the impact that their use 
of antimicrobials has in society. This lack of awareness has been 
previously described in human medicine and raises ethical issues 
[31, 32]. The veterinarian has an “obligation” to provide the best 
medical care to their patients and to ensure their health and 
welfare. On the other hand, misuse through underuse, excessive, 
inappropriate and unnecessary use both in administration and 
prescription of antimicrobials in veterinary practice,  can cause 
and lead to the spread of resistance in zoonotic pathogens 
such as methicillin-resistant Staphylococcus aureus (MRSA) or 
methicillin-resistant Staphylococcus pseudintermedius (MRSP) 
[31].The selection of antimicrobials less likely to cause AMR for 
treating an animal  may involve  selecting  one that can be equally 
effective as the first choice antimicrobial therapy [33]. However, 
on certain occasions, it possibly may not  be as effective as the 
first choice and can lead to therapeutic failure, compromising 
the health of the individual animal [34]. Therefore, careful 
consideration of available antimicrobials and their properties is 
needed when selecting animal therapy, so that the antimicrobial 
selected will be efficacious to treat the animal while having a 
low or no impact in AMR. 
Criteria for the selection of  
antimicrobials
The decision-making involved in the selection of antimicrobials 
for the treatment of animals is a complex process that often 
has to be made during the limited time available at an animal 
consultation. Appropriate antimicrobial usage involves the 
selection of the antimicrobial based on the infectious condition 
or infectious agent involved, the correct dosage, the frequency of 
dosage and the duration of therapy through the most adequate 
route of administration, in order to obtain the therapeutic 
concentration at the site of infection [35].
Selection of antimicrobials should follow, whenever possible, 
an evidence-based approach, taking into account the findings 
of a clinical examination and tests performed but it should 
also be supported by the scientific evidence available from the 
published research. The veterinarian must take into account 
several requisites to choose the appropriate antimicrobial 
substance. These include the characteristics of the animal 
patient (species, age and immune status) but also the potential 
pathogen(s) involved (pathogenicity, virulence and antimicrobial 
susceptibility) (Fig. 2). Furthermore, the veterinarian needs to 
take into consideration the characteristics of the antimicrobial 
itself. These include: a) spectrum of action, b) mode of action 
(bacteriostatic or bactericidal), c) penetration (lipophylic or 
hydrophilic), d) pharmacokinetics and e) pharmacodynamics of 
the antimicrobial considered. 
However, it is not always possible to obtain a definitive diagnosis 
from clinical examination and the clinician’s knowledge of 
infectious diseases. Further investigation may be required 
in those cases with collection and culture of samples and 
antimicrobial susceptibility testing (AST), or using cytology and 
Gram staining at practice level. Samples for AST should be sent 
to accredited diagnostic laboratories, which follow standardised 
laboratory procedures such as those described by the Clinical 
and Laboratory Standards Institute (CLSI) (http://www.clsi.org) 
[36].
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There is currently some discussion on the clinical value of the 
Minimum Inhibitory Concentration (MIC) used to define levels 
of resistance in ASTs. The MIC may not always be sufficient to 
determine if antimicrobial treatment will be effective and that 
clinical cure will occur. Consideration is now being given to new 
measurement units in conjunction with the MIC, such as the 
Mutant Prevention Concentration (MPC). The MPC takes into 
account the variation in antimicrobial susceptibility within high 
density bacterial populations and the likelihood of occurrence 
of less susceptible mutants in those same populations [37]. It is 
defined as the lowest concentration of antimicrobial necessary 
to inhibit the growth of the least susceptible organisms in 
highly dense bacterial populations [37]. The value of the MPC is 
consequently higher than that of the MIC. When such bacterial 
populations occur, antimicrobial dosage required for therapy 
should be based on the MPC, which may imply using higher 
dosages than those recommended by drug manufacturers or 
by current available scientific evidence. However, definition of 
standardised MPC measurements for different pathogens and 
antimicrobials is still ongoing and it may be some time  before 
these are adopted by microbiology laboratories and applied 
routinely to veterinary isolates [37]. 
As such, ASTs remain the ‘gold standard’ test to investigate 
antimicrobial resistant patterns of animal pathogens in everyday 
small animal practice. Interpretation of culture and AST findings 
by veterinary surgeons in practice is often challenging. It is 
important that the practitioner interprets the laboratory tests in 
the clinical context, taking into account the clinical findings and 
animal patient to be treated.
Stewardship strategies 
Stewardship of antimicrobials must be promoted at international, 
national and practice levels. In human medicine, antimicrobial 
stewardship programs are common in healthcare premises. 
Stewardship strategies include a) international and national 
awareness and educational campaigns for practitioners and 
general public, b) policies and guidelines at international, 
national and hospital/ practice levels, c) educational programs 
for medical, pharmacists and nurse staff, d) implementation 
of formularies and restrictions for antimicrobial use at hospital 
level, e) supervised/ revised prescription systems [30, 38]. 
General international guidelines and campaigns to promote the 
responsible use of antimicrobials can be used as a basis for the 
development of national guidelines taking into consideration 
common infectious conditions observed, licensed antimicrobial 
drugs and AMR patterns in each country. This will provide the 
veterinary surgeon with a tool in practice that can be used for 
the definition of protocols of antimicrobial usage in clinical and 
surgical cases. 
a) Guidelines and campaigns at international level
Promotion of responsible use of antimicrobials in practice is 
one of the main aims of FECAVA’s Working Group on Hygiene 
and Use of Antimicrobials in Practice. The Working Group 
aims to raise awareness in veterinarians of the occurrence of 
AMR and nosocomial infections in small animal practice and 
how to implement strategies that will prevent the occurrence 
of these infections. The Working Group will produce general 
recommendations for antimicrobial usage in therapy and 
prophylaxis of both clinical and surgical cases in the near future. 
At European level, other associations are also involved in 
promoting responsible use of antimicrobials. The EPRUMA 
initiative (European Platform for the Responsible Use of 
Medicines in Animals) is involved in raising awareness for not 
only use of antimicrobials but also for antiparasitic drugs for 
which resistance is also an issue that can also compromise 
animal health. Stakeholders of EPRUMA include FECAVA, FVE 
(Federation of Veterinarians of Europe), IFAH (International 
Federation for Animal Health), amongst others. Its campaigns 
and recommendations are aimed at veterinarians, farmers and 
animal owners (http://www.epruma.eu/) [39]. 
In America, the ISCAID (International Society for Companion 
Animals Infectious Diseases) is currently developing guidelines 
for antimicrobial therapy of common conditions in dogs and 
cats. This guidelines will be published in due time by ISCAID 
(http://www.iscaid.org/) [40].  
Often international guidelines and campaigns cannot represent 
or cover all the aspects and differences observed between 
countries in the care of companion animals and the prevalence 
of infectious diseases. Nonetheless, international guidelines and 
campaigns are important as these define a general framework 
of recommendations for national associations and veterinarians 
to support their decision-making process when selecting 
antimicrobial therapy.
 
b) Guidelines and interventions at national level
Development of guidelines in each country should take into 
account the prevalence of infectious diseases, the patterns of 
AMR and the extent of antimicrobial usage in small animal 
populations. Guidelines for antimicrobial usage will not be 
effective if these are not considered, as each country is different 
in its own way. Major differences may be observed in terms of 
licensed antimicrobials available for veterinary use, legislation, 
prevalence of common infectious diseases affecting small 
animals and levels and patterns of AMR in animal pathogens. 
As such, guidelines of a specific country cannot and should not 
be adopted by other countries without previous assessment of 
Fig. 2- Criteria considered for the selection of antimicrobials in 
small animal practice.
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how the situation observed in veterinary practice and animal 
populations differ between those countries. It is only when 
these guidelines have been adapted to the specific conditions 
observed in the country of interest that they will be effective in 
changing antimicrobial usage patterns in small animal practice.
Restrictions on the use of certain antimicrobials in veterinary 
practice may be imposed on veterinary practitioners in the near 
future. Recently in the UK there was a recommendation from 
the Chief Medical Officer, Sir Liam Donaldson to ban the use 
of fluoroquinolones and cephalosporins in animals due to the 
perceived risk of resistance to these antimicrobials in human 
pathogens [41]. It is thus vital that the veterinary profession 
promotes and uses antimicrobials responsibly and is aware of 
hygiene protocols and infection control measures at practice 
level to control the emergence and spread of AMR pathogens 
and determinants.
In a recent survey by FECAVA amongst its member states 
(n=36), only 4 countries possessed national guidelines for 
antimicrobial usage in companion animals. These were the 
UK, Norway, Sweden and Netherlands. Formats of guidelines 
varied from general principles of antimicrobial usage (i.e. “use 
narrow-spectrum antimicrobials whenever possible”) to specific 
approaches recommended for individual common bacterial 
clinical conditions in small animals, as observed in the UK and 
in Sweden, respectively [42, 43]. In a recent FECAVA survey of 
members of the British Small Animal Veterinary Association 
(BSAVA), over 80% of the veterinarians questioned about the 
usefulness of current guidelines for use of antimicrobials found 
them to be useful or moderately useful for everyday practice (Fig 
3). The extensive lack of national guidelines throughout Europe 
is alarming, as guidelines are important to promote responsible 
use of antimicrobials and raise awareness of the risk of AMR 
in companion animals. National guidelines will provide the 
framework for veterinarians to adapt appropriate protocols and 
policies to their own workplace. Furthermore, veterinary faculties 
should integrate teaching focused on evidence-based medicine, 
provide a relevant undergraduate training in antimicrobial and 
infectious diseases knowledge and raise awareness of AMR 
in small animal practice. National veterinary associations must 
become more active and support and inform their members 
of the promotion of rational use of antimicrobials in everyday 
practice. These associations should also promote further training 
of veterinarians in antimicrobial usage, knowledge of infectious 
diseases, hygiene and infection control in practice.
c) Guidelines and protocols at practice level
Antimicrobials protocols should be implemented for therapy 
of bacterial conditions commonly observed in practice. This 
would include clinical conditions such as pyoderma or urinary 
tract infections (UTIs) in dogs and conjunctivitis or rhinitis in 
cats. Protocols for the management of traumatic wounds and 
abscesses particularly in cats should be defined, as  these often 
do not require systemic antimicrobial therapy [44].
‘Prophylactic’ use of antimicrobials in surgical cases must be 
controlled at practice level. Current recommendations in the 
UK state that no antimicrobials should be used for ‘prophylaxis 
of infection’ in  surgical cases where proper theatre hygiene, 
surgical asepsis and good surgical techniques have been 
observed [42]. This is to reduce the unnecessary prophylactic 
use of antimicrobials in small animal practice. Antimicrobials 
should not be used as a substitute for good hygiene in practice. 
They should only be considered when there is evidence of a 
significant risk of bacterial infection, either because of the long 
duration of the surgery, poor surgical technique or where there 
is potential contamination of the surgical wound. 
A recent FECAVA survey of members of the British Small Animal 
Veterinary Association (BSAVA) revealed that only 48% of 
the participants (n=296) worked in veterinary practices with 
established protocols for antimicrobial usage. Of those, 36% 
had protocols for surgical prophylaxis, 15.0% had protocols for 
therapy of resistant infections (i.e. MRSA), and routine clinical 
cases but only 8.1% had protocols for therapy of immune-
suppressed animals (multiple answers were allowed).
Antimicrobial usage protocols in practice can include categories 
for use of antimicrobials for common clinical infectious 
conditions, so that antimicrobials can be separated into those 
Fig. 3 Perceived usefulness of current guidelines for antimicrobial 
usage by small animal veterinarians in the UK
Fig 4 Implementation of antimicrobial stewardship in practice 
(Adapted from Fishman, 2006, AJIC with authorisation of the 
author and the publisher). 
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Hand washing and disinfection has been proved to be effective 
in containing the spread of MRSA in healthcare professionals, 
their patients and the environment [46].  Transfer of MRSA in 
veterinary practice can occur in any direction between staff, 
animals and pet owners [2, 47]. Transmission of MRSA has 
also been observed between pet owners and their animals and 
vice-versa at household level [2]. In veterinary practice, it has 
also been observed that surfaces such as door handles and 
computer keyboards and telephones can be contaminated with 
MRSA and other pathogens [48, 49]. Cleaning and disinfection 
of equipment and facilities with approved products can prevent 
the occurrence and transmission of nosocomial infections in 
veterinary settings. Hygiene protocols in practice are therefore 
important to reduce the burden of infection at practice level 
and help to reduce the unnecessary use of antimicrobials in 
companion animals. 
Infection control in practice is essential, regardless of the size 
of the practice. Nosocomial infections are becoming more 
common in veterinary practices [50]. Pathogens involved are 
often resistant to antimicrobials and also have zoonotic potential 
[23, 51]. Control measures will probably vary according size 
of practice, veterinary services provided and nature of clinical 
and surgical cases involved. Nonetheless, even small veterinary 
practices should have basic infection control measures when 
dealing with infectious diseases. This will involve having written 
protocols that will provide clear instructions to veterinary staff.
Recently, the Working Group has developed a poster with 
recommendations for hygiene and infection control measures in 
practice (http://www.fecava.org/files/952.pdf) [52]. An earlier 
Category Definition Examples
First line •  Initial empirical therapy with known or suspected bacterial infections
•  Prior to culture and antimicrobial sensitivity tests
•   Antimicrobials are considered less important in human medicine for the therapy of 
infectious conditions
•   Antimicrobials less likely to induce or spread antimicrobial resistance in human 
pathogens and commensal bacteria 
• Penicillin
•  1st and 2nd generation 
cephalosporins
•  Trimethoprim- 
sulfonamides
Second line •   Antimicrobials used only when supported by results from culture and antimicrobial 
sensitivity tests
•   Animal and infection factors determine that first line antimicrobials are inadequate for 
therapy
•   Classified as critically important in human medicine for the therapy of life-threatening 
conditions 
•  Antimicrobials may give origin to antimicrobial resistance
• Fluoroquinolones
•  3rd and later generation 
cephalosporins
Third line •   To be used in life-threatening conditions but only supported by results of culture and 
antimicrobial sensitivity tests 
•  To be used when 1st and 2nd line antimicrobials are not indicated
•   Classified as critically important in human medicine for the therapy of life-threatening 
conditions
•   Loss of efficacy and AMR to this antimicrobial has serious implications for human health
• Carbapenems
Last resort 
(can be 
restricted 
for use in 
practice)
•   To be used in life-threatening conditions but only supported by results of culture and 
antimicrobial sensitivity tests when there aren’t any other therapeutic options available
•   Classified as critically important in human medicine for the therapy of life-threatening 
conditions
•   Loss of efficacy and AMR to this antimicrobial has serious implications for human health
• Vancomycin
to be used empirically (without AST but less likely to originate 
AMR) and those antimicrobials that are only indicated when 
supported by AST results (Table 1) [33, 45].   
Strategies for the control of antimicro-
bial resistance (AMR) and nosocomial 
infections in practice in conjunction 
with antimicrobial stewardship 
a) Hygiene and infection control
Hygiene is an important component of infection control 
measures in practice (Fig. 4). It has an important role in the 
containment and eradication of infectious agents in the 
workplace. Hygiene protocols are essential to contain the 
spread of nosocomial infections in human healthcare settings. 
Table 1 Example of classification of antimicrobials according to priority of use in companion animal practice [1, 2] (Permission for use 
obtained from Scott Weese the author of the table).
Key points of hygiene infection control
• Hand hygiene
• Cleaning & disinfection of premises
• Use of protective clothing
• Use of gloves
• Training of staff
• Education of pet owners
• Management of clinical waste
• Laundering of clothing and bedding materials
Table 2- Summary of the recommendations for hygiene and 
infection control in companion animal practice.
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version of this poster was presented at the Annual Conference 
of WSAVA in June 2010, during the “One Health” Symposium 
[52]. A brief summary of the key recommendations can be 
found in Table 2. The Working Group recommends that every 
veterinary practice should display this poster in their veterinary 
staff common area. These recommendations will act as a 
reminder and raise awareness of best practice to be followed 
by veterinary staff at all times to prevent and control nosocomial 
infections in the workplace.
b) Preventive Medicine protocols 
Vaccination and worming programs are important in the 
prevention of both infectious and parasitic diseases, respectively 
and play an important role in everyday practice. These help to 
reduce the burden of disease in populations and consequently, 
the need for antimicrobials is also reduced [30]. Promotion of 
health plan packages in veterinary practices to pet owners is 
becoming more common. Vaccination programs should be 
based on sound scientific evidence for the country of interest 
and follow current recommendations, as, for example, those 
published recently by the Working Vaccination Guidelines Group 
of the WSAVA [53].
Vaccination programs also have an important role in promoting 
awareness of pet owners of the risk of infectious diseases and 
their responsibility for the protection of their pets. Furthermore, 
consultations for vaccination purposes should include a full 
clinical examination of the animal. This will allow the veterinarian 
to monitor the health status of the animal regularly and not only 
when the animal is sick [33].   
c) Improvement of diagnostic tools in practice
Diagnostic tools are very important in everyday practice and are 
often vital to obtaining confirmation of the clinical diagnosis. 
Culture and antimicrobial susceptibility tests are often used for 
investigation of infectious agents and AMR pathogens in small 
animal practice [54]. Careful interpretation of AST findings in 
the clinical context is required. Microbiological reports can refer 
to the isolation of non-pathogenic bacteria and its antimicrobial 
susceptibility patterns and using that advice may lead to misuse 
of antimicrobials by the veterinarian. Although ASTs are very 
important diagnostic tools in bacterial infections, interpretation 
of results requires background knowledge of potential 
pathogens and antimicrobials. 
There are exceptions when pet owners are not willing or able 
to pay for ASTs or for other diagnostic tests deemed necessary 
by the veterinarian in order to obtain a final diagnosis [33]. In 
these particular cases, veterinarians can use in-house tests that 
may help to direct them, if not to a confirmed diagnosis, then 
at least to a presumptive diagnosis. Bacterial slides using quick-
staining techniques (i.e. Diff-Quik, Gram staining) may help to 
narrow the selection of antimicrobials by veterinarians when 
assessing the type of bacteria (i.e. rods, bacilli, cocci) isolated 
and the reaction to colouration (Gram negatives versus Gram 
positive) [54]. However, it is important to remember that these 
tests do not provide information of acquired resistance patterns 
as ASTs do. Furthermore, as the organism is not fully identified, 
the veterinarian cannot be certain that it is pathogenic. In 
contrast, quick-staining tests are often less expensive and faster 
than ASTs. The type of equipment needed for microbiology can 
be easily acquired even in small sized practices and can be very 
useful to help in the decision-making process involved in the 
selection of antimicrobials for animal therapy.  
d) Development of new antimicrobials and vaccines
Antimicrobial research and development by pharmaceutical 
companies has slowed down in the last couple of decades [55]. 
There is growing concern about the uncertainty associated 
with the production of new antimicrobials and whether new 
antimicrobials will be effective to treat infections caused by 
multi-resistant pathogens. This is mainly due to the high cost 
and length of time involved in research and development of 
antimicrobials, particularly relating to clinical trials [56].  
In contrast, development of vaccines is a growing market in 
both human and veterinary fields. In human medicine, research 
is being directed to the development of vaccines against 
susceptible bacteria (e.g. Staphylococcus aureus), as these have 
been shown to reduce the burden of disease and the incidence 
of infections with resistant-strains [57]. Recent studies have 
shown that vaccine development against MRSA would be cost-
effective for the control of this pathogen in populations at risk 
(e.g. neonates) [58].  In veterinary medicine, there is scope for the 
research of vaccines to prevent common bacterial diseases [59]. 
New vaccines in companion animals would protect susceptible 
populations, reduce the burden of disease and prevent the 
spread of infection. Consequently, the use of antimicrobials in 
small animal populations would be reduced.   
e) Promoting responsible use of antimicrobials in practice 
Training and education of veterinary staff is important at practice 
level to improve antimicrobial prescription behaviour and 
raise awareness of the risks to public health. Education of pet 
owners is also a vital part of the process. Good communications 
skills are vital to establish a relationship of trust with the pet 
owner and can improve compliance to prescribed therapies. 
Veterinarians should also use communication to raise awareness 
and educate clients concerning AMR issues in small animals 
[60]. Motivation and involvement of pet owners in the therapy 
of their animal is therefore important to achieve and improve 
compliance to prescribed therapy. “Involvement” means that 
after antimicrobial selection, the veterinarian should check with 
the pet owner on his/ her willingness or ability to administer 
the therapy and explain thoroughly the regimen prescribed. 
Written labels of prescribed therapies should include clear 
instructions to pet owners for drug delivery. Compliance of 
pet owners often decreases with long antimicrobial therapies 
(e.g. deep pyoderma) and with increased frequency of dosing 
in antimicrobial regimens [61]. Clients must be made aware of 
the importance of administering antimicrobials correctly and of 
finishing therapeutic courses. 
Effectiveness of stewardship programs
Antimicrobial stewardship programs should be constructed with 
the aim of achieving specific targets. Programs should aim to 
reduce the usage of antimicrobials that have a known impact 
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on the occurrence of AMR in specific animal pathogens and 
should aim to  reduce the incidence of nosocomial infections 
(e.g. MRSA, Clostridium difficile) in practice [33]. Stewardship 
programs that are too unspecific or too vague may be ineffective 
or even prejudicial, if selective AMR occurs as a consequence 
of the programme itself [30, 33]. Furthermore, stewardship 
programs should be implemented only if hygiene and infection 
control measures are also in place, in order to optimise results, 
as described above. In human medicine, stewardship programs 
are common and their efficacy is well documented. A recent 
review by MacDougall and Polk in human medicine showed that 
often antimicrobial stewardship programmes combine multiple 
strategies. As such, assessment of efficacy of stewardship 
programmes is often challenging due to their complexity [38]. 
Healthcare systems that include committed management and 
senior staff and available resources to support development 
of stewardship programmes are essential for an efficient 
programme. Furthermore, active involvement of staff (i.e. 
pharmacists, clinicians, surgeons, nurses), in the development 
of stewardship programmes has been shown to improve 
adherence by providing a sense of ownership [38]. Policies for 
antimicrobial usage which include restrictions of use of certain 
antimicrobials have also proven effective. However, these may 
raise concern due to the loss of clinical freedom associated with 
the act of prescribing. Review of prescriptions and provision of 
feedback by clinical pharmacists and specialists in infectious 
diseases to prescribers were effective and were not perceived 
to compromise clinical freedom [38]. From all stewardship 
programmes evaluated by MacDougall and Polk, those found 
to be least effective were guidelines for responsible use of 
antimicrobials (‘passive education of prescribers’) and cycling 
(i.e. rotation), of antimicrobials [38].
In veterinary medicine, evidence of efficacy of stewardship 
programs is scarce. Recently, Scott Weese described a study 
assessing the efficacy of implementation of guidelines stating 
categories for antimicrobial use in a veterinary teaching small 
animal hospital [62]. The objective of the program was to 
reduce usage of fluoroquinolones and imipenem. The study 
assessed antimicrobial usage before and after implementation 
of the guidelines (n=9 years). A decrease  overall in the number 
of antimicrobial prescriptions, as well as a decrease in the usage 
of fluoroquinolones was observed after the implementation of 
the guidelines [62].  
Conclusions
Antimicrobials are very important tools for everyday work 
in companion animal practice. Misuse of antimicrobials in 
both human and veterinary practice can lead to the loss of 
efficacy of these drugs in the long term and could have serious 
consequences for both animal and public health. However, 
there is currently lack of baseline surveillance data to determine 
the extent and patterns of antimicrobial consumption and AMR 
trends in companion animal populations. As such, it is difficult 
to evaluate the role of companion animals in the epidemiology 
of AMR and to develop informed guidelines and protocols for 
responsible use of antimicrobials in everyday practice. Promotion 
of responsible use in companion animal practice is important to 
prevent the occurrence of AMR and the spread of nosocomial 
infections with resistant organisms. Antimicrobial stewardship 
programs should be implemented in conjunction with infection 
control and hygiene measures in veterinary practices, regardless 
of the size of practice involved. 
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Antimicrobial resistance amongst organisms such as Escherichia coli, Pseudomonas aeruginosa, methicillin-resistant 
Staphylococcus aureus (MRSA) and S. pseudintermedius has become a serious threat to veterinary small animal practice. 
There is an urgent need to adopt measures which will control and reduce this problem. Risk factors for infection by 
resistant organisms in small animals are now becoming recognised and appear to mirror those in human medicine. 
They include contact with carriers or infected animals, hospital admission, invasive procedures and antimicrobial 
therapy. Key recommendations which enable such risk factors to be avoided are: development of protocols which 
ensure that antimicrobials are used only when necessary, selection of appropriate antimicrobials and compliance 
with correct dosage and administration, limitation of prophylactic and perioperative use, and recording of treatment 
outcomes so that therapeutic regimens can be evaluated and modified if necessary. In addition, there is a need for 
rigorous hygiene protocols to prevent survival and transfer of resistant bacteria in clinics and hospitals.
Key words: Risk factors, antimicrobials, therapy, resistance, hygiene, 
SUMMARY
GENERAL
Introduction
The problem of increasing antimicrobial resistance is now 
clearly recognised throughout the world not only in human 
and veterinary medicine but also in related industries such as 
agriculture and aquaculture [Gould, 2009]. This is a consequence 
of misuse of antimicrobial agents leading to the selection of 
multiresistant bacteria. 
Although the issue of multiresistance was first highlighted and 
publicised in the human field and agricultural use of antimicrobial 
agents as growth promoters was incriminated as a contributor, 
the role of small animal practice is becoming more apparent 
[Guardabassi et al, 2004]. Infections with strains of multi-resistant 
bacteria that are difficult to treat, such as Escherichia coli and 
Pseudomonas aeruginosa are now commonly encountered in 
dogs and cats, and methicillin-resistant Staphylococcus aureus 
(MRSA) infections are increasingly recognised. Outbreaks 
of infection with highly resistant strains of Acinetobacter 
baumannii are also being reported [Boerlin, 2001]. Worryingly, 
the common staphylococcal species associated with infections 
in dogs and cats, S. pseudintermedius [formerly S. intermedius; 
Sasaki et al, 2007] has now developed increased capacity for 
multiresistance, including acquisition of the mecA gene, giving 
resistance to all beta-lactam antibiotics. This methicillin-resistant 
S. pseudintermedius (MRSP) now has a worldwide distribution 
with high prevalence in certain countries and rapid spread in 
Europe since first described in Germany [Loeffler et al, 2007].
The consequences of the rise in frequency of these multiresistant 
bacteria in veterinary practice go beyond clinical difficulties 
experienced in treating cases successfully. These bacteria can 
cause zoonotic infections and act as a source of resistance genes 
for organisms associated with human infection.  Alarm has 
been raised in the human field with the suggestion that certain 
agents should be withdrawn from veterinary use. Indeed, the 
English Chief Medical Officer has suggested that quinolones and 
cephalosporins should be banned from animal use [Donaldson, 
2008]. Veterinary clinicians need to respond to these threats 
by more careful use of antimicrobials. This review summarises 
risk factors which can lead to the development of antimicrobial 
resistance and identifies measures which can be taken to reduce 
their significance in small animal practice.
Antimicrobial resistance risk factors
Risk factor analysis in relation to antimicrobial resistance requires 
systematic identification and assessment of factors that influence 
the probability and consequences of its development. Although 
there is a lack of such systematic studies both in human medicine 
and small animal medicine [Lloyd, 2007; Carmeli, 2008], there is 
agreement on the principal bacterial pathogens causing concern. 
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These include the pathogenic staphylococci and particularly S. 
aureus, Enterococcus spp., members of the Enterobacteriaceae, 
especially E. coli, and Ps. aeruginosa, organisms which share 
risk factors promoting nosocomial colonization and infection 
[Sadfar and Maki, 2002]. These bacteria can be carried by 
diseased and healthy individuals and may persist for long periods 
in hospitals and other healthcare institutions, and in domestic 
environments. The hospital or clinic environment is particularly 
suited to their survival and transmission; there is a continual 
supply of susceptible patients receiving antimicrobials to which 
the bacteria may be resistant and patients can thus be colonized 
or infected and cause further contamination. 
Sadfar and Maki [2002] reviewed evidence of risk factors for 
such organisms in a total of 74 studies in human medicine 
and demonstrated that advanced age; underlying diseases 
and severity of illness; inter-institutional transfer of the 
patient; prolonged hospitalization; gastrointestinal surgery 
or transplantation; exposure to invasive devices , especially 
central venous catheters; and exposure both individually and 
to combinations of narrow and broad spectrum antimicrobials 
were involved. Such studies are lacking in the veterinary field 
but there is evidence from publications on MRSA infection 
which indicates that risk factors for dogs and cats mirror those 
in the human field and include carriage of MRSA, contact with 
carriers, duration of hospital admission and invasive procedures 
[Lloyd et al 2007; Loeffler and Lloyd, 2010]. In the USA, [Black 
et al 2009] showed that amongst 74 dogs in an intensive care 
unit, multidrug-resistant patterns occurred in 27% of all isolates 
and were more likely to occur in organisms cultured after 48 
hours of hospitalisation. Veterinary staff members and owners 
are at increased risk of becoming carriers of such nosocomial 
organisms when they are in contact with infected animals 
[Loeffler and Lloyd, 2010]. Indeed studies in animal hospitals 
have shown that staff MRSA carrier rates as high as 27% can 
occur [Baptisite et al., 2005].
Strategies for avoidance of risk factors
There is now an impetus in many countries to define measures 
which can be taken to use antimicrobial agents in animals in 
responsible ways and reduce levels of resistance [Prescott 2008]. 
Guidelines are being created at different levels of complexity 
varying from general concepts to specific recommendations for 
individual disease conditions and specific infective organisms. 
An example of the latter is the article on dealing with MRSA 
in small animal practice [Lloyd et al 2007] commissioned by 
FECAVA (The Federation of European Companion Animal 
Veterinary Associations) which has established a Working Group 
on Hygiene and the Use of Antimicrobials in Veterinary Practice 
to bring together and co-ordinate recommendations within 
small animal practice in Europe [Lloyd et al, 2009].
In the UK, both the British Veterinary Association and the 
British Small Animal Veterinary Association have published 
recommendations on prudent use of antimicrobials on their 
websites [see BVA, 2009; BSAVA 2009]. The BVA has produced 
a downloadable poster suitable for display which lists an 8 point 
plan (summarized in Table 1) providing actions and advice suitable 
for veterinary practice. The key points are a) development of 
protocols which ensure that antimicrobials are used only when 
necessary, b) selection of appropriate antimicrobials following 
sensitivity tests if possible, and compliance with correct 
dosage and administration, c) limitation of prophylactic and 
The 8 Points Details and Comments
1.  Work with clients to avoid 
need for antimicrobials
Adopt integrated disease control programmes. Isolate infected animals wherever possible.
2. Avoid inappropriate use Restrict to ill or at risk animals. Advise clients on correct administration and the need for 
completion. Avoid underdosing.
3.  Choose the right drug for 
the right bug
Identify likely target organisms and their susceptibility. Create practice-based protocols for 
common infections based on clinical judgement and up-to-date knowledge. Know how 
antimicrobials work and their pharmacodynamic properties. Use antimicrobials with a spectrum 
as narrow as possible.
4.  Monitor antimicrobial 
sensitivity
While clinical diagnosis is often the initial basis of treatment, microbial sensitivity must be 
determined whenever possible so that modified treatment can be implemented if necessary.
5. Minimise prophylactics use Only when animals are at risk and usage indicates reduced morbidity and or mortality. Regularly 
assess prophylactic use. Develop written protocols for when prophylactic medication is 
considered appropriate. Monitor antimicrobial sensitivity trends.
6. Minimise use perioperatively Use only when necessary and supported by strict aseptic techniques alongside written practice 
guidelines.
7.  Record and justify deviations 
from protocols
Be able to justify your choice of antimicrobial and dose. Record treatment and outcome to help 
evaluate therapeutic regimens.
8.  Report suspected failure to 
VMD*
This may be the first indication of resistance. Report through the Suspected Adverse Reaction 
Surveillance Scheme of the VMD.
*UK Veterinary Medicines Directorate
Table 1. Summary of the British Veterinary Association 8-Point Plan for Responsible Use of Antimicrobials (BVA, 2009).
100
Recognising and controlling risk factors for antimicrobial resistance - D. H. Lloyd
Drug Class When Used Drug Examples
First-line Initial treatment of known or suspected bacterial infection in absence of 
susceptibility results. These drugs may commonly be used in human medicine 
but are usually considered less important for treating serious human (and 
animal) infections or raise less concern about development of resistance. 
Penicillin, most cephalosporins, 
trimethoprim-sulphonamides, 
tetracyclines
Second-line Used when culture and susceptibility testing, plus patient or infection factors, 
indicate that no first-line drugs are reasonable choices. Drugs in this class may 
be more important for treatment of serious human (and animal) infections or 
there may be particular concern about development of infection.
Fluoroquinolones, 3rd and later 
generation cephalosporins
Third-line Used in serious, life-threatening infections, with support of culture and 
susceptibility results, when no first-line or second-line drugs are indicated.
Carbapenems 
Restricted Used only in life-threatening infections when culture and susceptibility testing 
indicates no other options. 
Vancomycin
Table 2. Strategic use of antibacterials in animals (after Weese, 2006)
perioperative use, and d) maintenance of records of treatment 
outcomes so that therapeutic regimens can be evaluated and 
modified if necessary. 
Selection of appropriate drugs and their correct use is, of 
course, of vital importance. When treatment must be instituted 
rapidly or there is a high level of confidence that the causative 
organism and its sensitivity can be predicted, appropriate “first 
line” drugs can be selected (Table 2). Otherwise, sensitivity tests 
should be carried out and “second line” drugs may be required. 
An important component of this process is client education 
conveying the dual message that both avoidance of non-
essential antimicrobial administration and full compliance with 
dosage regimens of prescribed courses of antimicrobial drugs 
reduce the risk of increasing bacterial resistance.
To this list must be added the need for rigorous hygiene so that 
as resistant organisms are encountered, in infected animals or 
in healthy carriers, transmission to other patients or humans 
is prevented. This applies not only to hospital facilities, where 
barrier nursing or isolation needs to be applied if there is a 
risk of carriage, but also in the clinic where protective clothing 
should be worn and replaced after handling animals known 
or suspected to carry resistant bacteria and where surfaces 
touched by patients should be disinfected before admission to 
the consulting room of the next animal.
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The Staphylococcus genus contains a diverse group of species that are common commensals of the skin and 
mucous membranes of humans and an impressive range of animal species. While commonly found in or on 
healthy individuals, they are also important causes of opportunistic infections. The clinical relevance of different 
Staphylococcus species is quite variable, with some being important causes of infection and others minimally 
pathogenic. 
All staphylococci are Gram positive cocci (Figure 1) and can be divided into 2 groups, based on their production 
of the enzyme coagulase (Table 1). Coagulase positive staphylococci are the most important clinically. In dogs and 
cats, S. pseudintermedius, S. aureus and S. schleiferi subsp coagulans are the main coagulase positive species and main 
staphylococcal pathogens. Previously, S. intermedius was considered the most important Staphylococcus in dogs and 
cats, but it is now known that what was previously identified as S. intermedius is truly the closely related species 
S. pseudintermedius [1, 2], and S. intermedius is actually rare to non-existent in dogs and cats. Previously published 
reports of S. intermedius almost certainly actually involved S. pseudintermedius, and for the purposes of this review, 
older studies reporting S. intermedius are considered to be S. pseudintermedius. 
Coagulase negative staphylococci (CoNS) are common commensals that can cause disease but are more often found 
as skin contaminants. In general, they are considered minimally pathogenic, however certain CoNS might be 
more pathogenic, particularly S. schleiferi subsp schleiferi in pyoderma and otitis externa and S. felis in urinary tract 
infections.
INTRODUCTION
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Pathophysiology 
Staphylococci can possess an impressive array of virulence 
factors, and the role of these in development of disease is variable 
(and often poorly understood). Some virulence factors facilitate 
adhesion to host tissues (adhesins, clumping factors, fibronectin 
binding proteins, collagen binding protein, coagulase), some 
facilitate immune invasion (S. aureus protein a), while some 
encode secreted enzymes and toxins (haemolysins, hyaluronidase, 
hyaluronate lysate, lipase, leukocidins, enterotoxins, exfoliative 
toxin, toxic shock syndrome toxin). Some staphylococci are able 
to form biofilms; extracellular polysaccharide networks that help 
the bacteria evade the effects of antimicrobials and the immune 
system. The role of specific virulence factors in disease is poorly 
understood, and there are currently no virulence factors that can 
be used as important markers of clinical virulence in companion 
animals. 
Methicillin-resistant staphylococcal 
infections in pets
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Figure 1: Gram stain of Staphylococcus aureus. Note the Gram 
positive (purple) appearance and the tendency of cells to form 
clusters (Public domain, photo credit Dr. Richard Facklam, 
Centers for Disease Control and Prevention).
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Methicillin-resistance
From the first introduction of antimicrobials, staphylococci have 
demonstrated an impressive ability to develop antimicrobial 
resistance. Penicillin-resistance was identified shortly after 
penicillin became widely used. early in the ‘antibiotic era’, 
the obvious approach to overcoming clinical problems with 
penicillin-resistant staphylococci was development of new 
antimicrobials. New drug development outpaced resistance 
initially, but the ability of staphylococci to become resistant was 
repeatedly demonstrated as the introduction of new drugs was 
typically followed shortly by identification of resistant strains. 
Included in this pattern was resistance to methicillin. This 
penicillinase-resistant penicillin was released in humans in 1959, 
and the first report of methicillin-resistant S. aureus (MRSa), 
was published in 1961. Unlike penicillin-resistance, which was 
caused by secretion of beta-lactamase, methicillin-resistance 
was caused by production of an altered penicillin binding protein 
(PBP) [3]. Penicillin binding proteins are parts of the normal cell 
wall, and they are also the site of beta-lactam antimicrobial 
attachment. The abnormal PBP in MRSa (called PBP2a or PBP2`) 
has a poor affinity for beta-lactam antimicrobials and confers 
resistance not just to methicillin, but to virtually all beta-lactams; 
penicillins, cephalosporins and carbapenems. Production of 
PBP2a is mediated by the mecA gene, a gene that is located 
on a staphylococcal chromosomal cassette (SCCmec) [3]. This 
site also has the ability to acquire other resistance genes, and 
methicillin-resistant staphylococci are often resistant to a wide 
range of other antimicrobials. 
While the evolution of methicillin-resistance has been best 
studied in MRSa, the same mechanism is present in all methicillin-
resistant staphylococci. Methicillin-resistant staphylococci, 
particularly MRSa and methicillin-resistant S. pseudintermedius 
(MRSP) are emerging as serious problems in veterinary medicine. 
Methicillin-resistant Staphylococcus 
pseudintermedius (MRSP)
Epidemiology
MRSP has rapidly emerged as a critically important problem 
in companion animal practice. This organism appears to have 
emerged and disseminated internationally at a truly amazing rate, 
with rapid development of a very high level of drug resistance. 
MRSP infections are being identified virtually everywhere that 
people are looking, and the increase in incidence of disease, 
while not objectively studied, seems to be great. It has been 
called a serious emerging problem in small animal veterinary 
medicine and one that requires urgent action to control its 
spread [4]. 
To understand MRSP, it is critical to understand S. 
pseudintermedius. Staphylococcus pseudintermedius is the 
most common pathogenic Staphylococcus in dogs. It is also 
a common commensal and can be found in or on 31-68% 
of healthy dogs [5-8]. Higher rates (up to 100%) have been 
reported in puppies [9]. It is quite possible that colonization 
(also often termed ‘carriage’) is ubiquitous in dogs, and that 
S. pseudintermedius could be found on almost all dogs if one 
looked hard enough. Various body sites can be colonized, 
particularly the nasal passages, oral cavity, skin and perineal 
mucosa [5, 7]. While S. pseudintermedius is very common in 
healthy dogs, it is also a leading cause of infection, ranging 
from mild and superficial to fatal invasive infections. as with 
many opportunistic pathogens, certain predisposing factors are 
known or suspected to be associated with an increased risk of 
disease (e.g. atopy, flea allergy, surgery, immunocompromise), 
but infections can occur in the absence of any recognizable risk 
factor. 
This bacterium is less common in cats, being reported in 
6.8-22% of healthy cats [8, 10-12]. It is unclear whether this 
bacterium is truly adapted to cats as a commensal or whether 
it periodically and transiently colonizes or infects susceptible 
individuals. as with dogs, opportunistic infections can develop 
but S. pseudintermedius infections are less common in cats 
compared to dogs [13].
as with methicillin-susceptible strains, MRSP can be found in 
or on healthy dogs and cats. Carriage rates of 0-17% in dogs 
and 0-1.2% in healthy cats have been reported [6, 8, 14-16], 
and it appears that the rate of colonization is increasing in 
many regions. Risk factors for MRSP colonization have not been 
adequately investigated.
 as with susceptible staphylococci, MRSP is an opportunistic 
pathogen and colonization does not necessarily lead to disease. 
Indeed, it is likely that the vast majority of colonized animals 
never develop a clinical infection. The risk of infection in MRSP 
carriers has not been reported, but it is reasonable to assume 
that MRSP carriers are at some increased risk of MRSP infection, 
at least in certain situations (e.g. after surgery). limited study of 
risk factors for infection has been performed but antimicrobial 
administration, hospitalization or surgery within 30 days prior 
to the onset of infection were associated with MRSP versus 
methicillin-susceptible S. pseudintermedius infection in one 
study [17].
Clinical presentation
Staphylococcus pseudintermedius accounts for the vast majority 
of cases of pyoderma in dogs, and a lesser percentage in cats. 
It also causes a range of other infections including wound 
infections, surgical site infections, septic arthritis, osteomyelitis, 
urinary tract infections, endocarditis, liver abscess, peritonitis 
and ocular infections. as with other opportunistic pathogens, 
the spectrum of disease can range from mild to fatal, although 
fatal infections are rare. Fatal toxic shock and cellulitis [18] and 
necrotizing fasciitis [19] have been reported. 
Methicillin-resistant S. pseudintermedius causes the same 
spectrum of disease, with a predominance of skin, ear and 
Coagulase positive species Coagulase negative species
S. aureus
S. intermedius
S. pseudintermedius
S. schleiferi subsp coagulans
S. delphini
S. epidermidis
S. haemolyticus
S. schleifer subsp schleiferi
S. warneri
S. xylosus
S. hominis
Table 1: Examples of coagulase positive and coagulase negative 
staphylococci.
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other soft tissue infections [17, 20-22]. Post-operative infections 
appear to be increasingly common, particularly TPlO infections 
[17]. There is no indication that MRSP infections are more 
serious than infections caused by methicillin-susceptible strains, 
however they may be more difficult to treat. 
Methicillin-resistant Staphylococcus 
aureus (MRSA)
Epidemiology
as with MRSP, an understanding of MRSa requires basic 
knowledge of S. aureus. Staphylococcus aureus can be isolated 
from the nares, perineum or intestinal tract of 12-14% of 
healthy dogs and 4.3-20% of healthy cats [6, 8, 10]. Whether it 
is truly a canine and feline commensal, or whether isolation of 
S. aureus is the result of short-term acquisition of the bacterium 
from human sources is unclear. In a study of dogs and their 
owners, in 50% of households where S. aureus was isolated 
from both a dog and family member, the S. aureus strains were 
indistinguishable, strongly suggesting interspecies transmission, 
and likely from humans to animals [8]. Regardless, it does not 
particularly matter whether S. aureus is a true commensal or 
common short-term colonizer from human contact since the 
bacterium can clearly be isolated from a small percentage of 
healthy dogs and cats, and can cause opportunistic infections. 
emergence of MRSa in companion animals is probably a 
direct reflection of changes in the prevalence of MRSa in 
people in the general population. Specifically, the emergence 
of community-associated MRSa in humans in the 1990s and 
2000s, with increasing numbers of human MRSa carriers in 
households resulted in potential exposure of large numbers of 
pets to MRSa. It is quite clear that MRSa in companion animals 
is intimately linked to MRSa in humans, was probably a key 
event in the emergence (or spillover) of MRSa into companion 
animals. Humans are thought to be the source of infection for a 
large percentage, if not the vast majority, of infections in pets, 
and changes in the epidemiology of MRSa in humans can be 
reflected in changes in trends in pets. 
First reported in the 1990s, MRSa infection and colonization have 
now been identified in dogs, cats and other companion animals 
across the world [23-29]. as with S. aureus, MRSa can be found 
in healthy animals, particularly in the nasal passages, intestinal 
tract and perineum. Reported colonization rates are variable 
but tend to be 0-3.3% in healthy dogs and 0-6% in healthy 
cats [10, 30-34]. Higher rates can be encountered periodically 
in animals in veterinary facilities [25, 35], and being presented 
for veterinary treatment was a risk factor for colonization in one 
study [32]. However, most MRSa cases are not associated with 
veterinary hospitals. Higher rates can also be found in specific 
dog populations such as households where another pet has 
an MRSa infection [36], or during outbreaks in breeding or 
rescue kennels [37, 38]. Being owned by a human healthcare 
worker and participation in hospital visitation programs have 
been identified as risk factors for MRSa colonization in dogs, 
and are logical based on the increased likelihood of exposure 
to colonized people [24, 39]. Contact with children has also 
been identified as a risk factor [39]. While these, and potentially 
other, risk factors should be considered, MRSa can be identified 
in any animal and absence of known risk factors should not lead 
to excluding MRSa from consideration. 
Most animals that are colonized with MRSa have no signs of 
infection and may never develop a clinical infection. In humans 
and horses, MRSa colonization is known to be a risk factor 
for clinical MRSa infection in certain circumstances (e.g. after 
admission to hospital) [40, 41]. It is reasonable to assume that 
this also applies to dogs and cats yet this is not proven. 
The hypothesis that MRSa in companion animals is intimately 
linked to MRSa in humans is supported by the recurring 
observation that MRSa strains found in companion animals are 
predominantly the most common human strains in any given 
region [24, 28, 31, 39, 42-44]. Virtually all MRSa isolates from 
pets are recognized human epidemic clones and identification 
of other strains in dogs and cats is rare [28, 37, 39, 44, 45]. 
Sequence type 398 MRSa, a livestock-associated strain, has 
been found in a limited number of dogs [38, 46, 47], however 
dogs were more likely infected by people that were exposed to 
livestock. 
Clinical Presentation
S. aureus produces a similar range of disease as S. 
pseudintermedius. The main difference between S. 
pseudintermedius and S. aureus is the incidence of disease, not 
disease location or severity. Staphylococcus aureus infections 
may be more common in cats compared to dogs. 
Clinically, MRSa infections are indistinguishable from those 
caused by MSSa (methicillin resistant S. areus), predominantly 
skin and ear infections, with smaller numbers of other 
opportunistic infections [6, 13, 28, 44, 45, 48-51]. It is possible 
that infections more commonly associated with human-contact 
(e.g. wound and surgical site infections contaminated by hands 
of owners or veterinary personnel) are more likely to be caused 
by S. aureus (including MRSa) but objective data are lacking.  
Staphylococcus schleiferi
Staphylococcus schleiferi consists of two subspecies, the 
coagulase positive S. schleiferi subsp coagulans and coagulase 
negative S. schleiferi subsp schleiferi. These are less common 
causes of infection compared with S. pseudintermedius and 
S. aureus, however failure of many diagnostic laboratories to 
differentiate these organisms from S. pseudintermedius (S. 
schleiferi coagulans) and other coagulase negative staphylococci 
(S. schleiferi schleiferi) hampers proper assessment of their role 
in disease.
Staphylococcus schleiferi coagulans can be isolated in 0.8-4% of 
healthy dogs and 0-2% of healthy cats [6, 8, 10]. Colonization 
with methicillin-resistant S. schleiferi (MRSS) has been identified 
in 0-2% of dogs [6, 8, 15] and MRSS infections are being 
increasingly reported [13, 52, 53]. 
The most common clinical manifestations of S. schleiferi 
coagulans infection are pyoderma and otitis externa, but other 
opportunistic infections such as urinary tract infection (UTI) and 
pneumonia have been reported [6, 13, 54-58]. These infections 
are clinically indistinguishable from disease caused by other 
staphylococci, although it has been suggested that this species 
may tend to produce more superficial skin disease compared to 
S. pseudintermedius and S. aureus [13]. 
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less in known about S. schleiferi schleiferi, in large part because 
speciation of coagulase negative staphylococci is uncommonly 
performed by diagnostic laboratories. Colonization rates are 
unclear, but it is likely that S. schleiferi schleiferi is present in 
or on a small percentage of healthy dogs and cats. It has been 
implicated as a cause of pyoderma and otitis [13, 55, 57], and 
methicillin-resistant infections, while poorly characterized, 
presumably do the same.
Coagulase negative staphylococci
Epidemiology
Coagulase negative staphylococci (CoNS) are very common and 
generally of limited virulence. The prevalence of colonization 
is high [59], and with adequate effort CoNS could probably 
be found at one or more sites from most (if not all) dogs. 
Staphylococcus xylosus, S. epidermidis and S. sciuri are 
commonly isolated from healthy dogs [59-61], but various 
other species can be found.  Colonization with CoNS is also 
common in cats, with high isolation rates from skin, saliva and 
the vagina [11, 12, 62]. Staphylococus felis appears to be most 
common, with S. haemolyticus, S. epidermidis, S. simulans 
and S. saprophyticus also isolated [11, 12]. They are commonly 
isolated from the skin, nasal and oral cavities, pharynx, perineal 
mucosa, gastrointestinal tract and conjunctiva. The preferred 
site of residence of different CoNS varies, and some species are 
restricted to specific body sites. 
While colonization with CoNS is common, infection is not. 
CoNS infections may be overdiagnosed because CoNS can be 
isolated as contaminants from various superficial body sites. In 
human medicine, CoNS are primarily a concern in hospitalized 
individuals [63]. Community-associated CoNS infections in 
humans are usually UTIs caused by S. saprophyticus[63]. The 
situation may be similar in dogs and cats, with most CoNS being 
of minimal pathogenicity but some species (i.e. S. schleiferi 
schleiferi and S. felis) being potentially important causes of 
community-onset disease. 
Methicillin-resistance is not uncommon in commensal CoNS. 
Studies have reported prevalences ranging from 5-13% in 
healthy dogs and 5% in cats [16, 31, 32, 64]. as with other 
staphylococci, methicillin-resistant strains are inherently no 
more pathogenic than methicillin-susceptible strains, and 
the implications of colonization with MR-CoNS are typically 
inconsequential.
Clinical Presentation
Primary infections are uncommon and evaluation of clinical 
disease caused by MR-CoNS is complicated by difficulties 
in actually diagnosing infection. It is likely that many false-
positive diagnoses are made, particularly in skin and soft tissue 
infections, based on isolation of CoNS that are simply present at 
the infection site as contaminants. Infections, when they occur, 
are opportunistic and can involve various body sites, but this 
area has been poorly described. 
While CoNS are generally considered as a group, it is possible 
that there are differences between CoNS species. This mainly 
relates to three organisms; S. schleiferi subspecies schleiferi, S. 
epidermidis and S. felis. Staphylococcus schleiferi schleiferi and 
S. epidermidis have been implicated as a cause of pyoderma 
and otitis [13, 55, 57, 65]. a primary role of S. felis in UTIs in 
cats has also been suggested [66]. These species may, therefore, 
be relevant pathogens in community-associated disease, unlike 
most other CoNS.
 
Diagnosis
a suspicion of staphylococcal infection is based more 
on signalment and site of infection than any clinical, 
clinicopathological or diagnostic imaging result data. Cytological 
identification of clusters of gram positive cocci, particularly with 
abundant neutrophils and intracellular cocci, is suggestive.
Isolation of staphylococci from an infected site is the standard 
for diagnosis. While isolation of staphylococci tends to be 
relatively easy, interpretation of results can be challenging in 
some cases because of the presence of staphylococci as part 
of the commensal microflora. Therefore, consideration must be 
given to whether the organism is a cause of infection or simply 
present at the site of infection. This is often of greatest concern 
in skin and ear infections, which are also the most common 
locations of staphylococcal infection, and with CoNS. 
In general, isolation of coagulase positive staphylococci from 
a site where staphylococcal infections are common is strongly 
suggestive. Isolation of staphylococci from sites that are 
expected to be sterile (e.g. blood) is essentially diagnostic as 
long as the sample was properly collected. Determination of 
the relevance of isolation of CoNS is more difficult. Isolation of 
CoNS from a superficial site should be interpreted with caution 
as this could represent infection or contamination. If a CoNS 
and other potential pathogen are identified concurrently, the 
CoNS is typically considered a contaminant. Speciation of CoNS 
to identify species that are potentially more relevant (i.e. S. 
epidermidis, S. schleiferi schleifer, S. felis) might be of benefit 
but is uncommonly available. Isolation of CoNS from sterile sites 
(i.e. blood, pleural cavity) is more indicative of disease as long as 
samples were collected and handled properly. Since they are skin 
contaminants, low levels of contamination can occur in samples 
collected through skin sites. If quantitative or semi-quantitative 
culture results are provided, low growth (1+) of CoNS is of 
questionable relevance and quite possibly contamination, not 
infection.
Identification of methicillin-resistance is usually done through 
detection of phenotypic resistance (antimicrobial susceptibility 
testing). This can be problematic in some situations if proper 
methodology is not used. Methicillin testing is not performed 
because methicillin is poorly stable in vitro. Oxacillin was used 
for detection of methicillin-resistance in MRSa but has recently 
been supplanted by cefoxitin, since cefoxotin testing is less 
prone to false negative results with MRSa. However, cefoxitin 
is not optimal for MRSP [67, 68], and oxacillin appears to be 
more sensitive. Resistance to either oxacillin or cefoxitin is an 
indication of methicillin-resistance. Clinicians should be wary of 
multidrug resistant staphylococci that are reported as methicillin 
susceptible, since this is rarely true and in most situations, 
these are truly methicillin-resistant. Detection of PBP2a by latex 
agglutination test or mecA by PCR can be used for confirmatory 
testing, but this is rarely done clinically. 
One particular weakness of diagnostic testing in some regions 
is inadequate speciation of staphylococci. While there has been 
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general improvement, some laboratories still do not speciate 
coagulase positive staphylococci or differentiate S. aureus from 
other coagulase positive staphylococci. This is of concern for a 
few reasons. One is to be able to perform proper antimicrobial 
susceptibility testing. Testing guidelines for S. aureus are 
different from those for other staphylococci, and failure to 
properly identify isolates means that testing guidelines cannot 
be followed. additionally, public health risks are different 
between MRSa and other methicillin-resistant staphylococci, 
and knowing the species is important for discussing risks and 
appropriate recommendations for management of animals 
in veterinary clinics and in households. Ideally, coagulase 
positive organisms should be identified to the species level, or 
at least to the level of S. aureus versus others (predominantly 
S. pseudintermedius).  Speciation of CoNS is uncommonly 
available and of lesser importance, but as knowledge regarding 
different roles of CoNS in disease increases, it is possible that 
CoNS speciation will become more important. 
Therapy
There is no standard approach to management of staphylococcal 
infections because of the highly variable nature of disease. 
general factors such as infection site, infection type and in 
vitro susceptibility are more important that the Staphylococcus 
species that is involved or whether it is methicillin-resistant 
or -susceptible. The simple fact that an isolate is methicillin-
resistant should have minimal impact on the prescribed 
treatment beyond choice of the appropriate antimicrobial. There 
is no evidence that methicillin-resistant staphylococcal infections 
required longer, more intensive or different treatment than their 
susceptible counterparts. Factors such as surgical intervention 
and supportive care may be required but are not covered here. 
When to treat
The first thing to consider when dealing with a potential 
methicillin-resistant staphylococcal infection is whether it needs 
to be treated. Colonization, contamination and subclinical 
infection (e.g. subclinical bacteruria) do not require treatment, 
and only situations where a methicillin-resistant Staphylococcus 
sp has been isolated from a clinical infection and where it is 
thought to be involved in disease require treatment.
Systemic Antimicrobials
Systemic administration may be required for many, but not 
all, infections. When systemic antimicrobials are used, general 
principles of antimicrobial therapy apply, considering in vitro 
susceptibility testing results, infection factors (e.g. presence of 
organic debris, accessibility of the infected site to antimicrobials) 
and patient factors (e.g. comorbidities, drug intolerance) 
Broad recommendations for treatment of staphylococcal 
infections are difficult to make because of the variability 
in infection types and susceptibility patterns. Beta-lactam 
antimicrobials, including penicillin/beta-lactamase inhibitor 
combinations (e.g. amoxicillin-clavulanic acid), should not 
be used for methicillin-resistant staphylococcal infections. 
Diagnostic laboratories should report all methicillin-resistant 
staphylococci as resistant to all beta-lactams, however this is 
not always done. Occasionally, resistant staphylococci can 
appear susceptible to some beta-lactam antimicrobials in vitro, 
however this should be considered a false result and the use of 
beta-lactams in cases that are reported as methicillin-resistant is 
contraindicated. 
In humans, fluoroquinolones are considered to be contraindicated 
for the treatment of MRSa infections because of poor clinical 
response and rapid development of resistance [69]. This has not 
been objectively investigated in dogs and cats, but there is no 
reason to suspect that it would be different in these species, so 
fluoroquinolones probably should be avoided whenever possible 
as treatments of resistant staphylococcal infections. Inducible 
clindamycin resistance is a potential problem, particularly 
with MRSa. With this phenomenon, isolates appear to be 
susceptible to clindamycin in vitro, however resistance is induced 
upon exposure in vivo and treatment failure is expected. One 
study of reported inducible resistance in 71% of MRSa strains 
from animals[70] while another study reported that 55% of 
erythromyin-resistant, clindamycin-susceptible MRSa from 
dogs were inducibly resistant [71]. Inducible resistance appears 
to be less common in S. pseudintermedius [71, 72]. Inducible 
resistance can be detected in vitro using a “D-test” however 
this is not widely available in veterinary diagnostic laboratories. 
In the absence of specific testing for inducible resistance, 
erythromycin-resistant isolates (or those where erythromycin 
susceptibility was not reported) should be considered potentially 
clindamycin resistant. 
antimicrobials that are often used include trimethoprim-
sulfonamide, doxycycline, aminoglycosides and chloramphenicol, 
although susceptibility patterns and regulations regarding the 
use of certain drugs create significant regional variation in 
approaches. 
Treatment options may be limited, particularly with MRSP, 
but at this point in time there is almost always one or more 
viable treatment options. However, highly drug resistant strains 
are increasingly encountered and few to no viable treatment 
options may be present in some cases. as methicillin-resistant 
staphylococci become resistant to more antimicrobials, there 
may be increasing pressure to use antimicrobials that are 
critically important in human medicine, such as vancomycin, 
linezolid, tigecycline and quinupristin-dalfopristin. The use of 
drugs such as these, which are critically important for treatment 
of serious multidrug resistant infections in humans, raises 
many ethical questions. Concerns about the use of these drugs 
include increased pressure towards resistance and subsequent 
transmission to humans, since transmission of MRSP and MRSa 
between animals and humans clearly can occur. These concerns 
are often matched with concerns about animal health and 
welfare if proper treatment is not provided and the fact that 
animal use compromises a miniscule percentage of overall use 
of these drugs. There is currently no consensus on the topic. 
at a minimum, these drugs should be reserved for situations 
where there are no other viable treatment alternatives, where 
the infection is not amenable to other (i.e. local) therapy and 
where the infection is life-threatening but potentially treatable. 
Prior to considering drugs such as these, all other therapeutic 
options should be considered, and ideally, an infectious diseases 
specialist should be consulted. Currently, it is rare to require 
drugs such as these because there is almost always another 
treatment option.
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Local Antimicrobial Therapies
local or regional administration of antimicrobials can deliver high 
antimicrobial concentrations and this can be a highly effective 
sole or adjunctive approach for many infections. Possible 
methods include intrarticular injection, regional perfusion, 
intraosseus perfusion and the use of antimicrobial-impregnated 
beads, collagen sponges, or other materials. 
Topical Antimicrobials
Topical antimicrobial therapy may be a useful adjunctive or sole 
therapy. The ability to deliver high concentrations of antimicrobial 
directly to the site of infection, with minimal systemic exposure, 
can be very useful for treatment of superficial infections. 
Resistance of staphylococci from dogs and cats to topical 
antimicrobials such as mupirocin and fusidic acid is currently 
rare [73, 74] and the high local antimicrobial levels that can be 
achieved may largely offset acquired resistance. 
The main limitation to topical therapy is the ability of topically-
applied antimicrobials to reach the infection site. Thus, topical 
therapy is best reserved as a sole method for treatment of 
very superficial infections, such as superficial wound infection 
and surface pyoderma. Systemic therapy or a combination 
of systemic and topical therapy should be used for deeper 
infections or infections that do not respond completely to 
topical monotherapy. 
 
Other Topical Treatments
Topical administration of biocides (antiseptics) can be a useful 
sole or adjunctive treatment for some skin and soft tissue 
infections. The potential efficacy of biocides involves a balance 
between the bactericidal activity of the compound and the 
tissue damage from biocide application, something that may 
be difficult to assess because of limited information regarding 
both efficacy and safety. Some compounds have profound 
antibacterial properties but are not useful because of the degree 
of tissue damage that can ensue. For some biocides, the cost-
benefit of antibacterial properties and tissue damage are not 
well understood. as with topical antimicrobials, the ability to 
reach the infection site is the main limitation. 
available options include chlorhexidine, povidone iodine and 
benzoyl peroxide gel [75]. Other compounds such as accelerated 
hydrogen peroxide have also been proposed as topical therapies 
but there is currently little information about their use. Silver-
coated dressings may be useful for treatment of skin and wound 
infections [76]. essential oils are gaining popularity as topical 
therapies, although clinical data are currently lacking. Various 
essential oils, including tea tree oil, geranium oil, lavender oil and 
grapefruit seed extract have been shown to possess antibacterial 
properties, including activity against MRSa and MRSP [73, 77-
79]. However, tissue damage is a potential concern as some 
essential oils can have cytotoxic effects on mammalian cells [80, 
81]. Further study of efficacy and safety are required. 
The use of honey has undergone a resurgence. Honey 
has bactericidal effects against various bacteria, including 
staphylococci, in vitro and in vivo [82-85]. There are differences 
in bactericidal activity between different types of honey, and 
the best-investigated honey has been Manuka honey, produced 
by bees feeding from the blossoms of Leptospermum scoparium 
(Manuka). Manuka honey can be a useful sole or adjunctive 
treatment of conditions such as wound infections or infected leg 
ulcers in humans.[82, 83] 
 
Other Considerations
Both S. aureus and S. pseudintermedius are important causes 
of surgical implant-associated infections. These infections 
can be very difficult to treat because of the implant and 
associated biofilm. Often, antimicrobial therapy is inadequate 
for elimination of infection. Systemic antimicrobials may help 
control the infection, particularly if time is needed until he 
implants can be removed, but often infection will recur when 
antimicrobials are stopped if the implant is not removed. 
Public Health Considerations
Staphylococcus aureus
Significant attention has been given to public health concerns 
regarding pets and MRSa. given the importance of MRSa in 
human medicine, it is perhaps not surprising that serious concern 
has accompanied identification of MRSa in pets. However, as 
knowledge regarding MRSa advances it is becoming evident 
that while interspecies transmission of MRSa certainly does 
occur in households, human-to-animal transmission is probably 
most common. The role of pets in human MRSa infection is 
completely unclear. It is likely that pets play at best a very limited 
role in human MRSa infection, however zoonotic infections 
certainly cannot be dismissed.
Colonization of people in contact with infected or colonized 
dogs and cats (often with demonstration of the same strain 
in humans and animals) has been widely reported [24, 26, 28, 
45, 86-88]. Pets have been implicated as sources of infection 
for humans in households [26, 87], however conclusions are 
often overstated. Virtually all studies have involved concurrent 
testing of people and pets. While finding the same MRSa strain 
in both groups strongly supports interspecies transmission, it 
cannot determine the direction of transmission. Further, since 
the MRSa strains found in pets are human epidemic clones, and 
because the average pet has little contact with other people or 
animals, it is most likely that a human household member would 
bring MRSa into the home, with the potential for subsequent 
dissemination to other humans and animals. This assessment 
should not be taken as an indication that there is no risk from 
pets, since regardless of how a pet is ultimately infected, it could 
still transmit MRSa to humans.
Numerous studies of MRSa colonization in veterinary personnel 
have been performed, reporting colonization rates of up to 
18% in small animal veterinary personnel [89-92]. It cannot be 
determined with certainty that these colonization rates reflect 
acquisition of MRSa from animals; however identification of 
higher rates than present in the general population (1.5-3%) 
[93, 94], and the lack of other explanations as to why veterinary 
personnel would be at higher risk than others provide support of 
occupational origin. Whether this constitutes a significant health 
risk for veterinary personnel is unclear. There are limited reports 
of MRSa infection in veterinary personnel that have worked with 
infected or colonized animals [95, 96], along with numerous 
anecdotal reports. Further, the high rates of colonization could 
increase the risk of infection in some situations such as if 
colonized veterinary personnel undergo surgery or are admitted 
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to hospital. The other concern about high MRSa colonization 
rates in veterinary personnel is the potential for veterinary 
clinics to act as reservoirs of MRSa, resulting in infection or 
colonization of patients and potentially subsequent exposure of 
patients’ families. 
The true role of pets in human MRSa infections is impossible 
to determine at this point. given the epidemic of community-
associated MRSa infections in people and endemic MRSa in 
human healthcare facilities, pets certainly play a minor role 
in human infections. Yet, with the scope of this problem, a 
minor role from a population standpoint could still represent 
an important source of infection. The potential role of pets in 
human MRSa infections should be considered, but in a balanced 
manner. 
S. pseudintermedius
There is currently limited public health concern regarding MRSP . 
Staphylococcus pseudintermedius infections have been reported 
in humans [97-102], yet these appear to be very rare. There are 
very few reports of MRSP infections in humans [103], however 
that must be tempered with the understanding that MRSP has 
only recently become common in animals and that there is some 
potential for misdiagnosis of S. pseudintermedius as S. aureus 
by medical diagnostic laboratories, depending on the methods 
that are used [104].
Because of the very high prevalence of S. pseudintermedius 
colonization in healthy dogs and cats, human exposure must 
be very common. accordingly, the low reported colonization 
rates in veterinary personnel and pet owners (1-4%)[8, 105] and 
rarity of human infection indicate limited risk from contact with 
pets. Since MRSP is inherently no more virulent than methicillin-
susceptible S. pseudintermedius, the risks posed by MRSP should 
be similarly low. To date, reports on zoonotic transmission of 
MRSP are scarce. Transmission of MRSP between dogs and 
people is likely based on reports of indistinguishable isolates 
from people and dogs [106, 107] and isolation of MRSP from 
a small percentage of owners of dogs with MRSP pyoderma 
[108]. The risk posed by MRSP should be considered low, 
however given the highly drug resistant nature (and associated 
treatment difficulty) care should be taken to use good infection 
control practices around infected animals in households and 
veterinary clinics. 
Other staphylococci
Public health concerns regarding other staphylococci are 
currently limited. Human S. schleiferi coagulans infections are 
extremely rare. In one case, a dog with otitis was thought 
to be the source of S. schleiferi coagulans endocarditis in 
an immunocompromised person [109], however it was not 
possible to confirm that the dog was the source. Staphylococcus 
schleiferi schleiferi is likely a human commensal, so the risk 
posed by infected animals is probably low. 
Other coagulase negative staphylococci are common in both 
animals and humans. While many of the same CoNS species can 
cause disease in both people and pets, it is unlikely that animals 
are relevant sources of human infection.  
Infection Control Practices 
Decolonization
active elimination of MRSa colonization in humans is a 
contentious issue. active decolonization, often using topical 
antimicrobials such as mupirocin or fusidic acid, sometimes 
with concurrent oral antimicrobial therapy or antiseptic baths, 
is used as a means of MRSa control in some situations in some 
regions, although international consensus is lacking. The need 
for decolonization therapy in otherwise healthy individuals 
in the community is controversial and decolonization is most 
commonly used in specific populations, such as healthcare 
workers, patients undergoing surgical procedures, patients in 
intensive care units or individuals in households with recurrent 
MRSa infections. 
In some respects, active elimination of MRSP or MRSa 
colonization in dogs and cats could be desirable to reduce the 
risk of development of clinical infection or transmission to other 
individuals, including people. However, there is currently no 
evidence that therapy to eliminate colonization is indicated or 
even potentially effective in dogs and cats. adequate topical 
application of an antimicrobial to the entire nasal passages of a 
dog or cat is not realistic, and incomplete treatment could lead 
to further resistance. another major consideration is the fact 
that MRSa colonization appears to be transient in most if not 
all dogs and cats [28, 35, 39]. The use of good general hygiene 
measures to reduce re-infection almost invariably results in 
spontaneous decolonization, so it is questionable whether 
active decolonization is even indicated. 
Similarly, decolonization therapy is not recommended for dogs 
and cats carrying MRSP. While data are lacking, it is possible 
that MRSP could colonize dogs and cats for prolonged periods 
of time, particularly compared to MRSa, since it is presumably 
more adapted for dogs and cats than human MRSa clones. a 
way to eliminate colonization in long-term carriers, in animals 
with recurrent MRSP infections, or in animals about to undergo 
surgery could be desirable, however there is no information 
available indicating whether decolonization could be effective. 
given the lack of evidence of efficacy and need, active 
decolonization therapy for MRSP is not currently recommended.
Screening
In humans, MRSa screening is an important infection control tool 
in some hospitals. It allows for prompt identification of MRSa 
carriers, with subsequent use of enhanced infection control 
practices to reduce the risk of transmission. It also allows for 
identification of individuals at increased risk for MRSa infection, 
and may modify empirical antimicrobial treatment if the person 
develops an opportunistic infection. Screening of people outside 
of healthcare facilities is rarely (if ever) performed. 
When considering whether to screen for MRSa or any other 
pathogen, consideration must be given to the relevance of the 
results and the measures that will be taken based on the results. In 
companion animal veterinary practices, it is hard to justify routine 
MRSa screening from an infection control standpoint and there 
are few other situations where screening could be useful. Testing 
of pets for MRSa colonization is not indicated in situations 
where MRSa has been identified in a person in a household 
or when there are high-risk people in the household [110]. If a 
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pet was identified as colonized, the pet likely acquired MRSa 
from a person in the household. Standard recommendations 
would be to use good hygiene practices to allow the animal to 
naturally decolonize and to prevent reinfection. If the animal was 
negative, the household would still be considered high risk for 
MRSa exposure from the person’s disease, so hygiene would be 
emphasized to reduce the risk of transmission of MRSa to the 
pet. Since the recommendations would be essentially the same, 
whether the result was positive or negative, it is hard to justify 
screening.  The main situation when screening of pets might 
be indicated is in households with recurrent MRSa infections 
but only if the entire household (human and animal) is being 
concurrently evaluated and a plan is made regarding how to 
deal with colonized people and pets [110]. even then, unless 
there would be a different approach for negative versus positive 
results, screening might be of limited use. 
There are few indications to screen animals for MRSP carriage, 
apart from epidemiological studies. The main clinical situation 
where screening might be indicated would be when there is an 
increased likelihood that the animal is an MRSP carrier and it is 
to undergo elective surgery. In such a situation, knowing MRSP 
status might result in modification of infection control practices 
and perioperative antimicrobial choices.
Based on current knowledge, there is no indication to screen 
animals for carriage of other methicillin-resistant staphylococci. 
Routine screening of veterinary personnel for colonization with 
any methicillin-resistant Staphylococcus sp. is not indicated.
Conclusion
In a short period of time, methicillin-resistant staphylococcal 
infections have emerged as important problems in companion 
animal medicine. as infection rates, continue to increase, along 
with resistance to further antimicrobial classes, methicillin-
resistant staphylococci will pose a significant challenge to 
veterinary practitioners for management of individual cases, 
prevention and control of hospital-associated infection, 
prevention of zoonotic infections, and counseling of clients. 
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BSAVA Guide to Procedures 
in Small Animal Practice (First 
Edition)
Edited by Nick Bexfi eld and Karla Lee
Published by BSAVA 2010
Distributed by Wiley-Blackwell 248 pages 
Paperback (spiral bound) 
ISBN-978 1 905319 17 6 € 72.00 £ 60.00
Available from www.wiley.com/go/vet
BSAVA members should order from 
www.bsava.com for member prices
This practical pocket size guide with summa-
rised facts in an A-Z fashion is truly a step-by 
step manual to the most common practical 
techniques that are encountered in daily 
veterinary practice. The procedures are main-
ly based on the earlier BSAVA publications 
which enable the reader to easily access more 
indepth information as well as references. 
The guide is thorough and well written and 
the editors deserve compliments for provid-
ing us with this handy book.
The content of the guide is made up of routine 
procedures as well as emergency procedures. 
I particularly appreciate the included indica-
tions and contraindications for each proce-
dure which serve as a good reminder for 
us all. There are also a few parts on clinical 
examination of the major body systems and 
protocols for management of selected emer-
gencies. Also included are  helpful sections 
on extended diagnostics such as the ACTH 
stimulation test and water deprivation test. 
Some could argue that the guide should only 
contain practical procedures but personally 
I appreciate the extension to some selected 
investigative and examination protocols.  The 
neurological examination however is in my 
opinion a bit too detailed and lacks a system-
atic approach to the localisation of lesions 
in the neurologic patient. An addition of a 
fl ow chart like the one presented in the part 
regarding cardiopulmonary-cerebral resusci-
tation would certainly improve this part. A 
similar fl ow chart for emergency treatment of 
urinary obstruction would also be valuable.
Guide books like this enable veterinary prac-
titioners to easily follow standard operating 
procedures. This guide certainly contributes 
to this and is, without doubt, a book for 
every vet in practice.
Some of the procedures are nicely illustrated 
which is an helpfull aid especially in emer-
gency situations with procedures that are 
not encountered every day. The routines are 
orderly arranged by numbers. A page refer-
ence in conjunction with the current alpha-
betic register, although not necessary, would 
be helpful.
This fi rst edition is an excellent publica-
tion and there are possibilities to develop it 
even more in the next edition. It would be 
valuable to add some more procedures also 
seen in practice such as the management of 
heartfailure, principles of F.A.S.T. echocardio-
gram, management of the pregnant bitch in 
conjunction to labour, skull trauma, and the 
management of suspected spinal trauma to 
give some examples. The diffi cult task is to 
not add too much as the conveinience of 
the size of this book is essential. To improve 
the sustainability a plastic cover could be 
considered as this book will undoubtedly be 
well worn. This is a guide that will be sought 
after in all of Europe and probably overseas 
as well. It would not surprise me if this is the 
new BSAVA bestseller!
Alexandra Vilén DVM (Sweden)
BSAVA Manual of Canine 
and Feline Rehabilitation, 
Supportive and Palliative Care.
Case studies in patient 
management.
Edited by Samantha Lindley and Penny 
Watson
Published by BSAVA 
Distributed by Wiley-Blackwell  412 pages 
Extensively illustrated Paperback, 
ISBN: 978 1 905319 20 6 € 90.00  £ 75.00
Available from www.wiley.com/go/vet
BSAVA members should order from 
www.BSAVA.com  for member prices
In the best BSAVA tradition this Manual 
targets the veterinarian, nurse/technician, 
and other professionals working in the 
private or referral small animal practice.
I might offer a biased review as I really believe 
in rehabilitation and especially palliative care 
as defi ned on page 1 “we all give palliative 
care in dogs and cats suffering with chronic 
diseases”. I found very valuable the initial 
critical assessment of resources, distress 
and outcome, which can help in defi ning 
the magnitude of the therapeutic measures 
required and set humane endpoints.
The driving red line is to offer the busy veteri-
nary professional an evidence based update 
of core topics in supportive care. Accordingly, 
in Chapters 1 to 11 the “must know” notions 
in acute and chronic pain management, 
clinical nutrition (addressing both positive 
and especially negative caloric balance) and 
physical therapies are summarised. Each 
Chapter incorporates practical ‘Key Points’ in 
boxes that highlight the important concepts. 
I appreciated the efforts of authors to present 
evidence based information, supported by 
the most updated and relevant literature. 
This  allows the interested veterinary or 
animal professional to have an opportunity 
for in depth reading on specifi c topics in his/
her spare time. 
With a case based didactical approach these 
main concepts are systematically applied 
thereafter to individual cases, classifi ed by 
systems. The cases “as they really happen in 
practice” are accompanied by numerous illus-
trations making them very realistic and the 
Manual attractive. Whilst reading through 
the book, I recalled many patients and cases 
both with their frustrations and successes.
Great emphasis is given to “a multimo-
dal therapy” resulting from the interplay 
between pharmaceutical, physical and alter-
native methods of treatment and from the 
synergism of the knowledge and passion of 
many dedicated professionals in the prac-
tice’s team. The fi nal goal was to improve the 
welfare and quality of life of the small animal 
patient by offering state of the art medicine. 
The Manual refl ects this idea from the start 
as it is the result of the co-work of a remark-
able list of internationally renowned special-
ists. Sincere compliments should be given to 
this great team and to the two Editors for 
guiding them to a didactically modern and 
attractive book. 
To conclude this Manual is a very valuable 
instrument allowing the private practitioner 
to offer knowledgeable and state of the art 
rehabilitation, supportive and palliative care 
to a broad spectrum of patients, ranging 
from surgical, internal medicine, and pain 
cases. This will improve both animal welfare 
and client and operator satisfaction.
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I would like to conclude by asking the 
Authors their experience and opinion regard-
ing analgesic radiotherapy which might well 
fi nd an indication in the cases of some of the 
patients discussed in this Manual. Possibly 
this could be included in the next Edition.
Enjoy reading!
Alessandra Bergadano
DVM, Dr.Med.Vet., Dip.ECVAA, PhD (CH)
Small Animal Neurology – an 
illustrated text
Edited by Andre Jaggy and Simon Platt
Published by Schütersche Verlagsgellschaft
GmbH & Co. KG, Hanover.
http://www.buecher.schluetersche.de 2009 
580 pages, Hardback, 
ISBN: 978-3-89993-026-9 
€ 166 Approx £ 140
This is a very well-presented book that should 
be added to the collection of any specialist in 
veterinary neurology or indeed anyone with 
an interest in this subject.  Its price of 166 
euros at ( £140) may deter some potential 
purchasers.  However, it has 580 pages of 
good quality paper bearing many excellent 
photographs and drawings – it’s certainly 
worth the money.  This second edition, again 
principally edited by Andre Jaggy, has been 
generally upgraded and contains two excel-
lent new sections on emergency neuromedi-
cine and comparative sectional anatomy of 
the canine and feline brain.  Another addi-
tional attribute is a CD-Rom featuring the 
details of clinical investigation together with 
a sound commentary and also a number of 
clinical cases with a stated localisation. 
Unfortunately results of ancillary tests and 
diagnoses are omitted and there is no sound 
track for these cases.  
Originally written in German, the translation 
into English has been very competently done. 
Errors do occur in the text but it is the duty 
of the proof reader to spot those, eg. lumber 
(p.517), siseases (p VIII), Charle’s (p.1).  I was 
surprised to fi nd gabapentin missing from 
the Appendix 5 (Drugs) but I can forgive 
that small omission in an otherwise excellent 
book.  There were 43 contributors to this 
book, all well-known established experts in 
veterinary neurology; to a certain extent this 
very fact has been responsible for a lack of 
cohesiveness in the writing.  Sometimes it 
is diffi cult to gather all the information on 
a particular topic; more cross-referencing 
would have been helpful since the Index 
does not always come to the reader’s aid. 
However, some patience and determination 
will be rewarded since the derived informa-
tion is likely to be found somewhere.  Unusu-
ally the list of Contents is extensive and more 
helpful than the Index but patience is needed 
again as it is not alphabetically arranged.  The 
acronym ‘VITAMIN D’ classifi cation system 
is applied throughout the text with all but 
one letter given a clear defi nition; for some 
reason I for Idiopathic is omitted. 
In a very competitive fi eld this book stands 
out as the most comprehensive compilation 
of small animal neurology currently available; 
it certainly has my recommendation.
Geoff Skerritt 
BVSc MIBiol CBiol DipECVN FRCVS (UK)
RCVS & European Specialist in 
Veterinary Neurology
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Calendar of main European National Meetings  
and other continuing education opportunities 
A list of the addresses and telephone numbers of the Secretariat or person holding information is attached. 
WSAVA & FECAVA Congresses (Red) 
Principal annual meetings (blue)
2011
2-3 April ESAVA Tallinn CE Clinical genetics and haematology English
9-10 April VÖK Wels Neurology Seminar & Workshop German
9-10 April CSAVA Hradec Kralove SA Emergency Medicine Czech, English
18-22 April ESAVS Luxembourg Radiology I English
26 April BSAVA Gloucester CE Respiratory diseases of the dog and cat: A comprehensive review English
28 April BSAVA Manchester CE Endocrinology II: Endocrine emergencies, collapse and effect on 
blood pressure
English
28-30 April NACAM Amsterdam Voorjaarsdagen Dutch, English
5 May BSAVA Belfast Northern 
Ireland
BSAVA Dispensing Course English
10 May BSAVA Gloucester CE Trauma Patients English
12 May BSAVA Gloucester CE Seizures: Managing your worst nightmare English
14-15 May VÖK Rankweil Urogenital tract Surgery Seminar German
19-21 May SVK/ASMPA Interlaken Annual Congress German, French, 
English
19-21 May ESAVS Luxembourg Ultrasonography English
20-25 May ESAVS Estoril (P) Excellence in Veterinary Therapy: Cardiology & Oncology English
24 May BSAVA Kettering CE Geriatric Cats English
24 May BSAVA Gloucester CE Too much fluid, Too low flow: Caring for the patient with heart 
disease
English
26 May BSAVA Manchester CE Interpretation of biochemical data and an introduction to 
diagnostic cytology
English
30-31 May HVMS/ Branch 
of Companion 
Animals
Thessaloniki Intensive care in the dog and cat /Continuing Education Course for 
Companion Animal Practice
Greek, English
7 June BSAVA Gloucester CE Bleeding, Anaemia and transfusion medicine English
13-17 June ESAVS Halmstad (S) Dentistry II English
14 June BSAVA Gloucester Introduction to practical cytology English
20-24 June ESAVS Berne (CH) Emergency and Critical Care II English
20 June - 1 July ESAVS Toulouse (F) Ophthalmology II English
21 June BSAVA Kettering Geriatric Dogs English
23-26 June ISFM (formerly 
ESFM)
Vienna, (A) Annual Congress Feline Opthalmology and feline respiratory disease English
28 June BSAVA Gloucester CE I'll never see a case of this… Will I? Emerging infectious diseases 
of dogs and cats
English
30 June BSAVA Manchester GIT I: Diseases of the canine and feline liver and pancreas English
4-15 July ESAVS Vienna (A) Dermatology I English
5 July BSAVA Gloucester CE Sepsis, SIRS, and support English
16-20 July ESAVS Estoril (P) Cardiology I English
18-20 July ESAVS Luxembourg Radiology II - Advanced English
18-29 July ESAVS Vienna (A) Dermatology III English
23-24 July VÖK Ried/Traunkreis 2. Cardiology-Forum German
28-30 July ESAVS Vienna (A) Rehabilitation & Physiotherapy of Small Animals I English
8-12 August ESAVS Berne (CH) Neurology III / Neurosurgery English
15-19 August ESAVS Berne (CH) Neurology IV / Neurosurgery English
17-21 August ESAVS Luxembourg Diagnostic Ultrasound I English
19-23 August ESAVS Luxembourg Cardiology II English
20-24 August ESAVS Berne (CH) Neurology I English
22-26 August ESAVS Benalmádena (E) Feline Medicine & Surgery I - Gastroenterology and Urinary Tract 
Diseases
English
24-28 August ESAVS Luxembourg Cardiology III - Introductory Echocardiography English
29 Aug. -2 Sept. ESAVS Benalmádena (E) Feline Medicine & Surgery II - Infectious Diseases English
29 Aug. – 2 Sept. ESAVS Vienna (A) Soft Tissue Surgery I English
1-3 Sept. EVDS Chalkidiki European Congress of Veterinary Dentistry English
7-10 Sept. FECAVA/TSAVA Istanbul 17th FECAVA EuroCongress
                                              
                                                 
English, Turkish
8-10 Sept. ESVD-ECVD Brussels (B) Annual Congress English 
8-10 Sept. ESAVS Bruno (CZ) Exotic Pets Medicine & Surgery English
12-16 Sept. ESAVS Luxembourg Behavioural Medicine I English
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14 Sept. BSAVA Gloucester CE Diabetes English
15-17 Sept. ESAVS Giessen (D) Surgery / Lasersurgery in Veterinary Medicine English
16-18 Sept. VÖK Salzburg 26th Annual Congress German, English
19-23 Sept. ESAVS Milan (I) Small Animal Reproduction III English
22-24 Sept.                         ESVN-ECVN Trier (D) 24th Annual Congress (“Neurogenetics”) English
27 Sept. BSAVA Gloucester CE A practical guide to oncology: No more lumps in your throat Part I English
29 Sept. BSAVA Manchester GIT II: Oesophagus, stomach and intestines English
29 Sept. - 2 Oct. AVEPA Barcelona AVEPA/SEVC Annual Congress English, Spanish, 
French, German, 
Polish
2 October LSAPS Riga WSAVA CE Dermatology English
8-9 October VÖK Kufstein Neurology, Ophthalmology, Gastroenterology Seminar German
8-9 October CSAVA Hradec Kralove !9th Annual Congress SA Endocrinology Czech English
15-16 October VÖK Ried/Traunkreis Urogenital tract Surgery Seminar German
15-16 October          SkSAVA Nitra Annual congress - Nova Veterinaria 2011  English, Czech, 
Slovak
19- 22 October       ESVOT Lyon(F) Wetlab session in University                                     English ,French
24-28 October ESAVS Madrid (E) Cardiology IV - Advanced Echocardiography English
25 October BSAVA Gloucester CE A practical guide to oncology: No more lumps in your throat: Part II English
27 October BSAVA Manchester CE Haematology English
4-5 November HVMS/ Branch 
of Companion 
Animals
Patra Management of the acute abdomen in the dog and the cat/ 
Continuing Education Course for Companion Animal Practice
Greek, English
5-6 November VÖK Steyr Ultrasound-Basic-Seminar German
6 November LSAPS Riga WSAVA CE Dermatology English
10-11November  SSAVA Uppsala Haematology – haemostasis and inflammation                                                                                   Swedish ,English 
TBC
14-25 November ESAVS Utrecht (NL) Internal Medicine I English
19 November VÖK Krems X-Ray-Seminar German
22 November BSAVA Gloucester Medical neurology of the dog and cat: how to make sence of the 
wobbly, weak or collapsing patient
English
24 November BSAVA Manchester CE Clinical Nutrition: Let food be your first medicine English
26 November VÖK/VUW Vienna Otitis-Workshop German
2 - 4 December AFVAC Lyon Annual Congress French
3-4 December           SkSAVA Smolenice Small animal stomatology                    English, Czech, 
Slovak
9-14 December ESAVS Davos (CH) Excellence in Veterinary Therapy: Internal Medicine & Emergency Care English
Advance notice
2012 HVMS 28-29 January CE Rabbits and Rodents ESVN Annual Congress 14-15th September
HVMS March Annual Congress VÖK Salzburg 21-23 September
FECAVA /WSAVA/BSAVA Birmingham April 12-15 April WAVD 7th World Congress of Veterinary Dermatology
Voorjaarsdagen 26-28 April
2013 Voorjaarsdagen 25-27 April
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 Contact Address for Information Tel/Fax E-mail/Website
AFVAC Secretariat: 40 rue de Berri – F-75008 Paris
President: Eric Guaguère  Director: Jean François Rousselot
Tel: (33) 1 53 83 91 60 – Fax: (33) 1 53 83 91 69 www.afvac.com 
jfrousselot@afvac.com
AIVPA Secretariat: AIVPA - Medicina Viva, Via Marchesi 26D - I-43100 Parma, Italy. 
Director: Andrea Vercelli. First contact use Director.
Tel: (39) 0521-290191 – Fax: (39) 0521-291314 segreteria@aivpa.it 
www.aivpa.it  andrea.vercelli@
ambulatorioveterinario.com or 
ebaver@libero.it
AMVAC President: Dr Valentin Nicolae Lt.Av. Ion Garofeanun, r.8, district 5, Bucharest. 
Romania
office@amvac.ro
APMVEAC Director: Dr. José H. Duarte Correia/ Secretariat: Rua Américo Durão, 18D, 
1900-064 Lisboa, PORTUGAL 
Tel: +351 218 404 179 – Fax: +351 218 404 180 geral@apmveac.pt  
www.apmveac.pt
AVEPA Secretariat: Paseo San Gervasio 46-48, E7, E-08022 Barcelona Spain Tel: (34) 93 2531522 – Fax: (34) 93 4183979 www.avepa.org
BASAV Director: Dr. Boyko Georgiev, Institute of Biology and Immunology
of Reproduction, Tzarigradsko shousse 73 Sofia 1113, Bulgaria
Tel: (359) 888 272529 – Fax: (359) 2 866 44 50 boykog@netbg.com
BHSAVA Contact: Dr. Josip, Krasni - Avde Hume 6,  71000 Sarajevo – Bosnia and 
Herzegovina
Tel +387 61 133 368 – Fax 387 33 235 333 karaulaj@lol.ba
BSAVA Secretariat: Woodrow House 1 Telford Way, Waterwells Business Park 
Quedgeley, Gloucester GB-GL2 2AB
Tel: (44) 1452 726700 – Fax: (44) 1452 726701 customerservices@bsava.com
www.bsava.com
CSAVA Director: Dr. Miloš Urban, Secretariat: B. Mišurcová, Palackého 1-3, 612 42 
Brno - Královo Pole, Czech Republic
Tel: (420) 602 336 846 – Fax: (420) 311 513241 milos.u@centrum.cz
www.cavlmz.cz
CSAVS Director: Dr. Davorin Lukman, Specijalisticˇ a Veterinarska Praksa 
Trnovecka 6, 42000 Varazdin, Croatia
Tel/Fax: (385) 42 331 895 dr.lukman@vz.t.com.hr 
DSAVA Secretariat: Den Danske Dyraegeforening, Emdrupevej 28 A, DK-2100 
Østerbro. Att: Johanne Østerbye. 
Tel: (45) 38 71 08 88 – Fax: (45) 38 71 03 22 ddd@ddd.dk
ESAVA Director: Dr. Janne Orro Loomakliinik Pikk 64 Tartu Estonia 50603 Tel: (372) 7400941 – Fax: (372) 641 3110 janne@ orrokliinik.ee
FAVP Director: Dr. Oili Gylden, Paarijoentie 185, 11710 Riihimäki, Finland Tel: (358)  45 1300 530 & (358) 19 785 899 
Fax: (358) 19 414 940
oili.gylden@gmail.com
GSAVA Secretariat: Dr. Birgit Leopold-Temmler, Gneisenaustr. 10, D- 30175 Hannover Tel: (49)511-85 80 60 or 99 – Fax: (49)511-85 80 45 info@tierpraxis.de
HSAVA Director: Ferenc Biró, Isvan u. 2 Budapest H-1078 Tel: (36) 305950750
Mobile: (36)302003445
biro.feri@freemail.hu   
HVMS Director of HVMS/ Branch of Companion Animals: Dr. Katerina Loukaki, 
Protopapa 29, Helioupolis, GR- 163 43 Athens
Secreteriat of HVMS/ Branch of Companion Animals: Maria Zafiropoulou- 
HVMS – P.O.Box 3546- Central Post Office, 102 10 Athens
Tel/Fax: (30) 2109932295
Tel.: +30 210 8642284, 8645744
Fax: +30 210 8645744
loukaki1@otenet.gr
hvms@hol.gr
LAK DIirector :Dr. Katia Di Nicolo, Médecin Véterinaire, 36 rue des Redoutes,
L-6476 Echternach
Tel: (352) 691711795 katiadinicolo@gmx.net
LSAPS Director: Dr. Linda Jakušenoka, Meža iela 4 – 76, Tukums, LV-3101
President: Dr. Lita Konopore, Dïka iela 4 – 1, Rïga, LV–1004 
Tel: (371) 26575228 – Fax: (371) 63115801 lindaj@inbox.lu 
LSAVA Director: Dr. Vytautas Macijauskas, Tilzes 18, LT-47181 Kaunas
President: Dr. Saulius Laurusevicius, Tilzes 18,  LT-47181 Kaunas
Tel: (370) 698 89133 – Fax: (370) 37 363490
Tel: (370) 698 45876 – Fax: (370) 37 363490
v.macijauskas@lva.lt
sac@lva.lt
MASAP President: Dr Predrag Stojovic Ul.Ilije Plamenca lamela 103 bb, 
(Montvet), 81000 Podgorica, Montenegro
Tel: 00382 69 014 726 – Fax: 00382 81 662 584 montvet@t-com.me
MSAVA Director: Pero Bozinovski, Vetkoll, str. 29 Noemvri, 4-G, 1000 Skopje, R Fyrom Tel: (389) 2 3110 268 – Fax: (389) 2 3110 268 vetkoll@mail.com
pero.bozinovski@gmail.com
MVA Director: Dr. C.L. Vella, Blue Cross Veterinary Clinic Msida Road, Birkirkera, 
Malta
Tel: (356) 79 22 53 63 – Fax: (356) 21 49 21 74 carmellinovella@onvol.net
NACAM Secretariat: NACAM, KNMvD, PO box 421, 3990 GE, Houten,  
The Netherlands
Tel : (31) 30 63 48 900 – Fax: (31) 30 63 48 909 moniquemegens.ggg@knmvd.nl
www.gggknmvd.nl
NSAVA Secretariat: SVF v/Dr. Ellef Blakstad, PO Box 6781 St. Olavs Plass N-0130 Oslo Tel: (47) 22 994600 – Fax: (47) 22 994601 Ellef.blakstad@vetnett.no
PSAVA Director: Dr.Roman Aleksiewicz, Secretariat PSAVA 20-934, Lublin Tel: (81) 44 56 158 www.pslwmz.org.pl
PVA Director: Dr. Yiannis Stylianov, PO Box 5284, 1308 Nicosia Cyprus Tel: (357)99603 499 drstylianou@cytanet.com.cy
RSAVA Contact: Dr. A. Tkachov-Kuzmin, V-Kojinoi, 23 – 121096 Moscow, Russia Tel/Fax: (7) 095 921 6376 movet01@mail.ru
SAVAB Dr Alexandre Bongartz, Rue des Frères,Grisleins 11, B-1400, Nivelles, Belgium Tel: (32) 475 45 27 91 alexandrebongartz@yahoo.fr 
SkSAVA Director: Dr. Igor Krampl, Sibirska 41, 83102 Bratislava, Slovak republic Tel: (421) 905 511971 info@savlmz.org
www.savlmz.org
SASAP Director: Denis Novak, Veselina Maslese 55, 11 000 Belgrade, Serbia Tel/fax: (381) 11 2851 923 – (381) 11 382 17 12 d.novak@sbb.rs
www.sasap.org.rs
SSAVA Director: Dr. Alexandra Vilén, Regiondjursjukhuset i Helsingborg,
Bergavägen 3, Box 22097, S-250 23 Helsingborg, Sweden
Tel: (46) 421 68 000 – Fax: (46) 421 68 066 alexandra@vilen.se 
SVK/ASMPA Director: Dr. Kathy Brunner, Tramstrasse 34 ,CH- 4142 Munchenstein Tel: (41) 61 701 40 40 – Fax: (41) 61 701 44 58 kubrunner@bluewin.ch
SZVMZ Director: Dr. Zorko Bojan, Veterinary Faculty, Gerbiceva 60, SLO-1000 
Ljubljana, Slovenija 
Tel: (386) 14779277 – Fax: (386) 647007111 Bojan.zorko@vf.uni-lj.si
TSAVA President: Erkut Goren, Vali Konagi Caddesi Akkavak Sokak. No. 11/3 
Nisantasi, Istanbul, Turkey
Tel: +90 212 351 71 41 – Fax: + 90 212 352 69 73 tsava.org@gmail.com
www.tsava.org
USAVA Director: Dr. Vladimir Charkin, 8 Filatova str., Apartement 24, Odessa 65000, 
Ukraine 
Tel.: (380) 503369810 - Fax: (380) 482 606726 v.charkin.hotmail.com or usava 
@ukr.net www.usava.org.va
VICAS Director: Dr. Peter A. Murphy, Summerhill Veterinary Hospital, Wexford, Co. 
Wexford Ireland 
Tel: (353) 5391 43185 – Fax: (353) 5391 43185 
by request
hq@vetireland.ie
drpamurphy@eircom.net
www.veterinaryireland.ie
VÖK Director: Dr. Silvia Leugner, Schönbrunnerstraße 291/1/1/3, A-1120 Wien Tel. (43) 664/8212318 or (43) 1 8791669 - 18 
or (43) 1 8132983 - Fax (43) 1 8791669 - 7033
silvia.leugner@royal-canin.at
office@voek.at www.voek.at
Associate members
ESAVS Contact: ESAVS Office Birkenfeld, Schadtengasse 2, D-55765 Birkenfeld Tel: (49) 6782 2329 – Fax: (49) 6782 4314 ewelina.skrzypecka
@esavs.org or info@esavs.org
www.esavs.org
ECVD Contact: Dr. Dominique Héripret, Clinique Vétérinaire Frégis 43, avenue 
Aristide-Briand F-94110 Arcueil 
Tel: (33) 149 85 83 00 – Fax: (33) 149 85 83 01 dheripret@fregis.com 
www.ecvd.org
ECVS Contact: Executive Secretary – ECVS Office Vetsuisse Faculty University Zürich 
Winterthurerstrasse 260, CH-8057 Zürich
Tel: (41) 44 635 84 08 – Fax: (41) 44 313 03 84 ecvs@vetclinics.uzh.ch
www.ecvs.org
ESFM Contact: Claire Bessant, Taeselbury, High Street, Tisbury, Wiltshire, GB - SP3 
6LD, UK
Tel: (44) 1747 871872 - Fax: (44) 1747 871873 claire@fabcats.org or 
esfm@fabcats.org
ESVC Contact: Dr.Nicole Van Israël, Rue Winamplanche 752, 
B-4910 ,Theux, Belgium
Tel: +32-(0)87-475813 – Fax + 32-(0)87-776994 nicolevanisrael@acapulco-vet.be
www.acapulco-vet
ESVCE Contact: Dr. Sarah Heath, 10 Rushton, Upton, Chester GB-CH2 1RE Tel: (44) 1244 377365 – Fax: (44) 1244 399288 heath@brvp.co.uk or 
admin@brvp.co.uk
ESVD Contact Luc Beco  Cabinet Vétérinaire, Avenue Reine Astrid, 104  4900 Spa 
- Belgique
Tel: (32) 87 774722 Mobile: (32).495.797815 
Fax: (32).87.774512
President@esvd.org 
Luc.beco@skynet.be
ESVIM
ECVIM-CA
Contact : Dominique Peeters dpeeters@ulg.ac.be
www.ecvimcongress.org 
congress@ecvim-ca.org
ESVN Contact: Dr. Jacques Penderis, School of Veterinary Medicine, University of 
Glasgow, Bearsden, Glasgow, GB- G61 1QH
Tel: (44 )141 330 5738 - Fax: (44) 141 330 3663 Jaques.penderis@glasgow.ac.uk
www.esvn.org
ESVOT Contact: Dr. Aldo Vezzoni, via Massarotti 60/A, I-26100 Cremona Tel: (39) 0 372 23451 - Fax: (39) 0 372 20074 www.esvot.org
EVDS President: Jerzy Gawor, UL. Chlopska 2A 30 - 806 Krakow, Poland Tel: (48) 12 6588 365 president@evds.org
EVSSAR Contact/President: Angelika von Heimendahl, Veterinary Reproduction Service, 
27 High St, Longastanton, Cambridge, CB24 3BP, UK
Tel: (44) 7976224648 vetrepro@yahoo.co.uk
ISFM Contact: Amanda Dennant, ISFM, Taeselbury, High Street, Tisbury, Wiltshire, 
GB - SP3 6LD, UK
Tel: (44) 1747 871872 - Fax: (44) 1747 871873 conferences@isfm.net
amanda@isfm.net
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